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ABSTRACT 
 
Select Nutrients, Secreted Phosphoprotein 1 and Insulin-Like Growth Factor 2: Effects 
on Trophectoderm of Ovine Conceptuses. (May 2010) 
Jin Young Kim, B.S., Dankook University; 
M.S., Seoul National University 
Co-Chairs of Advisory Committee:  Dr. Fuller W. Bazer 
                                                              Dr. Thomas E. Spencer 
 
Histotroph, secretions from luminal (LE), superficial glandular (sGE) and 
glandular (GE) epithelia and molecules selectively transported into the uterine lumen, 
are essential for peri-implantation ovine conceptus development and maternal 
recognition of pregnancy.  Among them, several components of histotroph including 
nutrients, cell matrix proteins and growth factors may activate mTOR (mammalian 
target of rapamycin; also known as FRAP1) to stimulate hypertrophy, hyperplasia, 
and/or migration of conceptus trophectoderm cells, as well as expression of IFNT for 
pregnancy recognition and critical proteins for conceptus development.  Therefore, 
studies were conducted to examine effects of select nutrients (arginine, leucine, 
glutamine and glucose), IGF2 and SPP1 on mTOR signal transduction pathways and 
determine their biological effects on  proliferation, migration and/or attachment of ovine 
trophectoderm (oTr) cells and conceptuses (embryo and it extra-embryonic membranes).   
The first study defined the expression of IGF2, RPS6K, phosphorylated AKT, 
RPS6K, P38 and ERK1/2 MAPK by the uterus and conceptus during the peri-
implantation period.  In addition, effects of IGF2 on the PI3K signaling pathway were 
evaluated using  oTr cells  isolated from Day 15 conceptuses.  IGF2 was  most abundant 
in compact stroma of endometrial caruncles and also present in all cells of the conceptus, 
but particularly abundant in the endoderm and yolk sac.  Phosphorylated AKT1, RPS6K, 
P38 and ERK1/2 proteins were abundant in nuclei of endometrial LE  and conceptus 
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trophectoderm.   IGF2 activated multiple cell signaling pathways including 
PDK/AKT/mTOR/RPS6K and MAPKs that are  critical to survival, growth and 
migration of the ovine trophoblast cells.   
The second study demonstrated the multifunctional effects of secreted 
phosphoprotein 1 (SPP1) on oTr  cells including  cell signaling transduction, migration, 
and adhesion.  Novel results of this study indicated that SPP1 binds αvβ3 and α5β1 
integrins to activate PI3K/mTOR/RPS6K, MAPK as well as crosstalk between mTOR 
and MAPK pathways that are essential for expansion and elongation of conceptuses and 
attachment of trophectoderm to uterine LE during implantation. 
The third study identified effects of arginine (Arg), leucine (Leu), glutamine 
(Gln) and glucose on oTr  cells.  Arg, Leu and glucose, but not Gln, activated PI3K-
AKT1 and mTOR-RPS6K-RPS6 signaling pathways.  Arg, Leu and glucose increased 
abundance of p-RPS6K in nuclei and p-RPS6 in cytoplasm  of oTr cells.  In addition, 
results of this study demonstrated that Arg and Leu are remarkably stimulatory to  cell 
proliferation and migration.   
The fourth study determined effects of Arg on signal transduction pathways and 
oTr cell proliferation, as well as inhibition of oTr cell proliferation by L-NAME (an 
inhibitor of NOS) or Nor-NOHA (an inhibitor of arginase) on oTr cells.  Arg increased 
p-mTOR, RPS6K and 4EBP1 protein and also increased protein synthesis and reduced 
protein degradation in oTr cells.  Both NO and polyamines enhanced cell proliferation in 
a dose-dependent manner.  The effects of Arg were partially inhibited by both L-NAME 
and Nor-NOHA.  These results indicate that Arg enhances production of polyamines and 
NO and activates the mTOR-FRAP1-RPS6K-RPS6 signaling pathway to stimulate 
proliferation of oTr.   
The fifth study identified differential effects of Arg, Leu, Gln and glucose on 
gene expression and protein translation in explants cultures of ovine  conceptuses.  
Expression of  mRNAs was not affected by treatments with the select nutrients; however, 
Arg, Leu, Gln and glucose increased abundance of total and phosphorylated forms of 
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mTOR, RPS6K, 4E-BP1 and RPS6.  Arg, Leu, Gln and glucose also increased the 
amounts of NOS and ODC1, but only Arg stimulated a  significant  increase in 
abundance of IFNT.  
Collectively, these studies indicated that IGF2, SPP1 and select nutrients  
activate mTOR cell-signaling pathways that converge on AKT1 and that are likely  
critical to  mechanism(s) responsible for survival, elongation an development of 
conceptuses.   A more complete understanding of this mechanism will be important to 
development of strategies to reduce  early embryonic  losses in  ruminants and and in 
other species including humans.   
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CHAPTER I 
INTRODUCTION 
 
Establishment of pregnancy requires  complex interactions and communication 
between the maternal endometrium and the developing conceptus (embryo/fetus and 
associated extraembryonic membranes).  During the peri-implantation period, 
development of conceptus is supported by uterine secretions, referred to as histotroph, 
which are primarily regulated by progesterone (1-3).  Histotroph is a complex mixture of 
a number of factors including ions, amino acids, sugars, growth factors, enzymes, 
adhesion proteins, cytokines, hormones, and transport proteins that are required for 
growth and development, and implantation of the conceptus (4).  Results from the uterine 
gland knockout ewe (UGKO) established that secretions of the endometrial  GE are the 
main source of histotroph and essential for peri-implantation conceptus elongation and 
survival (5, 6).  
FRAP1 (FK506 binding protein 12-rapamycin associated protein 1, also formerly 
known as mTOR) is a key component of a signaling pathway that regulates cell growth 
and development in response to amino acid levels, energy sufficiency and growth factors 
(7-9).  FRAP is a giant serine-threonine protein kinase, which forms a complex with 
scaffold protein raptor (MTORC1) or rictor (mTORC2) to regulate 70-kDa ribosomal 
protein S6 kinase 1 (RPS6K, also known as p70S6K1), and the eukaryotic translation 
initiation factor 4E binding protein 1 (eIF4E-BP1) as well as cytoskeleton reorganization. 
The best characterized cell signaling molecules downstream of MTORC1 are  RPS6K 
and eI4EBP1.  Phosphorylation of RPS6K enhances the translation of mRNA by 
activation of ribosomal proteins and translation elongation factors.  4E-BP1, which binds 
to eIF4E and represses translation initiation, is  relieved of repressive effects following 
phosphorylation by mTOR.  The mTORC2 has an independent, rapamycin-resistant 
function which is implicated in the control of actin cytoskeleton dynamics through 
activated AKT or Rho cell signaling (10).   
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Disruption of the FRAP1 gene leads to early post-implantation lethality due to 
impaired cell proliferation and hypertrophy in both the inner cell mass and trophoblast 
(11, 12).  In addition, ablation of Raptor, mLST8 (13), Rictor (13, 14), and Mapkap1 (15) 
genes results in disfunction of mTORC1 and mTORC2, respectively with fetal lethality 
occuring at different stages of development.  These studies suggest that both  FRAP1 
complexes are required for embryonic and trophoblast development. 
Components in uterine secretions, including amino acids and glucose, may 
regulate FRAP1 activity in conceptus development.  In mouse embryos, leucine (Leu), 
arginine (Arg) and glutamine (Gln) uptake is increased (16) at a the time of implantation 
and other hormones may regulate trophectoderm differentiation through a classical 
FRAP1-dependent pathway (17, 18).  In the absence of amino acids, growth factor 
signals have little or no impact on mTORC1 signaling (17) indicating the significance of 
amino acids as  regulators of FRAP1.  Glucose itself and glucose metabolites may 
regulate the activity of FRAP1 via insulin and insulin-initiated signaling (19, 20) or via 
an insulin-independent pathway to regulate proliferation of trophectoderm cells (21).  
Further, secreted phosphoprotein 1 (SPP1) is the secreted ECM protein in histotroph that  
may activate the mTORC2 complex through signaling that converges with  nutrient-
activated signaling pathways to increase trophoblast cell migration. 
Collectively, available results  established that the FRAP1 is  important in 
conceptus development through effects on translation of mRNAs for proteins required for 
growth,  proliferation and differentiation of the trophoblast (22) as well as mobility of 
cells for adhesion and attachment which is required for synepitheliolchorial placentation.  
However, the mechanism whereby  FRAP1 activity is regulated in ovine conceptuses and 
uteri  remains poorly understood.  Therefore, the present studies were conducted to 
identify molecular mechanisms and biological functions of FRAP1  with respect to 
responses of ovine trophoblast  to  nutrients (amino acids and glucose), a growth factor 
(IGF2) and an extra cellular matrix protein (SPP1), each of which may be critical for 
conceptus growth and development in sheep. 
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CHAPTER II 
LITERATURE REVIEW 
 
Conceptus Development in Sheep 
In sheep and other ruminants, implantation is classified as synepitheliochorial due to 
variations in the length of the different phases of implantation and the degree of 
endometrial invasion by the trophoblast (23-25).  Developmental events of the pre-
implantation conceptus are achieved in four steps including cleavage, compaction, 
shedding of the zona pellucida and rapid elongation.  In response to a surge of 
Luteinizing Hormone from the anterior pituitary, ovulation of the oocyte occurs 
approximately 24-30 h after onset of estrus (26).  The unfertilized ovum enters the 
oviduct and is fertilized by sperm at the ampullary-isthmic junction.  Following 
fertilization, the zygote (27) surrounded by a mucopolysaccharide coat, the zona 
pellucida, travels through the isthmus of the oviduct and undergoes multiple mitotic 
divisions (28-30).  During this period, the first cleavage to the 2-cell stage occurs 
approximately 39 to 52 h post-breeding, the second cleavage to the 4-cell stage at 52 to 
75 h and the third cleavage to the 8-cell stage at 75 h or 3 days post-breeding (29).  
Between Days 4 and 5, the embryo undergoes compaction and it becomes difficult to 
count individual blastomeres  (termed the  morula stage) and it enters the uterine lumen 
(Fig. 2.1).  There are two distinct cell populations known as inner cell mass which gives 
rise to the fetus and trophoblast that gives rise to  the  placenta.  When the morula  is 
formed, inner cells of the morula develop gap junctions between adjacent cells that 
increase intercellular communication and coordination.  The outer cells of morula begin 
to be compacted by forming cell-cell adhesions known as tight junction that  alter their 
polarity and permeability, resulting in accumulation of a fluid in a central cavity called 
the  blastocoele (27-32)  The blastocoele is surrounded by trophoblast cells while the 
inner cell mass is localized to a single pole of the blastocyst.  At this time, the embryo is 
called a blastocyst that contains approximately 3000 blastomeres and is 150 to 200 μm in 
diameter (28, 32).  As the blastocyst continues to grow by mitotic divisions, fluid fills  
the blastocoele and increases the volume and pressure, resulting in stretching of the zona  
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Fig. 2.1.  Early pregnancy events in sheep.  The embryo enters the uterus on Day 4 after 
mating (Day 0 = estrus/mating) at the morula stage of development and then develops 
into a blastocyst on Day 6.  Between Days 8 and 9, the blastocyst emerges from  the zona 
pellucida as  lysis occurs in response to enzymes such as uterine and/or embryonic 
proteases.  After Day 10, the blastocyst elongates into a tubular and then into a 
filamentous conceptus, and then appears to be immobilized in the uterine lumen 
becoming closely associated with the endometrial luminal epithelium (LE) followed by 
unstable adhesion.  Between Days 16 and 22, the trophoblast begins to adhere firmly to 
the LE by interdigitation between uterine epithelial microvilli and projections of the 
trophectoderm cells, and/or penetration into the superficial duct of the uterine glands 
(sGE) by papillae of the trophoblast.  During this time, the trophoblast giant cells migrate, 
appose, and fuse to the apical surface of the endometrial LE to form syncytial plaques.  
Eventually, as a part of synepitheliochorial placentation in sheep, the syncytial plaques 
cover the caruncular surface and aid in formation of the placentome which are structures 
formed by fusion of placental cotyledons and endometrial caruncles.  Adapted from 
Spencer et al., 2007 and originally drawn by Dr. Greg A. Johnson. 
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pellucida occurs in response to proteolytic enzymes from the trophectoderm, leaving the 
blastocyst surrounded by monolayer of trophoblast cells and establishment of an internal 
layer of endodermal cells, the extra-embryonic endoderm, separated by a basement 
membrane (28, 30-33). 
 Once the zona pellucida is shed, the blastocyst continues to expand and undergo a 
morphological transition from a spherical to tubular conceptus (embryo and its associated 
extra-embryonic membranes) on Day 12 measuring 11 mm and then becomes an elongated 
filamentous conceptus of about 100 mm by Day 14 and 150 to 190 mm on Day 15 while 
the width remains approximately 1 to 1.5 mm throughout the period of elongation  (23, 28-
30, 32, 33).  In sheep, embryonic development to the morula and blastocyst stage is not 
entirely dependent on the uterus (34, 35).  However, blastocysts or trophoblastic vesicles, 
derived from Day 12 conceptuses survive, but are unable to undergo elongation in vitro.  
When these trophoblastic vesicles are transferred into the uterus the trophoblast elongates and 
produces interferon tau (IFNT), the pregnancy recognition signal in ruminants (36-39).  This 
evidence indicates  that ovine blastocyst elongation is a uterine dependent event and may be 
species-specific, because in rodents, trophectoderm growth  requires  the presence of the 
inner-cell mass (37) (see Fig. 2.1).  
 
IFNT During the Peri-Implantation Period in Sheep 
In ruminants, elongation of the blastocyst results in production of  IFNT which is 
the pregnancy recognition hormone (38-40) that acts in paracrine manner on the uterine 
endometrial epithelia to prevent development of the luteolytic mechanism, thereby 
maintaining a functional ovarian corpus luteum (CL) for continued production of 
progesterone (P4) (41-44).  This antiluteolytic effect of IFNT is required for successful 
establishment of pregnancy and development of the conceptus. 
During the peri-implantation period, IFNT is synthesized and secreted by the 
mononuclear trophectodermal cells of conceptus between Days 10 and 21-25 (maximally 
on Days 13-16) (39, 40, 45, 46)  Maximal secretion of IFNT by the trophoblast is directly 
related to the stage of development of the blastocyst or morphological transition of the 
conceptus from spherical to filamentous forms (45, 47).  
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As the pregnancy recognition signal molecule, IFNT acts directly on the 
endometrial LE and sGE to suppress transcription of ESR1 which then prevents estrogen-
induced expression of the oxytocin receptor (OXTR) gene (44, 48), thereby inhibiting 
oxytocin-induced pulsatile release of prostaglandin F2α (PGF) from the uterine epithelium 
(Fig. 2.2).  During the normal estrous cycle, expression of the progesterone receptor 
(PGR)  decreases in LE and shallow GE while expression of estrogen receptor alpha 
(ESR1)  increases after about  Day 13 and then estradiol (E2) induces OXTR expression 
from  Days  14 to 16 (49, 50), thereby allowing oxytocin from the posterior pituitary 
and/or CL to induce release of luteolytic pulses of PGF on Days 15 to 16 (51). 
In contrast, during early pregnancy, IFNT from elongating conceptus suppresses 
ESR1 expression which prevents E2-induced OXTR expression (52-56).  Collectively, 
these antiluteolytic actions of IFNT prevents increases in epithelial ESR1, PGR, and 
OXTR gene expression, which are all E2 responsive, by directly inhibiting transcription 
of the ESR1 gene, thus maintaining secretion of P4 by the CL (48, 57, 58).  In addition to 
its anti-luteolytic effects, IFNT also induces or enhances the expression of a number of 
genes within the endometrium that are hypothesized to support establishment of apical 
interactions between trophoblast and epithelial cells during early pregnancy (41, 58-60).  A 
subpopulation of mononuclear trophoblast cells become binucleated between Days 14 
and 16 and begin to migrate and differentiate to form  syncytia  with uterine LE, resulting 
in loss of endometrial LE (25).  Giant binucleate trophoblast and multinucleated 
syncytiotrophoblast cells also alter endometrial gene expression by secretion of placental 
hormones such as placental lactogen (CSH1) and pregnancy associated glycoproteins 
(PAG) (25, 61-63) (see Fig. 2.2).  
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Fig. 2.2.  Schematic illustrating current working hypothesis on IFNT signaling in the 
ovine endometrial stroma and glandular epithelium.  During the peri-implantation period, 
ovine IFNT is synthesized and secreted by the mononuclear trophectodermal cells 
between Days 10 and 21-25 (maximally on Days 14-16) and  acts directly on endometrial 
LE and sGE to suppress transcription of ESR1 and OXTR genes, thereby preventing 
production of luteolytic pulses of PGF.  During the estrous cycle, ESR1 expression 
increases and PGR expression decreases on Days 11 to 13 and then E2 induces OXTR 
expression on Days 13 to 14, thereby allowing oxytocin from the posterior pituitary 
and/or CL to induce release of luteolytic pulses of PGF on Days 15 to 16.  In contrast, 
during early pregnancy, secreted IFNT from fully elongated conceptus silences ESR1 
expression which prevents E2-induced OXTR expression.  However, IFNT does not 
stabilize PGR expression in endometrial epithelia during pregnancy.  Adapted from 
Spencer et al., 2007. 
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The Stage of Implantation of Concepuses 
Ruminant (sheep, cattle, and goats) and pig conceptuses do not invade into the 
maternal endometrium, but superficially attach to the endometrium LE.  After attachment, 
placentomes form by interdigitation between maternal caruncles and placental cotyledons, 
which allow transport of hematotrophic nutrition via  placentomes in ruminants.  The stages 
of implantation in ruminant species include: 1), shedding of the zona pellucid; 2) 
precontact and blastocyst orientation; 3) apposition; 4) adhesion; and 5) endometrial 
fusion which differs markedly from  implantation schemes in species with  invasive 
implantion  such as primates and rodents (Fig 2.3) (23, 24, 64).  During the period of 
conceptus elongation, apposition of the conceptus trophectoderm and endometrial LE is 
initiated on Day 14 followed by attachment and interdigitation of trophectoderm cells and 
microvilli of the LE (24, 64).  During attachment, this interdigitation ensures firm adhesion 
of the fetal maternal interface in both caruncular and intercaruncular areas on Day 16 which 
makes it impossible to recover the conceptus intact from the uterine lumen via surgical 
flushing by Day 18 of pregnancy.  During this stage in sheep, trophoblast giant binucleate 
cells begin to fuse apically with the endometrial LE to form syncytia, thereby assimilating 
and replacing the endometrial LE (65) (see Fig. 2.3). 
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Fig. 2.3.  The phases of blastocyst implantation in sheep.  Shedding of the zona pellucida 
(Phase1): The embryo enters the uterus on Day 4. The blastocyst is formed on Day 6 and 
the zona pellucida is shed on Day 8 or 9 due to blastocyst growth and uterine and/or 
embryonic proteases. After Day 10, the blastocyst elongates and develops into a tubular 
and then into a filamentous conceptus. Precontact and blastocyst orientation (Phase 2): 
Between Days 9 and 14, there is no definitive cellular contact between the conceptus 
trophectoderm and the endometrial epithelium, but the blastocyst appears to be positioned 
and immobilized in the uterus. During this time, elongation of the blastocyst plays an 
important role in developmentally regulated production of IFNT in sheep. Apposition 
(Phase 3): The conceptus trophectoderm associates closely with the endometrial LE 
followed by unstable adhesion. In ruminants, the trophoblast develops finger-like villi or 
papillae and thereby penetrates into the superficial ducts of the uterine glands. This event 
has been hypothesized to anchor the peri-attachment conceptus and allow it to absorb 
histotroph from uterine glands. Adhesion (Phase 4): On Day 16, the trophoblast begins to 
adhere firmly to the endometrial LE. The interdigitation of the trophectoderm and 
endometrial LE occurs in both the caruncular and intercaruncular areas of the 
endometrium. During this time, the mononuclear trophectoderm cells differentiate into 
trophoblast giant binucleate cells. Adapted from Spencer et al., 2007 and originally 
drawn by Dr. Greg A. Johnson. 
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The Requirement for Histotroph for Conceptus Development in Sheep 
During early pregnancy, interactions and communication between conceptus and 
various endometrial cells, especially LE, GE, and stroma, are essential to coordinate 
conceptus development, uterine angiogenesis, maternal recognition of pregnancy, and 
transport of amino acids and glucose into the uterine lumen (1, 63, 66).  To support these 
key events of pregnancy, mammalian uterine glands produce and secrete complex array of 
molecules referred to as histotroph.  Histotroph include growth factors, ions, amino acids, 
mitogens, nutrient transport proteins, hormones, enzymes, proteases, protease inhibitors, 
glucose, cytokines, lymphokines, and many other substances (1, 3, 67-69).  The function 
of these secretions may differ depending upon the type of epithelium from which they  
originate.  Secretions from the LE appear to assist in implantation, while those from GE 
may aid in development and nutrition of post-implantation conceptuses (3, 69, 70).  The 
importance of these secretions has been demonstrated to be essential in both primate and 
subprimate species as regulators of conceptus development and survival, pregnancy 
recognition, and implantation/placentation (5, 6, 32, 71, 72).  
Compared to events in domestic livestock, the period of pre-implantation embryonic 
development is extremely short in rodents.  Although the pre-implantation period is short, 
evidence from studies of  mice in which genes have been knocked out identified  several 
factors in  histotroph, including leukemia inhibitory factor (73) and calcitonin, that are 
only secreted by the uterine glands and are required for successful establishment of uterine 
receptivity and  implantation of blastocysts (74, 75).  The prolonged nature of pre-
implantation conceptus development in domesticated species such as the pig, cow, horse, and 
sheep suggests that endometrial support via histotroph is particularly critical in these species. 
Studies of the uterine gland knockout ewe (UGKO) revealed an essential role for 
secretions from uterine glands for regulation of luteolysis during normal estrous cycles, 
early conceptus development and initiation of pregnancy recognition signaling (5, 6, 76).  
The UGKO ewe model is produced by the administration of a synthetic, non-
metabolizable progestin to neonatal ewe lambs during the critical period of endometrial 
gland morphogenesis from birth to postnatal Day 56 (77). This early exposure to  a 
progestin permanently ablates development of GE without apparent defects in 
development of the myometrium or other Müllerian duct-derived structures in the female 
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reproductive tract or function of the hypothalamic-pituitary-ovarian axis (77, 78).  The 
adult UGKO ewes are unable to experience normal estrous cycles or to support early 
embryonic development for blastocyst elongation due to the absence of endometrial 
glands and a markedly reduced uterine LE surface area.  Transfer of hatched blastocysts 
from normal synchronous ewes into the uteri of UGKO recipient ewes also failed to 
ameliorate the pregnancy defect (6).  Further, blastocysts can be found in the uterine 
flushings of bred UGKO ewes on Day 9 of pregnancy suggesting that early conceptus 
development does not require uterine secretions (5, 6).  In UGKO ewes, blastocysts hatch 
from the zona pellucida around Day 8 as expected; however,  there is failure of blastocyst 
elongation and ultimately the conceptuses die or they are  severely growth-retarded by 
Day 14 of pregnancy.   
 In UGKO ewes, molecular components in uteri that were not altered included  
steroid hormone receptors, the anti-adhesive factor mucin 1 (MUC1), integrins on the 
surface of LE, and  IFNT responsiveness of the endometrium (5, 76).  However, uterine 
flushings recovered from UGKO ewes on Day 14 contained either very low or 
undetectable amounts of galectin-15 (LGALS15), glycosylated cell adhesion molecule 1 
(GLYCAM1), and secreted phosphoprotein 1 (SPP1, also known as osteopontin), which 
are adhesion molecules that regulate apposition and attachment of trophectoderm to the 
LE (5, 79, 80).  These results indicated that failure of blastocysts to elongate was due to a 
lack of uterine glands and their secretions which are essential for peri-implantation 
conceptus growth and survival.  Further, unidentified components of histotroph are 
absent or reduced in flushings from UGKO ewes and may affect the fertility of these 
ewes.  Similarly, neonatal exposure to a progestin alters uterine morphology and luminal 
protein content resulting in a reduction or failure in successful establishment and/or 
maintenance of pregnancy in adult UGKO  cows (81). 
 Indeed, uterine histotroph is a complex fluid which makes it complicated to 
analyze specific components as to whether they originate from the endometrium or the 
conceptus.  Two-dimensional gel electrophoresis identified a number of proteins in 
uterine histotroph in a number of species including ewes and cows (45, 82-87); however, 
establishment of their identity and function has been limited.  Recently, quantitative 
proteomic approaches and mass spectrometry enabled the identification of proteins in 
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uterine histotroph or components of the endometrial proteome, but these techniques have 
yielded limited findings despite the improved protein sequence databases.  Among them, 
Berendt et al. (88) reported an increase in four endometrial proteins associated with 
conceptus–maternal interactions in cattle including Rho GDP dissociation inhibitor beta, 
20 alpha-hydroxysteroid dehydrogenase, soluble NADP+-dependent isocitrate 
dehydrogenase 1, and acyl-CoA-binding protein.  Uterine histotroph also contains lipids, 
amino acids and sugars.  In pigs, non-protein components of histotroph include amino 
acids, lipids, and sugars that undergo distinct changes in  in the uterine lumen as well as 
fetal fluids as pregnancy progresses (89-91).  Glucose and amino acids have important 
roles for pre-implantation embryonic development (92-95).  Both amino acids and their 
transporters have been implicated in blastocyst implantation and differentiation of the 
trophoblast through modulation of nutrient-sensing pathways (22, 95-97).   
 
Cellular and Molecular Aspects of mTOR Cell Signaling 
mTOR/FRAP1 (FK506-binding protein 12-rapamycin complex-associated protein 
1; formerly known as mTOR) is a highly conserved serine/threonine protein kinase that 
senses and responds to changes in amino acid levels and energy, as well as hormones, 
mitogens and stress (7, 9, 98, 99), and has a critical role in cell metabolism and growth.  
FRAP1 and associated proteins comprise two distinct signaling complexes, referred to as 
mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) (13, 98, 100) (see Fig. 
2.4).  The mTORC1 complex consists of RAPTOR (regulatory-associated protein of 
TOR) and LST8 (also known as G protein β subunit-like) (101-104), while mTORC2 
consists of RICTOR (rapamycin-insensitive companion of mTOR), MAPKAP1 
(mitogen-activated protein kinase-associated protein 1), and LST8 (105, 106).  The 
FRAP1-associated proteins seem to determine the specificity of the different cell 
signaling pathways (107-110) mediated by mTOR complexes, associated regulators, and 
effectors. The mTORC1 controls cell proliferation  in part by phosphorylating S6Kinase 
1 (S6K1) and the eIF-4E-binding protein 1 (4EBP1), known regulators of protein 
synthesis.  The mTORC2 regulates actin cytoskeleton organization and Akt/PKB 
phosphorylation (108), which regulates cell migration,  growth, survival, and metabolism.  
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Fig. 2.4.  The mTOR complexes include mTORC1 and mTORC2.  mTORC1 comprises 
FRAP1, LST8, and RAPTOR, and its known effectors include EIF4EBP1 and RPS6KB1. 
mTORC2 comprises FRAP1, LST8, RICTOR, and MAPKAP1, and its known effector is 
AKT. Under the control of the upstream regulators, the TSC1/TSC2 complex (which has 
GTPase-activating properties) regulates conversion between GTP and guanosine 
diphosphate (GDP) and, therefore, the activity of RHEB. RHEB-GTP activates FRAP1 in 
mTORC1 (and possibly mTORC2). Adapted from Gao et al., 2009 (111). 
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FRAP1 and associated members of the mTORC1 and mTORC2 cell signaling 
pathways are likely critical for growth and development of the conceptus, as well as 
implantation. Disruption upstream of FRAP1, such as TSC, blocks functioning of 
mTORC1 and mTORC2 and impairs cell proliferation (hyperplasia) and hypertrophy 
(hypertrophy) in the embryonic disc and in the trophoblast, resulting in post-implantation 
lethality of blastocysts (14, 15, 112).  In mice germ-line disruption of mTOR causes 
embryonic lethality at early or post-implantation stages of development (11, 12).  FRAP1 
may also affect conceptus growth by regulating translation of proteins in the uterus, 
including insulin-like growth factor 2, ornithine decarboxylase 1, and nitric oxide 
synthases (22, 113, 114).  In addition, FRAP1 promotes translation of 5’-terminal 
oligopyrimidine tract mRNAs (115) that are  critical to fetal and placental development 
(116-118), as well as development, differentiation, and motility of  trophoblast cells (22, 
96, 119).   
During pregnancy, substantial synthesis and secretion of histotroph by uterine 
glandular epithelium (GE) occurs in response to the conceptus or conceptus-derived 
pregnancy recognition signals, to provide sufficient nutrients (61, 68).  In this system, 
mTOR cell signaling is the central regulator since available  evidence indicates  that  
mTOR regulates the expression and trafficking of  glucose transporters (120-122) and 
amino acid transporters (123, 124).  Further, FRAP1 and associated proteins including 
raptor, rictor and RHEB are localized to uterine LE and GE and trophoblast cells in the 
ovine conceptus between Days 13 and  18 of pregnancy.  Therefore, the mTOR cell 
signaling complexes likely regulate conceptus development during the peri-implantation 
period, particularly in species with an epitheliochorial or synepitheliochorial type of 
placentation characterized by a rapid elongation of conceptus trophectoderm and a 
protracted period of implantation (23).   
 
Tumor suppressors (TSC) and RHEB  
Most upstream regulators of mTOR appear to function through the tumor 
suppressor Tuberous Sclerosis Complex 1 (TSC1) and Tuberous Sclerosis Complex 2 
(TSC2). Functionally, TSC1 is thought to be the regulatory component, while TSC2 is 
thought to be the catalytic component (125).  In the typical mTOR cell signaling pathway, 
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TSC1 and TSC2 form a heterodimer to inhibit mTORC1 (109), which functions as a 
glutamyl transpeptidase (GTPase)-activating protein toward RHEB to stimulate 
mTORC1 activity (110, 112). Phosphorylation of TSC2 by various upstream protein 
kinases such as AKT/PRKB and MAPK3 ablates the inhibitory effects of TSC1/TSC2 on 
mTORC1. In contrast, their functions with respect to mTORC2-mediated cell signaling 
have not been well investigated, except to demonstrate that mTORC2 phosphorylates 
AKT/PRKB-FOXO and PRKCA (13).  Results of studies in mice devoid of 
4932417H02Rik (Raptor), Gbl (Lst8) (13), 4921505C17Rik (Rictor) (13, 14), 
Mapkap1(15), and Frap1 indicate that components of mTORC1 and mTORC2 are 
required for embryonic development, although the timing of formation of these functional 
complexes may differ (13).  
 
Downstream targets of mTORC1 
Downstream of mTOR, two of the most well characterized targets are S6K1 and 
4EBP-1 (99).  As a result of tight regulation of these two proteins by mTOR, they are 
often used as functional markers of mTOR activity.  S6K1, which is phosphorylated and 
activated by mTOR, phosphorylates the ribosomal S6 protein which is a component of 
the 40S ribosomal subunit.  Activation of S6 leads to increased ribosomal biogenesis to 
recruit translational components.  Interestingly, mutational loss of the S6K1 
phosphorylation sites on S6 leads to increased global protein translation without 
increasing the percentage of ribosomes engaged in the polysomes (20).  On the other 
hand, 4EBP-1 is inactivated by mTOR phosphorylation. The 4EBP-1 in its 
hypophosphorylated form binds to and inactivates elF4E, which is responsible for nuclear 
cap binding complex (CAP)-dependent translation (9, 126).  Therefore, 
inactivation/phosphorylation of 4EBP-1 by mTOR increases CAP-dependent protein 
translation.  
 
IGF II 
Insulin-like growth factors (IGFs), including IGF-I and IGF-II, are small 
polypeptide hormones with an approximate molecular weight of 7 kDa (127).  They are 
members of the structurally related insulin/IGF super family. Mature IGF-I and IGF-II 
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peptides consist of A, B, C, and D domains. The A and B domains of IGFs are 
homologous to the A and B domains of insulin, and the C domains of IGFs share 
sequence homology to the C peptide of proinsulin which is cleaved off in mature insulin 
during prohormone processing.  IGFs contain an additional D domain, which is not found 
in insulin (128, 129).   
Both IGF-I and -II  act as endocrine, paracrine and autocrine factors in various 
cell types to stimulate proliferation, survival and differentiation.  Their effects are 
mediated by binding to Type I IGF receptor (IGF-IR), insulin receptors (IRs) and Type II 
IGF receptors (IGF-IIR), which are tetrameric receptors with two extracellular α-subunits 
containing the ligand binding domain, and two β-subunits with a tyrosine kinase domain 
(130).  Upon ligand binding, the activated receptors recruit and phosphorylate scaffold 
proteins, such as insulin receptor substrate 1 (IRS-1) and IRS-2, leading to the activation 
of several intracellular signalling pathways including the phosphatidylinositol-3 kinase 
(PI3K) and the mitogen-activated protein kinase (MAPK) pathways (131, 132).   
The IGFs are considered important regulators of pre-implantation conceptus 
development and placental development as well as normal growth (116, 117, 133-136), 
since both IGF-I and  IGFII knockout mice have birth weights that are 60%  of normal 
control mice (136, 137).  Null mice carrying mutations in both IGF-I and IGF-II die 
invariably after birth (136, 137).  Deletion of IGF-I Type 1 receptor responsible for the 
actions of both IGF-I and IGF-II causes a greater degree of fetal growth retardation than 
deletion of either IGF suggesting that both ligands signal through IGF1R to promote 
growth in the fetus (137).  In mice, IGF-II appears especially involved in the 
establishment of placental function because mice deficient in IGF-I have normal 
placental weights (137), whereas placental weights are  markedly reduced in IGF-II 
deficient mice (135).  During the preimplantation period, both IGF-I and IGF-II are 
expressed in the uterus, oviduct, ovary, and conceptus of domestic mammals, including 
cattle (138-142), sheep (116, 143-147), and pigs (148).  IGF-II is an imprinted and 
paternally expressed gene in the fetus and placenta of mice, humans, and sheep (149), 
and plays an important role in regulation of fetal-placental growth/differentiation, 
stimulation of extravillous trophoblast migration/invasion, and facilitation of nutrient 
transfer through the development of placental exchange mechanisms (135, 150-156).  In 
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mice, deletion of IGF-II in the labyrinthine trophoblast of the placenta reduced placental 
and fetal growth, and decreased passive permeability for placental exchange of nutrients 
(153).  Consequently, alteration of IGF-II expression in human trophoblast during the 
first and early second trimester causes serious complications of pregnancy such as 
increased risk of intrauterine growth restriction, premature delivery, and preeclampsia. 
(157).   
Although little is known of the roles of IGF-II in the peri-implantation ovine 
conceptus and endometrium, emerging evidence suggests that expression and differential 
actions with IGF-I, IGF-II and their receptor regulates epithelial-stroma interactions and 
endometrial gland morphogenesis to support uterine development (53, 158-160).  Further 
IGF-II has been shown to affect expression of a number of nutrient transporters in human 
and murine placentae (161).  In the IGF-II null placenta, system A amino acid 
transporters were decreased, while continuous expression of IGF-II increased amino acid 
and glucose transporters in the uterus.   Therefore, IGF-II affects growth of fetal tissues 
not only directly as a mitogen, but also indirectly through changes in the placental 
environment that are necessary for delivery of nutrients to the fetus.  
 
Secreted Phosphoprotein One (SPP1) During Pregnancy in Sheep 
General structure of SPP1 
SPP1, also known as osteopontin, is an acidic glycosylated phosphoprotein 
member of the small integrin binding ligand N-linked glycoprotein (SIBLING) family of 
proteins.  Originally described in the mineralized matrix of bovine bone (162), SPP1 has 
since been detected in numerous epithelial cells and fluids (101-104).   SPP1 contains a 
polyaspartic acid motif that can bind to hydroxyapatite and calcium ions and an RGD 
(Arg-Gly-Asp) amino acid sequence which binds to specific integrin heterodimers (163-
165).  Other characteristics of SPP1 include a hydrophobic leader sequence found in 
secreted proteins, a thrombin cleavage site and two glutamines that serve in 
transglutaminase-supported multimer formation (166).  As a monomer of approximately 
300 amino acids in length, SPP1 is subject to extensive post-translational modifications 
including phosphorylation, glycosylation and cleavage that results in various isoforms 
ranging in size from 25-75 kDa (167).  Interistingly only ovine and bovine SPP1, but not 
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that of other species, has a 22 amino acid deletion that contains a potential calcium 
binding site and substitution of KS for RS at the  thrombin cleavage site (166).   
SPP1 interacts with αvβ1, αvβ3, αvβ5, αvβ6, αvβ8, α4β1, α5β1, and α8β1 via its 
(Arg-Gly-Asp (RGD) sequence to promote cell adhesion, spreading and migration.  In 
addition to the RGD interactions, SPP1 mediates cell attachment through non-RGD 
mediated sites by its association with the α4β1 integrin for leukocyte adhesion  through 
an LDV (Leu-Asp-Val) peptide sequence (168).  There is also a cryptic adhesive 
sequence recognized by α9β1 (169).  A secondary receptor for SPP1 is CD44 which is a 
hyaluronic acid receptor that mediates  cellular responses similar to those of integrins 
including adhesion, migration, and proliferation (170, 171).  
 
Function of SPP1 in the uterus 
SPP1 affects a number of diverse processes such as bone mineralization, cancer 
metastasis, cell-mediated immune responses, inflammation, angiogenesis, and cell 
survival (164, 167).  SPP1 has also been linked to the establishment and maintenance of 
pregnancy.  As a major component of histotroph, SPP1 is recognized as the most highly 
upregulated protein during the early stages of pregnancy in  uteri of humans and other 
mammalian species, including sheep (167, 172-177).  SPP1 is capable of eliciting various 
effects throughout the body, through various proteolytic cleavage sites in the amino acid 
chain and through its integrin receptors (178).  Multiple integrin receptors for SPP1 are 
present on trophoblasts and LE of humans and domestic animals, some of which increase 
during the peri-implantation period (179-182).  Ovine and porcine trophoblast and LE 
cells show evidence of integrin receptor activation and cytoskeletal reorganization in 
response to SPP1 (181, 183).  Further, polymerized SPP1 has high tensile strength when 
simultaneously binding receptors on different cells during adhesion and matrix assembly 
(184) which is supported by high levels of focal adhesion assembly at the maternal-
conceptus interface (185).  In the SPP1 knockout mouse (Spp1-/-), there were no 
significant differences in the number of embryos carried by pregnant females, but the 
females had decreased pregnancy rates at mid-gestation and conceptuses were 
significantly smaller at all stages of gestation (186). 
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In sheep, SPP1 is synthesized and secreted during the peri-implantation period, a 
time when firm adhesion is developing between the uterine LE and conceptus (172, 187).   
SPP1 secreted by the uterine GE is progesterone regulated as administration of a PGR 
antagonist ablates SPP1 mRNA expression (188).  Among the isoforms, the 45 kDa form 
of SPP1 is more abundant in uterine flushings from pregnant than cyclic ewes (172, 189) 
and has greater binding affinity for ανβ3 integrin than the native 70 kDa form (190).    
In the process of implantation, SPP1 co-localizes with integrin ανβ3 and plays a 
role in endometrial-embryonic signaling or facilitates embryonic attachment to uterine 
LE prior to invasion/attachment (179, 188, 191).  SPP1 expression also increased in the 
caruncular component of placentomes, suggesting that in addition to progesterone, factors 
from the conceptus stimulate expression of SPP1 in uterine stroma that aid in 
vascularization at the maternal-conceptus interface (192).  In the human endometrium, 
ανβ3 integrin appeared abruptly on postovulatory Days 5 to 6 and maximal SPP1 
expression (mRNA and protein) was observed during the mid- to -late secretory phase of 
the menstrual cycle (193).  The co-localization of SPP1 with  integrins at the apical 
surface of conceptus trophoblast and endometrial LE indicates that they may stimulate 
changes in proliferation, migration, survival, adhesion and remodeling of the conceptus 
during morphological changes and adherence to the uterine LE during implantation.   
 
Amino Acids in Conceptus Development 
Arginine 
Arginine is the nitrogenous precursor for ornithine and nitric oxide (NO), a key 
signaling molecule with enormous physiological importance as it  regulates vital 
metabolic pathways (194) such as implantation, embryogenesis, and uterine quiescence 
throughout gestation (91, 195-197).  Arginine is one of the most abundant amino acids 
deposited in fetal tissue proteins and it increases in uterine fluid during the period of  
conceptus elongation (95, 198-200).  In addition, supplementation of the diet with 
arginine  increased embryonic and conceptus survival and growth rates in gilts and rats 
(201, 202).  This  evidence suggests that arginine is quantitatively important for  fetal 
growth and development during pregnancy. 
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NO, a product of L-arginine catabolism, is essential to placental growth and 
angiogenesis for increasing uterine and placental-fetal blood flows (203).  Polyamines are 
required for DNA and protein synthesis and for proliferation and differentiation of cells 
(204).  In most animals, including sheep, synthesis of arginine occurs in enterocytes of 
the small intestine, which produce citrulline (the precursor of arginine) from glutamine 
and proline (205).  However, this synthetic pathway is absent from uteri, placenta, and 
endometria of sheep (206).  Limiting  arginine or inhibiting NO synthesis resulted in 
increased fetal resorptions, intrauterine growth retardation (IUGR), increased perinatal 
mortality, and decreased number of live fetuses in pregnant rats (207).  In contrast, 
intravenous administration of arginine enhanced fetal growth in an ovine model with 
IUGR (208).  Similarly, dietary supplementation with arginine to gilts or rats during 
pregnancy increased the live-born litter weight (201, 202).  Therefore arginine has an 
important role as a  nutrient  to the fetus that  supports fetal survival and growth.  
Moreover, arginine is the critical regulator of  nutrient utilization and protein synthesis 
through FRAP1 and NO signaling pathways (22, 96, 209).  
 
Leucine 
Since leucine is particularly important for mTOR signaling, and since blastocysts 
cultured in vitro consistently accumulate leucine and not other amino acids present in  the 
culture media (96), it has been suggested that leucine uptake through transporters, such as 
sodium-dependent system SLC3A1 and sodium independent system L, stimulates mTOR 
signaling which  triggers  trophoblast motility and differentiation.  This is supported by: 
1) an increase in  Na+ in uterine secretions at the time of implantation; 2) high expression 
of SLC3A1 at the blastocyst stage of development; 3) detection of SLC3A1 transport 
activity in porcine oocytes (96, 210); and 4) the presence of SLC7A5 and SLC7A8 across 
the trophoblast brush border of the pig placenta and sheep conceptus (211, 212).  Leucine 
may also function to drive arginine transport as a counter transporter for uptake of 
arginine through the sodium-dependent system SLC3A1.  
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Glutamine 
Glutamine is the physiological precursor of both ornithine and arginine in 
mammals, including pigs, sheep and rats (205, 213)(198).  In particular, glutamine serves 
as an essential precursor for the synthesis of purine and pyrimidine nucleotides for cell 
division, amino sugars and NAD+ (nicotinamide adenine dinucleotide) (214)(199) and as 
an important energy source for rapidly dividing cells.  In sheep, the maternal to fetal flux 
of glutamine was the greatest among all amino acids, especially between Day 13 and Day 
16 pregnancy (95, 215) when conceptus growth is most rapid.  The abundance of 
glutamine in fetal fluids is consistent with its important role in fetal nitrogen and carbon 
metabolism (216), as well as in early mammalian embryogenesis (217).  Glutamate, a 
product of glutamine hydrolysis by glutaminase, binds with the N-methyl-D-aspartic acid 
receptor, resulting in an increase in the influx of calcium and its intracellular 
concentration and consequently activation of neuroral NOS (nNOS) for NO synthesis 
(218).  Recently, Nicklin and coworkers (219) described a mechanism in which  
glutamine is required to facilitates the uptake of leucine, thereby leading to mTORC1 
activation.  
 
Glucose in Conceptus Development 
Glucose, a major energy source for conceptuses (220), is delivered into the uterine 
lumen by glucose transporters (221, 222) and increases during pregnancy with associated 
conceptus elongation, especially in species with epitheliochorial and synepitheliochorial 
placentae (223).   Transport  of glucose from the maternal circulation into the uterine 
lumen is essential for pregnancy (224) as it can enhance rapid growth of conceptus 
trophectoderm by increasing cell proliferation through activation of the 
glutamine:fructose-6-phosphate amidotransferase (GFAT)-mediated MTOR signaling 
pathway (21).  In pregnant pigs, total recoverable glucose in uterine flushings is greater 
than for cyclic pigs, but only increases after Day 12 of pregnancy in association with 
conceptus elongation (223).  However, the presence and transport of glucose is related to 
a calcium spike and estrogen production by pig conceptuses that is coordinate with their 
survival and development (223).  In ovine uterine flushings, total recoverable glucose 
increases 6-fold between Days 10 and 15 of gestation, but not the estrous cycle (95).  
  
22
Transport of glucose across the cell membrane can be mediated by facilitative 
transporters (also known as GLUT) and/or sodium-dependent transporters (also known as 
SGLT) (225). Intensive studies on facilitative glucose transporters revealed that, of 13 
family members, SLC2A1 to SLC2A12 and SLC2A13 are expressed in preimplantation 
blastocysts and conceptuses in mice, humans and cattle (222, 226, 227).  Sodium-
dependent glucose transporters, such as SLC5A1 and SLC5A11, transport glucose 
against electrochemical gradients, e.g., from endometrium into the uterine lumen (228).  
In sheep, SLC2A1 and SLC5A1 mRNAs and proteins were most abundant in uterine 
LE/sGE, whereas SLC2A4 was present in stromal cells and GE. SLC5A11 mRNA was 
most abundant in endometrial GE. SLC2A1, SLC2A3 and SLC2A4, SLC5A1 and 
SLC5A11 were expressed in trophectoderm and endoderm of conceptuses.  Further, P4 
induced and IFNT stimulated expression of SLC2A1 and SLC5A11, indicating that 
facilitative and sodium-dependent glucose transporters both function in ovine uteri and 
conceptuses to transport glucose into the uterine lumen and for its uptake by the 
conceptus (94). 
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CHAPTER III 
INSULIN-LIKE GROWTH FACTOR II ACTIVATES 
PHOSPHATIDYLINOSITOL 3-KINASE-PROTOONCOGENIC PROTEIN 
KINASE 1 AND MITOGEN-ACTIVATED PROTEIN KINASE CELL 
SIGNALING PATHWAYS, AND STIMULATES MIGRATION OF OVINE 
TROPHECTODERM CELLS 
 
Introduction 
Establishement and maintenance of pregnancy in eutherian mammals, including 
sheep, require reciprocal communication via endocrine and paracrine signals from the 
ovary, conceptus (embryo/fetus and associated extraembryonic membranes), and 
endometrium to support implantation and placentation. Implantation of the conceptus is 
an important and complex developmental event of early pregnancy and is a key 
evolutionary advance associated with viviparity (4, 41). During the peri-implantation 
period in the ovine uterus, the spherical blastocyst elongates to a tubular and then a 
filamentous form, and develops into a conceptus that then attaches to the uterine luminal 
wall.  These events are supported by endometrial epithelial secretions and selective 
transport of molecules, including growth factors, cytokines, ions, glucose, and amino 
acids that are predominantly regulated by progesterone, and are required for peri-
implantation conceptus survival, elongation, and development (4, 6, 24, 41, 61, 68, 76-
78). 
IGFs I and II are single chain polypeptides that are structurally similar to 
proinsulin (127, 229). The IGFs function as endocrine and paracrine/autocrine hormones 
that stimulate proliferation and differentiation in a variety of cell types, and mediate their 
effects by binding to specific cell membrane receptors, the type I and type II IGF 
receptors (IGF-IR and IGF-IIR, respectively) (230, 231).  The IGFs are considered 
important regulators of pre-implantation conceptus development and placental 
development (116, 117, 133-136). During the preimplantation period, both IGF-I and 
IGF-II are expressed in the uterus, oviduct, ovary, and conceptus of domestic mammals, 
including cattle (138-142), sheep (116, 143-147), and pigs (148). IGF-II is an imprinted 
and paternally expressed gene in the fetus and placenta of mice, humans, and sheep (149), 
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and plays an important role in regulation of fetal-placental growth/differentiation, 
stimulation of extravillous trophoblast migration/invasion, and facilitation of nutrient 
transfer through the development of placental exchange mechanisms (135, 150-155). In 
mice, deletion of IGF-II in the labyrinthine trophoblast of the placenta reduced placental 
and fetal growth, and decreased passive permeability for placental exchange of nutrients 
(153). Furthermore, Smith et al. (157) reported that altered expression of IGF-II in 
human trophoblast during the first and early second trimester resulted in serious 
complications of pregnancy such as increased risk of intrauterine growth restriction, 
premature delivery, and preeclampsia. 
Little is known of the biological roles of IGF-II in the peri-implantation ovine 
conceptus and endometrium. However, in the neonatal ovine uterus, expression of IGF-I, 
IGF-II, and IGF-IR regulates epithelial-stroma interactions and endometrial gland 
morphogenesis, suggesting that the ovine IGF system is important to support uterine 
development (158, 159). In sheep the IGF-IR is present in the pre-implantation blastocyst 
and in the luminal epithelium (LE), glandular epithelium (GE), and to a lesser extent, the 
caruncular stroma and myometrium of the uterus (144, 159, 160, 232). Specific cell 
signaling pathways stimulated by IGF-II in other cell types include activation of: 1) 
phosphatidylinositol 3-kinase (PI3K)/protooncogenic protein kinase 1 (AKT1); 2) FK506 
binding protein 12-rapamycin associated protein 1 (FRAP1), also known as mammalian 
target of rapamycin (mTOR); 3) ribosomal protein S6 kinase (RPS6K); 4) ERK1/2 (also 
known as p42/p44 or MAPK); and 5) P38 MAPK. However, these signaling pathways 
and their regulation by IGF-II in the ovine conceptus have not been investigated. Our 
working hypothesis is that IGF-II from the endometrium and within the conceptus 
regulates trophoblast growth and differentiation via the PI3K-AKT1 and MAPK 
signaling pathways. As a first step in testing this hypothesis, the present study  was 
conducted to determine:  1) the distribution of IGF-II mRNA in ovine endometria and 
conceptuses during early pregnancy; 2) effects of IGF-II on PI3K-AKT1 and MAPK 
signaling pathways in mononuclear ovine trophectoderm (oTr) cells; and 3) effects of 
IGF-II on oTr  cell migration. 
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Materials and Methods 
Experimental design 
Animals  
Mature crossbred Suffolk ewes (Ovis aries) were observed daily for estrus in the 
presence of vasectomized rams and used in experiments after they had exhibited at least 
two estrous cycles of normal duration (16–18 d). All experimental and surgical 
procedures were in compliance with the Guide for the Care and Use of Agriculture 
Animals and approved by the Institutional Animal Care and Use Committee of Texas 
A&M University. 
 
Study 1 
Tissue collection 
At estrus (Day  0), ewes were mated to either an intact or vasectomized ram and 
then hysterectomized (n = 5 ewes per day) on either Day  10, 12, 14, or 16 of the estrous 
cycle, or Day  10, 12, 14, 16, 18, or 20 of pregnancy as described previously (62). At 
hysterectomy, the uterus was flushed with 20 ml 10mmTris buffer (pH 7.0). Pregnancy 
was confirmed on Day  10–16 after mating by the presence of a morphologically normal 
conceptus(es) in the uterine flush. It was not possible to obtain uterine flushes on either 
Day  18 or 20 of pregnancy because the conceptus is firmly adhered to the endometrial 
LE. At hysterectomy, several sections (~0.5 cm) from the midportion of each uterine horn 
ipsilateral to the corpora lutea were fixed in fresh 4% paraformaldehyde in PBS (pH 7.2). 
After 24 h, fixed tissues were changed to 70% ethanol for 24 h, dehydrated through a 
graded series of alcohol to xylene, and then embedded in Paraplast-Plus (Oxford Labware, 
St. Louis, MO). The remaining endometrium was physically dissected from myometrium, 
frozen in liquid nitrogen, and stored at -80 C for subsequent protein extraction. In 
monovulatory pregnant ewes, uterine tissue samples were marked as either contralateral 
or ipsilateral to the ovary bearing the corpora lutea, and only tissues from the ipsilateral 
uterine horn were used in subsequent analyses. 
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Cloning of partial cDNA for ovine RPS6K 
A partial cDNA for ovine RPS6K mRNA was amplified by RT-PCR using total 
RNA from Day 18 pregnant ovine endometrial tissues by specific primers based on data 
for the bovine RPS6K mRNA (GenBank accession no. AY396564; forward, 5_-ATT 
TGC CTC CCT ACC TCA CG-3_; reverse, 5_-AAT TTG ACT GGG CTG ACA GG-
3_). PCR amplification was conducted as follows for ovine RPS6K: 1) 95 C for 5 min; 2) 
95 C for 45 sec, 56.5 C for 1 min, and 72 C for 1 min for 35 cycles; and 3) 72 C for 10 
min. The partial cDNAs for RPS6K were cloned into pCRII using a T/A Cloning Kit 
(Invitrogen Corp., Carlsbad, CA), and the sequence was verified using an ABI PRISM 
Dye Terminator Cycle Sequencing Kit and ABI PRISM automated DNA sequencer 
(PerkinElmer Applied Biosystems, Foster City, CA). 
 
In situ hybridization analyses 
Location of mRNA expression in sections (5 µm) of ovine uterine endometria and 
conceptuses was determined by radioactive in situ hybridization analysis as described 
previously (70). Briefly, deparaffinized, rehydrated, and deproteinated uterine tissue 
sections were hybridized with radiolabeled antisense or sense cRNA probes generated 
from linearized ovine IGF-II (39) and RPS6K partial cDNA using in vitro transcription 
with [α-35S]uridine 5’-triphosphate. After hybridization, washing, and ribonuclease A 
digestion, slides were dipped in NTB-2 liquid photographic emulsion (Kodak, Rochester, 
NY), and exposed at 4 C for 6 days for IGF-II and 4 wk for RPS6K. Slides were 
developed in Kodak D-19 developer, counterstained with Gill’s hematoxylin (Fisher 
Scientific, Fairlawn, NJ), dehydrated through a graded series of alcohol to xylene, and 
coverslips affixed with Permount (Fisher Scientific). Images of representative fields were 
recorded under bright-field or dark-field illumination using a Nikon Eclipse 1000 
photomicroscope (Nikon Instruments Inc., Lewisville, TX) fitted with a Nikon 
DXM1200 digital camera. 
 
Immunohistochemistry 
Immunocytochemical localization of phosphorylated (p)-AKT1, p-P38 MAPK, p-
RPS6K, and p-ERK1/2 protein in ovine uteri and conceptuses was performed using 
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methods described previously (62). Rabbit antimouse phospho-AKT1 polyclonal IgG 
(Ser493/Thr308) (catalog no. 3061) at a 1:100 dilution, rabbit antihuman phospho-P38 
MAPK monoclonal IgG (catalog no. 4631) at a 1:50 dilution, and rabbit antihuman 
phospho-RPS6K polyclonal IgG (Thr421/Ser424) (catalog no. 9204) at a 1:500 dilution 
were purchased from Cell Signaling Technology, Inc. (Danvers, MA), and rabbit 
antimouse phospho-ERK1/2 monoclonal IgG (catalog no. sc-7383) at 2.0 µg/ml was 
purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Antigen retrieval was 
performed using Pronase E digestion for p-AKT1, p-ERK1/2, p-RPS6K, and the boiling 
citrate method for p-P38 MAPK localization. Negative controls included substitution of 
the primary antibody with purified rabbit IgG at the same final concentration. 
 
Study 2 
Cell culture 
Mononuclear oTr cells from Day 15 conceptuses were isolated and cultured as 
described previously (233). One cell line, referred to as oTr, was cultured in DMEM-F12 
that included 10% fetal bovine serum, 50 U penicillin 50 µg streptomycin, 0.1 mm each 
nonessential amino acids, 1 mm sodium pyruvate, 2 mm glutamine, and 0.7 µM insulin. 
When the density of cells in dishes reached about 80% confluence, they were passaged at 
a ratio of 1:3, and frozen stocks of cells were prepared at each passage. For experiments, 
monolayer cultures of oTr cells (between passages 9 and 13) were grown in culture 
medium to 80% confluence on 100-mm tissue culture plates. Cells were serum and 
insulin starved for 24 h, and then treated with recombinant human IGF-II (50 ng/ml; 
R&D Systems, Inc., Minneapolis, MN) for 0, 15, 30, 60, and 90 min. Based on 
preliminary dose-response experiments, 50 ng/ml IGF-II was the dose selected for use in 
all experiments in the present study. This design was replicated in three independent 
experiments. 
 
Western blot analyses 
Whole cell extracts and immunoblot assays were prepared and performed as 
described previously (46). To harvest total cellular protein for Western blot analyses, oTr 
cells were rinsed with cold PBS and lysed by incubation in lysis buffer (1% Triton X-100, 
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0.5% Nonidet P-40, 150mmNaCl, 10mmTris, 1mmEDTA, 1mmEGTA, 0.2mmNa3VO4, 
0.2 mm phenylmethylsulfonylfluoride, 50 mm NaF, 30 mm Na4P2O7, 1 µg/ml leupeptin, 
and 1 µg/ml pepstatin) for 30 min at 4C. Cell lysates were passed through a 26-gauge 
needle and clarified by centrifugation (16,000 xg, 15 min, 4 C). The protein content was 
determined using the Bradford protein assay (Bio-Rad Laboratories, Inc., Hercules, CA) 
with BSA as the standard. Proteins were denatured, separated using SDS-PAGE, 
transferred to nitrocellulose, and Western blot analyses were performed as described 
previously (43) using enhanced chemiluminescence detection (SuperSignal West Pico; 
Pierce, Rockford, IL) and X-OMAT AR x-ray film (Kodak) according to the 
manufacturer’s recommendations. All antibodies used in these experiments were 
purchased from Cell Signaling Technology. Multiple exposures of each Western blot 
were performed to ensure linearity of chemiluminescent signals. Western blots were 
quantified by measuring the intensity of light emitted from correctly sized bands under 
UV light using a ChemiDoc EQ system and Quantity One software (Bio-Rad 
Laboratories). 
 
Sandwich ELISA 
Whole cell extracts were prepared as described previously (234, 235) and 
subjected to Sandwich ELISA according to the manufacturer’s recommendations. 
Endogenous amounts of phospho-AKT1, phospho-P38 MAPK, and phospho-ERK1/2 
protein were measured by Sandwich ELISA (catalog nos. 7160, 7140, and 7315, 
respectively) from Cell Signaling Technology. 
 
Migration assay 
Migration assays were conducted with oTr cells as described previously (236) 
with minor modifications. Briefly, oTr cells (50,000 cells per 100 µl serum and insulin-
free DMEM) were seeded on 8-µm pore Transwell inserts (Corning Costar no. 3422; 
Corning, Inc., Corning, NY).  Treatments were then added to each well (n = 3 wells per 
treatment).  After 12 h, cells on the upper side of the inserts were removed with a cotton 
swab. For evaluation of cells that migrated onto the lower surface, inserts were fixed in 
50% ethanol for 5 min. The transwell membranes were then removed, placed on a glass 
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slide with the side containing cells facing up, overlaid with Prolong antifade mounting 
reagent with 4’,6- diamidino-2-phenylindole, and overlaid with a coverslip (Invitrogen- 
Molecular Probes, Eugene, OR). Migrated cells were counted systematically in five 
nonoverlapping locations, which covered approximately 70% of the insert membrane 
growth area, using a Zeiss Axioplan 2 fluorescence microscope with Axiocam HR digital 
camera and Axiovision 4.3 software (Carl Zeiss Microimaging, Thornwood, NY). The 
entire experiment was repeated at least three times with different batches of oTr cells 
between passages 7 and 10. 
 
Statistical analyses 
All quantitative data were subjected to least squares ANOVAs using the General 
Linear Model procedures of the Statistical Analysis System (SAS Institute Inc., Cary, 
NC). Western blot data were corrected for differences in sample loading using the α 
tubulin data as a covariate. All tests of significance were performed using the appropriate 
error terms according to the expectation of the mean squares for error.  A P value less 
than or equal to 0.05 was considered significant. Data are presented as least-square means 
(LSMs) and their standard errors. 
 
Results 
IGF-II mRNA expression during the estrous cycle and pregnancy  
IGF-II mRNA was abundant within caruncular stroma and, to a lesser extent, 
within the intercaruncular stratum compactum and stratum spongiosum stroma on Days  
10 –12 of the estrous cycle and pregnancy (Fig. 3.1). By Day  14, for both cyclical and 
pregnant ewes, IGF-II mRNA was less abundant within the intercaruncular stroma, 
whereas IGF-II mRNA remained abundant within the endometrial caruncle.  As ewes 
approached estrus on Day  16 of the estrous cycle, IGF-II mRNA was also localized to 
the LE in addition to the caruncular and intercaruncular stroma. Furthermore, IGF-II 
mRNA was more abundant within the myometrium on Day  16 of the cycle compared 
with any of the previous days of the estrous cycle and all days of pregnancy studied (data 
not shown). On Day  16 of pregnancy, IGF-II mRNA also increased in LE as noted for 
cyclical ewes; however, abundance of IGF-II mRNA within the caruncles declined 
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Fig. 3.1.  In situ hybridization analyses of IGF-II mRNA in the uteri of cyclical and early 
pregnant ewes. Cross-sections of the uterine wall from cyclical (C) and pregnant (P) ewes 
were hybridized with radiolabeled antisense or sense ovine IGF-II cRNA probes. IGF-II 
mRNA was most abundant in compact stroma (S) of endometrial caruncles of both 
cyclical and pregnant ewes. Interestingly, IGF-II mRNA expression transitioned from the 
stroma to the luminal and superficial glandular epithelia in intercaruncular endometria 
between Days  15 and 20 of pregnancy. IGF-II mRNA was also present in all cells of the 
conceptus and particularly abundant in the yolk sac (YS) as shown for Day  18 of 
pregnancy. Scale bar represents 5 µm. En, Endoderm; Tr, trophectoderm. 
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Fig. 3.2.  Immunohistochemical localization of p-AKT1, p-ERK1/2, and p-P38 MAPK 
protein in endometria from pregnant (P) ewes from study 1. A, C, and E, Immunoreactive 
p-AKT1, p-ERK1/2, and p-P38 MAPK proteins, respectively, were localized using rabbit 
antimouse phospho-AKT1 polyclonal antibody (Ser493/Thr308), rabbit antimouse 
phospho-ERK1/2 monoclonal antibody, and rabbit antihuman phospho-P38 MAPK 
monoclonal antibody. Normal rabbit IgG was substituted for the primary antibody as a 
negative control. Sections were not counterstained. Scale bar represents 5 µm. B, D, and 
F, Immunoreactive p-AKT1, p-ERK1/2, and p-P38 MAPK proteins were present at low 
levels in most endometrial cells, but p-AKT1 and p-P38 MAPK were particularly 
abundant in the nuclei of endometrial LE and conceptus trophectoderm (Tr) of pregnant 
ewes. Sections were not counterstained. Scale bar represents 2.5 µm. En, Endoderm; S, 
stroma. 
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compared with Day 16 of the cycle and previous days of pregnancy.  IGF-II mRNA on 
Day  18 of pregnancy was also localized to LE and caruncular stroma, similar to Day  16 
of pregnancy.  IGF-II mRNA was particularly abundant in the yolk sac of the conceptus, 
but less abundant in the conceptus trophectoderm and endoderm. By Day  20 of 
pregnancy, IGF-II mRNA in the caruncular stroma was low, whereas expression in LE 
was abundant, but variable in localization due to  loss of the LE from fusion with 
trophoblast giant binucleate giant cells (BNCs). The conceptus endoderm, but not 
trophectoderm, expressed abundant IGF-II mRNA on Day  20 of pregnancy. 
 
Localization of p-AKT1, p-ERK1/2, and p-P38 MAPK protein in ovine endometrium 
and conceptus 
Immunohistochemical analyses revealed that p-AKT1, p-ERK1/2, and p-P38 
MAPK proteins were present at low levels in most endometrial cells, but p-AKT1 and p-
P38 MAPK were particularly abundant in the nuclei of endometrial LE and conceptus 
trophectoderm in pregnant ewes.  Localization of immunoreactive p-ERK1/2 and p-
P38MAPK proteins in conceptus trophectoderm, including BNCs, was based on cell 
morphology (Fig. 3.2). 
 
Localization of RPS6K mRNA and p-RPS6K protein in ovine endometrium and 
conceptus 
In situ hybridization analysis indicated that RPS6K mRNA was expressed mainly 
in endometrial LE and superficial ductal GE (sGE) (Fig. 3.3A). Furthermore, RPS6K 
mRNA was abundant in the conceptus trophectoderm. Immunohistochemical analysis 
revealed that p-RPS6K protein was present at low levels in a majority of endometrial 
cells but was particularly abundant in the nuclei of endometrial LE and conceptus 
trophectoderm of pregnant ewes (Fig. 3.3B). 
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Fig. 3.3.  In situ hybridization analysis of RPS6K mRNA and immunohistochemical 
analysis of RPS6K protein in the uteri of early pregnant ewes. A, Cross-sections of the 
uterine wall from pregnant (P) ewes were hybridized with radiolabeled antisense or sense 
ovine RPS6K cRNA probes. RPS6K mRNA is expressed only in endometrial LE and sGE, 
and trophectoderm (Tr) of the conceptuses. B, Immunoreactive p-RPS6K protein was 
localized using rabbit antihuman phospho-RPS6K (Thr421/Ser424) polyclonal antibody. 
Normal rabbit IgG was substituted for the primary antibody as a negative control. 
Sections were not counterstained. Scale bar represents 10 µm (A) and 2.5 µm (B). S, 
Stroma. 
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Fig. 3.4.  IGF-II-induced phosphorylation of PDK1, AKT1, and GSK3B in oTr cells. 
Monolayers of 80% confluent oTr cells were serum starved for 24 h and then treated with 
IGF-II (50 ng/ml) for the indicated times. Blots were imaged to calculate the normalized 
values presented in graphs (bottom) by measurements of levels p-protein relative to total 
protein. The bars represent the relative abundance of p-protein. A, Phosphorylation of 
PDK1 by IGF-II. Representative Western blots for p-PDK1 (237) and total PDK1 
(middle; visualized with total PDK1 antibody after stripping the same blot). IGF-II 
increased p-PDK1 level 2.5-fold (P < 0.01) over basal levels, within 15 min, and this 
activation was maintained to 90 min. B, Phosphorylation of AKT1 by IGF-II. 
Representative Western blots for p-AKT1 (237) and total AKT1 (middle; visualized with 
total AKT1 antibody after stripping the same blot). IGF-II increased p-AKT1 level 4-fold 
(P < 0.001) over basal levels within 15 min, and this activation was maintained to 90 min. 
C, Phosphorylation of GSK3B by IGF-II. Representative Western blots for p-GSK3B 
(237) and total GSK3B (middle; visualized with total GSK3B antibody after stripping the 
same blot). IGF-II increased p-GSK3B level 1.4-fold (P < 0.05) within 15 min, and this 
activation was sustained through 90 min. D, Measurement of endogenous levels of 
phospho-AKT1 protein in oTr cells using a Sandwich ELISA. Results of a Sandwich 
ELISA to determine activation of AKT1 (P < 0.001) were consistent with results from 
Western blot analyses. All quantitative data are presented as LSMs with overall standard 
errors of the means. 
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 IGF-II activates PI3K-AKT1 and FRAP1-RPS6K signal transduction in ovine 
trophoblast cells 
Western blot analyses of whole oTr cell extracts with antibodies to phophorylated 
(p), i.e, activated target proteins, found that IGF-II increased levels of p-pyruvate 
dehydrogenase kinase (PDK) 1 and p-AKT1 by 2.5- (P< 0.01) and 4-fold (P< 0.001) 
over basal levels, respectively, within 15 min, and this activation was maintained to 90 
min (Fig. 3.4A and B).  In addition, results of a Sandwich ELISA to determine activation 
of AKT1 (P< 0.001) were consistent with results from Western blot analyses (Fig. 4D). 
IGF-II also stimulated a rapid 1.4-fold increase in p-glycogen synthase kinase (GSK) 3B 
(P< 0.05) within 15 min (Fig. 4C), as well as increases in p-FRAP1 (P< 0.05) and p-
RPS6K (70/85 kDa) (P< 0.001) protein abundance between 0 and 15 min post-treatment 
that were sustained through 90 min (Fig. 3.5A and B). To determine the cell signaling 
pathways mediating effects of IGF-II on AKT1 and RPS6K, oTr cells were pretreated 
with pharmacological inhibitors of PI3K (200 nm wortmannin or 25µm LY294002) and 
FRAP1/mTOR kinase activity (50 nm rapamycin), respectively.  Induction of p-AKT1 
and RPS6K by IGF-II was inhibited by both PI3K inhibitors (P< 0.01 or P< 0.001), 
whereas rapamycin only inhibited RPS6K (P< 0.01) (Fig. 3.5C). These results suggested 
that activation of the PI3KAKT1 pathway by IGF-II is required for translational 
activation of both p-FRAP1 and p-RPS6K in the IGF-II-induced cell signaling cascade. 
 
IGF-II activates ERK1/2 and P38 MAPK phosphorylation in ovine trophoblast cells 
Effects of IGF-II on MAPKsignaling transduction cascades in oTr cells were 
evaluated on SDS-PAGE gel-separated and immunoblotted proteins probed with 
antibodies against p-P38 MAPK and p-ERK1/2 (p42/p44) proteins. In response to IGF-II, 
p-P38 MAPK increased 2.3-fold (P< 0.01) over basal levels within 30 min and decreased 
only slightly by 90 min (Fig. 3.6A). Meanwhile, IGF-II stimulated a rapid 2.6-fold (P< 
0.01) increase in p-p44 (ERK1) and a 1.8-fold (P< 0.05) change in p-p42 (ERK2) within 
15 min that was attenuated by 90 min (Fig. 3.6B). Results from the Sandwich ELISA 
verified that IGF-II activated p-P38 MAPK and p-ERK1/2 proteins within 15 min (P< 
0.05) and that these proteins returned to basal levels at 90 min (Fig. 3.6 C and D). 
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Fig. 3.5.  IGF-II-induced phosphorylation of FRAP1 and RPS6K in oTr cells. 
Monolayers of 80% confluent oTr cells were serum starved for 24 h and then treated with 
IGF-II (50 ng/ml) for the times indicated. Blots were imaged to calculate the normalized 
values presented in the graph (bottom) by measurements of levels p-protein relative to 
total protein. The bars represent the relative abundance of p-protein. A, Phosphorylation 
of FRAP1 by IGF-II. Representative Western blots for p-FRAP1 (237) and total FRAP1 
(middle; visualized with total FRAP1 antibody after stripping the same blot). IGF-II 
increased p-FRAP1 level 1.9-fold (P < 0.05) within 15 min, and this activation decreased 
about 1.7-fold by 90 min. B, Phosphorylation of RPS6K by IGF-II. Representative 
Western blots for p-RPS6K (237) and total RPS6K (middle; visualized with total RPS6K 
antibody after stripping the same blot). IGF-II increased p-RPS6K (70/85 kDa) level 1.4-
fold (P<0.001) within 15 min, and this activation was sustained through 90 min. C, 
Inhibition of AKT1 and RPS6K phosphorylation. Serum-starved oTr cells were 
pretreated with either 200 nm wortmannin, 25 µm LY294002, or 50 nm rapamycin for 30 
min and then stimulated with IGF-II (50 ng/ml) for 15 min. Representative Western blots 
for p-AKT1 (237), RPS6K (middle), total AKT1, and total RPS6K (bottom; visualized 
with total AKT1 and total RPS6K antibody after stripping the same blot) are presented. 
Blots were imaged to calculate the normalized values presented in the graph by 
measurements of levels p-AKT1 (238) and RPS6K (lower) relative to total AKT1 and 
total RPS6K. The bars represent the relative abundance of p-protein. Induction of p-
AKT1 and RPS6K by IGF-II was inhibited by both PI3K inhibitors (P < 0.01 or P < 
0.001), whereas rapamycin only inhibited RPS6K (P < 0.01). The asterisk (*) denotes an 
effect of treatment (* P < 0.01; ** P < 0.001). All quantitative data are presented as 
LSMs with overall standard errors of the mean. 
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 Fig. 3.6.  IGF-II-induced phosphorylation of P38 MAPK and ERK1/2 in oTr cells. 
Monolayers of 80% confluent oTr cells were serum starved for 24 h and then treated with 
IGF-II (50 ng/ml) for the times indicated. Blots were imaged to calculate the normalized 
values presented in the graph (bottom) by measurements of levels p-protein relative to 
total protein. A, Phosphorylation of P38 MAPK by IGF-II. Representative Western blots 
for p-P38 MAPK (237) and total P38 MAPK (middle; visualized with total P38 MAPK 
antibody after stripping the same blot). IGF-II increased p-P38 MAPK level 2.3-fold (P < 
0.01) within 30 min, and values decreased slightly by 90 min. B, Phosphorylation of 
ERK1/2 (p44/p42) induced by IGF-II. Representative Western blots for p-ERK1/2 (237) 
and total ERK1/2 (middle; visualized with total ERK1/2 antibody after stripping the same 
blot). IGF-II stimulated a rapid 2.6-fold (P < 0.01) increase in p-p44 (ERK1) and a 1.8-
fold (P < 0.05) change in p-p42 (ERK2) within 15 min that was attenuated by 90 min. C, 
Measurement of endogenous levels of phospho-P38 MAPK protein in oTr cells using a 
Sandwich ELISA. D, Measurement of endogenous levels of phospho-ERK1/2 protein in 
oTr cells using a Sandwich ELISA. Results from the Sandwich ELISA verified that IGF-
II activated p-P38 MAPK and p-ERK1/2 proteins within 15 min (P < 0.05), and that 
these proteins returned to basal levels at 90 min. All quantitative data are presented as 
LSMs with overall SE values. 
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IGF-II stimulates trophectoderm cell migration  
To investigate functional effects of IGF-II in oTr cells, cell migration assays were 
conducted. After longer incubation periods with IGF-II (12–48 h), amounts of total 
AKT1, P38 MAPK, and ERK1/2 (p42/p44) in oTr cells did not change (Fig. 3.7).   
In cell migration assays (Fig. 3.8), treatment of oTr cells with IGF-II in serum and 
insulin-free DMEM increased their migration approximately 197%. Meanwhile, 
treatment of oTr cells with wortmannin, LY294002, and rapamycin along with IGF-II 
decreased oTr cell migration about 52, 73, and 46%, respectively. Of note, treatment of 
the oTr cells with the inhibitors alone for 12 h did not affect cell numbers (data not 
shown). Collectively, these results strongly support our hypothesis that IGF-II from 
endometrial LE acts in a paracrine manner on conceptus trophectoderm to stimulate cell 
migration via activation of PI3K-AKT1 and MAPK signaling cascades. 
 
Discussion 
Ovine conceptuses undergo growth and morphological differentiation (transition 
from spherical to tubular to filamentous forms) between Days  13 and 14, immediately 
before attachment to the uterine epithelium (239). Factors affecting early placental 
development appear to have an important impact on the ability of the dam to supply 
sufficient nutrients for fetal growth because ovine placental growth occurs during the first 
half of pregnancy and reaches a plateau by Day  90 in advance of the period of rapid fetal 
growth and development (116). Among these factors, IGF-II is a recognized potent 
stimulator of cell proliferation, differentiation, and development, and it is considered to 
play a central role during implantation and establishment of pregnancy in most 
mammalian species, including humans, mice, and domestic animals (116, 140, 142, 148, 
153, 157). IGFs play pivotal roles in fetal-placental development and may act, in part, to 
affect transfer of maternal nutrients to fetal-placental tissues throughout gestation (116, 
142, 160). All components of the IGF system are present in the reproductive tract or 
placenta of ruminants at some stage of pregnancy (116). However, regardless of their 
spatial and temporal expression, mechanisms of action of IGFs have not been defined 
clearly. Results of the present study are the first to provide detailed analyses of temporal 
and spatial expression of IGF-II mRNA in both the ovine uterus and conceptus  
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Fig. 3.7. Effects of IGF2 on total AKT1, P38 MAPK and ERK1/2 proteins in oTr cells. 
Monolayers of 80% confluent oTr cells were serum-starved for 24 h and then treated with 
IGF2 (50 ng/ml) for the indicated times. IGF2 did not change the abundance of AKT1, 
P38 MAPK or ERK1/2 (p42/p44) proteins in oTr cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
40
 
 
 
 
 
 
 
 
Fig. 3.8.  IGF-II stimulates migration of oTr cells. The oTr cells were cultured in a 
transwell plate (n = 3 wells per treatment) and treated with recombinant human IGF-II, 
wortmannin, LY294002, rapamycin, or their combination. Cells grown in serum- and 
insulin-containing DMEM served as a negative control. Cell migration was determined 
after 12-h treatment and expressed as LSMs ± SE. IGF-II stimulated (P < 0.01) and the 
inhibitors blocked (P < 0.01) the effect of IGF-II on cell migration. The asterisk (*) 
denotes an effect of treatment (P < 0.01). 
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throughout the estrous cycle and peri-implantation period of early pregnancy, as well as 
IGF-II-induced cell signaling pathways in oTr cells. The present results establish a direct 
link between IGF-II and cell signaling pathways (PI3K-AKT1-FRAP1-RPS6K, and/or 
ERK1/2 or P38 MAPK) which are clearly implicated in growth and differentiation of 
ovine conceptuses (Fig. 3.9). 
In Study 1 IGF-IImRNA was most abundant in the compact stroma of 
endometrial caruncles, and was lower in the stroma of intercaruncular endometria of both 
cyclical and pregnant ewes (Fig. 3.1), as reported previously (144, 147). However,  there 
was also abundant IGF-II mRNA in LE of intercaruncular endometria of  Day 16  cyclic 
ewes. In human endometria, IGF-II mRNA is predominantly expressed in the mid- to -
late secretory phase and is proposed to be a progestamedin (240-242). Notably, low 
levels of IGF-II mRNA are expressed in the rat and pig uterus, and does not exhibit 
distinct temporal or spatial (cell specific) changes during the estrous cycle (242-244). 
Interestingly, in the present study, IGF-II mRNA expression transitioned from stroma to 
LE in intercaruncular endometria between Days 15 and 20 of pregnancy, and was also 
expressed in all cells of the conceptus, but particularly abundant in the yolk sac. Similarly, 
in human and mouse, abundant IGF-II transcripts are found in primitive endoderm and 
extraembryonic mesoderm during early implantation (242, 245). It is known that the IGF-
IIR acts as a signaling antagonist that prevents IGF-II responses by targeting IGF-II to 
lysosomes for degradation. For example, targeted disruption of the IGF-IIR gene in mice 
and studies with cultured rat granulosa cells showed that IGF-IIR is likely functioning as 
a clearance receptor for IGF-II (136, 246).  Therefore, effects of IGF-II are considered to 
be mediated through the IGF-IR. Reynolds et al. (147) reported that IGF-IR mRNA is 
expressed by epithelial cells of superficial and deep uterine glands in ewes during early 
pregnancy. The IGF-IR was also detected in the trophectoderm cells of cotyledons of 
placentae of pregnant ewes using affinity cross-linking and immunohistochemical 
analyses (247). The spatial distribution of IGF-II mRNA in compact caruncular stroma 
and in LE of intercaruncular endometria supports our hypothesis that IGF-II plays 
essential roles in conceptus development and implantation in the ovine uterus, and that 
IGF-II mediated autocrine-paracrine cell signaling is essential for conceptus development. 
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Fig. 3.9.  Schematic illustrating the current working hypothesis on IGF-II-induced PI3K-
AKT1-FRAP1-RPS6K and MAPK signaling cascades in oTr cells during the peri-
implantation period. Evidence from the present study indicates that IGF-II stimulates 
multiple cell-signaling pathways noted by the asterisks. LY294002 and wortmannin are 
selective PI3K inhibitors. Rapamycin inhibits FRAP1. EIF2, eukaryotic translation 
initiation factor 2; EIF2B, eukaryotic translation initiation factor 2B; EIF4E, eukaryotic 
translation initiation factor 4 ; EIF4EBP1, eukaryotic translation initiation factor 4E-
binding protein 1; Ras, synaptic Ras-GTPase-activating protein. 
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The activities of both IGF-I and IGF-II are modulated by their association with 
members of a family of IGF binding proteins (IGFBPs) (231). By binding IGF-I and IGF-
II, IGFBPs have growth-inhibitory effects by restricting availability of these ligands for 
binding to IGF-IR (231, 248). However, IGFBPs can also regulate IGF bioavailability by 
maintaining a circulating reservoir of IGFs and prolonging their half-life (249).  IGFBPs 
synthesized in the uterus are considered to have important roles in implantation and 
placental development in many species (117, 244, 250). In the ovine uterus, IGFBP-1 and 
IGFBP-3 mRNAs were detected in the LE during early pregnancy (147, 251), IGFBP-2, 
IGFBP-4, and IGFBP-6 mRNAs were expressed in dense caruncular stroma beneath 
overlying LE (147, 252), and IGFBP-5 (253) mRNA was found in endometrial LE, GE, 
and stroma. Available evidence indicates that expression of IGFBPs is regulated by 
steroid hormones during the estrous cycle and also by conceptus factors during pregnancy 
(116, 242). Therefore, results of the present study and others indicate that ovarian factors 
(e.g. estrogen and progesterone) and conceptus-derived factors (e.g. IFNT) may act on 
ovine endometria to regulate IGFBP and IGF-II expression, as well as their interactions 
during implantation and placentation. 
The PI3K-AKT1 cell signaling pathway has emerged as a critical component of 
insulin and IGF signaling cascades.  Toyofuku et al. (254) demonstrated that IGF-I 
activates AKT1 via PI3K in human endometrium and decidua. However, to our 
knowledge, little is known of the signal transduction pathways activated by IGF-II in the 
conceptus during the peri-implantation period. In the present studies,  oTr cells were used 
to demonstrate that IGF-II induces activation of PDK1-AKT1-GSK3B within 15 min and 
maintains activation to 90 min. Furthermore, IGF-II-induced phosphorylation of AKT1 
was inhibited completely by wortmannin (PI3K-AKT1 inhibitor).  In addition, 
immunoreactive p-AKT1 protein was present at low levels in most endometrial cells, but 
was particularly abundant in the nuclei of endometrial LE and conceptus trophectoderm 
of early pregnant ewes. These results suggest that IGF-II plays an essential role in 
trophoblast survival, growth, and differentiation by activating the PI3K/AKT1 cell 
signaling pathway in the ovine uterus during the peri-implantation period. 
Furthermore,  IGF-II was found to induce phosphorylation of FRAP1-RPS6K in 
oTr cells. The FRAP1-RPS6K cellsignaling cascade also mediates cell signaling by 
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nutrients such as amino acids and by mitogenic signals (255) to stimulate cell 
proliferation, differentiation, and gene expression.  FRAP1, also known as mTOR, and 
PI3K-AKT1 pathways act in parallel to transduce growth factor signals and regulate 
common downstream targets such as RPS6K (242). In the present study,  that low levels 
of RPS6K mRNA and protein were expressed in endometrial epithelia of pregnant ewes, 
while  RPS6K mRNA and protein were most abundant in conceptus trophectoderm 
during the periimplantation period. These results suggest that the FRAP1-RPS6K cell 
signaling cascade induced by IGF-II plays an important role in implantation events in the 
ovine uterus. 
Results of the present study further demonstrated that IGF-II stimulates activation 
of ERK1/2 and P38 MAPK phosphorylation in oTr cells. As a family of protein kinases, 
MAPKs are highly conserved in most organisms, from yeast to humans (256). Among the 
three well-characterized subfamilies of MAPKs, the ERK1/2 and P38 MAPK pathways 
play important roles in differentiation processes, including embryonic and placental 
development (232, 257-259). However, little is known about either member of the 
MAPK subfamily in oTr development during early pregnancy. In the present study, 
immunoreactive ERK1/2 and P38 MAPK proteins were detected in ovine endometrial 
epithelia and conceptus trophectoderm, including BNCs. Furthermore, IGF-II induced 
rapid increases in phosphorylation of both ERK1/2 and P38 MAPK, reaching a maximum 
at 15 or 30 min for oTr cells, respectively, followed by a decline through 90 min. 
Involvement of ERK1/2 and P38 MAPK in IGF-II-induced cell signaling in oTr cells 
indicates a novel cell signaling pathway.  Therefore,  IGF-II may influence ovine 
fetal/placental development by activating these MAPK pathways during the peri-
implantation period. 
In addition to activation of PI3K-AKT1 and MAPK cell signaling pathways, IGF-
II increased migration of oTr cells, which was prevented by inhibitors of PI3K and 
FRAP1 (Fig.3.8). Thus, results of the present studies strongly support the hypothesis that 
IGF-II from the endometrial LE and/or conceptus tissues acts in a paracrine or autocrine 
manner tostimulate migration of conceptus trophectoderm via activation of PI3K-AKT1 
and MAPK signaling cascades. 
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In conclusion, IGF-II activates the PI3K-AKT1-FRAP1- RPS6K and stimulates 
the MAPK signal transduction cascades likely involved in expression of growth- and/or 
development-related genes affecting ovine fetal/placental cell migration during the peri-
implantation period (Fig. 3.9). These results provide important insights into the 
mechanisms by which IGF-II regulates conceptus development during the peri-
implantation period of sheep. 
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CHAPTER IV 
SECRETED PHOSPHOPROTEIN 1 BINDS INTEGRINS TO INITIATE 
MULTIPLE CELL SIGNALING PATHWAYS, INCLUDING FRAP1/mTOR, TO 
SUPPORT ATTACHMENT AND FORCE-GENERATED MIGRATION OF 
TROPHECTODERM CELLS 
 
Introduction 
The mammalian target of rapamycin (mTOR/FRAP1) cell signaling  pathway is 
an evolutionarily conserved serine/threonine kinase located downstream of 
phosphatidylinositol 3-kinase that controls cell growth and proliferation through 
regulation of protein synthesis (100, 260), as well as initiation of mRNA translation, 
ribosome synthesis, expression of metabolism-related genes, autophagy and cytoskeletal 
reorganization (102).  mTOR is a “nutrient sensing system” that may be stimulated by 
molecules including insulin-like growth factor 2 (IGF2) and selected amino acids (22, 
113, 114) to support blastocyst/conceptus (embryo and extra-embryonic membranes) 
development.  Homozygous Frap1 null mice die shortly after implantation due to 
impaired cell proliferation and hypertrophy in both the embryonic disc and trophoblast 
(12). 
 Cell attachment and migration are key events in implantation of blastocysts in 
uteri of all mammals.  Trophectoderm cells (Tr) of blastocysts attach to the uterine 
luminal epithelium (LE) for juxtaposition of conceptus and maternal circulations, leading 
to the establishment of a functional placenta.  Attachment of Tr to LE is facilitated by a 
mosaic of interactions between integrins and extracellular matrix (ECM) proteins which 
contribute to stable adhesion at implantation (182, 261, 262).  In sheep, conceptus 
elongation occurs prior to and is a prerequisite for the initiation of implantation and 
involves a rapid transition from spherical to tubular and filamentous forms between Days 
10 and 15.  Elongation of conceptuses involves extensive cytoskeletal reorganization in 
Tr cells to support their hypertrophy and migration (263).  Implantation in sheep is 
noninvasive with increasing apposition and adhesion between Tr and uterine LE between 
Days 18 and 50 to 60 of gestation (24). 
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 Secreted phosphoprotein 1 (SPP1/osteopontin),  a multifunctional ECM protein, 
binds to cell surface integrin receptors to regulate basic cell-cell and cell-matrix 
interactions essential to cell adhesion, migration and proliferation (164, 167).  SPP1 
contributes to implantation in several mammalian species (167) and multiple integrin 
receptors for SPP1 are present on Tr and LE of humans and domestic animals, some of 
which increase during the peri-implantation period (167, 179, 182).  Binding of SPP1 to 
integrins results in activation of integrin receptors and recruitment of cytoskeletal 
proteins to form focal adhesions in Tr cells (264), and Spp1-/- and Spp1+/- mice display 
decreased pregnancy rates at mid-gestation (186).  
  SPP1 induces motility in human trophoblast cells through mTOR signaling (265) 
and rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion 
proteins stimulated by insulin-like growth factor (IGF1) such as focal adhesion kinase 
(FAK) (266).  These results suggest a role for SPP1-induced mTOR complex signaling in 
key events of pregnancy.  However, little is known about downstream transcription factor 
activation and transcription factor-mediated gene expression induced through SPP1-
integrin interactions in mammalian Tr cells.  Therefore, this study was designed to 
identify relationships and crosstalk between multiple membrane and intracellular cell 
signaling cascades activated by SPP1, including mTOR, and integrin binding to ovine Tr 
cells that control cell proliferation, migration, attachment and adhesion in conceptuses 
during the peri-implantation period of pregnancy.  Results of these studies provide strong 
evidence for SPP1-induced integrin-mediated force-generated migration and cell 
adhesion mechanisms in Tr cells utilizing mTOR, MAPK14 (p38), MAPK1/MAPK3 
(Erk1/2), as well as a novel link between p38 and mTOR signaling pathways. 
 
Materials and Methods 
Animals and tissue collection 
 All animal experiments complied with the Guide for Care and Use of Agricultural 
Animals and were approved by the Institutional Agricultural Animal Care and Use 
Committee of Texas A&M University.  Ewes (Ovis aries) were observed daily for estrus 
in the presence of vasectomized rams.  At estrus (Day 0) ewes were mated to rams and 
tissues were collected and prepared for analysis as previously described on either Day 16, 
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18 or 20 of pregnancy (n = 5 ewes/day) (267).  Mononuclear ovine trophectoderm (oTr1) 
cells from Day 15 conceptuses were isolated and cultured as described previously (268).  
These cells constitute a relevant cell line for these studies because they exhibit numerous 
properties of ovine trophectoderm cells in vivo.  Native SPP1 was isolated from bovine 
milk as described previously (269).   
 
Integrin affinity chromatography and immunoprecipitation   
 Affinity chromatography experiments were performed as previously described 
(264).  Bovine milk SPP1 (bSPP1) was coupled to cyanogen bromide-activated 
Sepharose 4B (Sigma, St. Louis, MO) at 1 mg/ml according to the manufacturer’s 
instructions.  Surface biotinylation of oTr1 cells was performed as previously described 
(270). Briefly, oTr1 cells were surface-labeled with biotin in 75 cm2 flasks for 1 hour at 
room temperature and washed with PBS.  Cells were lysed with 50 mM octyl-β-D-
glucopyranoside (OG) (Fisher Scientific, Pittsburgh, PA) containing 1.5 mM each MnCl2, 
and MgCl2 for 30 min on an orbital shaker at 4C.  Cell extracts were centrifuged and then 
mixed at 20 min intervals with SPP1-Sepharose (0.5 ml) for 2 h at 0°C.  The column was 
washed with 20 ml of 1% OG plus Mg2+ and Mn2+, and 0.5 ml fractions were eluted with 
4 ml of 1% wt/vol OG + 10 mM EDTA.  Thirty microliters  of each fraction were 
separated on a 7% polyacrylamide gel under non-reducing conditions, transferred to 
polyvinylidene difluoride (PVDF) and blocked for 30 min with 5% wt/vol nonfat dry 
milk in Tris-buffered saline containing 0.1% vol/vol Tween 20.  Blots were probed for 
biotin using streptavidin-alkaline phosphatase as previously described (168, 269). 
Integrins on oTr1 cells which bound to the SPP1-Sepharose column were identified by 
immunoprecipitation or Western blotting (264) using antibodies to human integrins 
including αvβ3 (clone LM609, Chemicon International, Temecula, CA), β1 (clone DE9, 
Upstate), αvβ5 (clone P1F6, Chemicon), β6 (clone CSβ6, Chemicon), α4 (clone HP2/1, 
Abcam, Cambridge, MA), α5 (AB1928, Chemicon), αv (AB1930, Chemicon), and β3 
(AB1968, Chemicon).  Protein A-Sepharose (Pierce, Rockford, IL) was washed and 
suspended 1:1 with 0.5% vol/vol Triton X-100 in TBS.  In 1.5 ml microcentrifuge tubes, 
200 µl of the bead mixture, 5 µg of antibody, 150 µl of pooled EDTA eluates and 600 µl 
of 0.5% vol/vol Triton X-100 in TBS were combined.  This mixture was rotated gently 
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overnight at 4°C, centrifuged briefly and washed 6 times with 1 ml of 0.5% vol/vol 
Triton X-100 in TBS.  Beads were combined with 100 µl of 2X sample buffer and boiled 
for 10 min.  Samples (30 µl) were separated by 7% SDS-PAGE under non-reducing 
conditions and transferred to PVDF.  The blots were probed for biotin 
To identify integrins that bound SPP1 directly, using Western blotting, 30 µl of 
labeled oTr1 cell lysate and pooled column eluates were separated by nonreducing SDS-
PAGE and transferred to PVDF.  The blots were blocked in 5% wt/vol nonfat dry milk 
for 1 h at room temperature and incubated overnight at 4C with antibodies directed to α5 
integrin (AB1928, Chemicon) or β1 integrin (AB1952, Chemicon) subunits and 
visualized on autoradiography film using enhanced chemiluminescence (ECL). 
 
Immunofluorescence microscopy for detection of integrin activation  
 The oTr1 cells were seeded onto bSPP1-coated Lab-Tek coverglass slides (Nalge 
Nunc International, Rochester, NY). After 2 h, cells were fixed with -20°C methanol and 
immunofluorescence staining was performed using an antibody to human integrin αvβ3 
(LM609, Chemicon) or human talin (TLN)(clone 8d4, Sigma) as previously described  
(181).  Cells were then incubated with Alexa Fluor 488 goat anti-mouse IgG secondary 
antibody (A11029, Invitrogen).  Images were captured using a Zeiss Axioplan 2 
microscope (Carl Zeiss) fitted with an Axiocam high-resolution digital camera using 
Axiovision 4.1 software.  Alpha-actinin (ACTN) was localized in OCT-embedded uterine 
cross sections (Day 20 of pregnancy, n=4) as previously described (181).  Tissue-bound 
ACTN antibody (A2543, Sigma) was detected with secondary antibody and slides were 
overlayed with DAPI before images were captured. 
 
Activation of cell signaling intermediates   
 Effects of SPP1 on oTr1 cells were evaluated by cell culture and Western blot 
analyses (268).  Briefly, oTr1 cells were cultured to 80% confluency, serum- and insulin-
starved for 36 h and then treated with 100 ng/ml bSPP1 for 0, 15, 30, 60 or 90 min.  For 
experiments utilizing inhibitors of cell signaling, including 50 nM rapamycin (mTORC1 
inhibitor), 25 µM LY294002 (PI3K inhibitor), 25 µM PD098059 (MEK inhibitor), 10 
µM SB203580 (inhibitor of p38) and 10 µM blebbistatin (inhibitor of myosin II) 
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incubation was for 60 min.  Cell extracts were separated using 8, 10 or 12% SDS-PAGE 
and then cell signaling intermediates were detected using the antibodies and visualized 
using enhanced chemiluminescence detection (SuperSignal West Pico, Pierce, Rockford, 
IL).  Correctly-sized bands were quantified using a ChemiDoc EQ system and Quantity 
One software (Bio-Rad, Hercules, CA).  All inhibitors were tested for cytotoxicity by 
MTT analysis (271).  Immunocytochemical localization of p-RPS6 protein in ovine uteri 
and conceptuses was performed using boiling citrate buffer for antigen retrieval and 
methods described previously (268).   Immunoprecipitation was performed on whole cell 
extracts  after antibodies to P70S6K or p38 were added to extracts and bound proteins 
were purified using Protein A/G Plus agarose (234).  Proteins liberated from beads were 
separated by SDS-PAGE and analyzed by Western blotting. 
 Effects of bSPP1 on p-p38 were evaluated using Sandwich ELISA.  Whole cell 
extracts were prepared as described previously (234) and subjected to Sandwich ELISA 
(Cell Signaling Technology, 7140) according to the manufacturer’s recommendations. 
 
Cell proliferation assay 
 Effects of SPP1 on proliferation of oTr1 cells seeded at 50% confluency in 
polystyrene microwells (Corning-Costar) were evaluated following treatment with 
soluble bSPP1 or BSA at 10, 100 or 1000 ng/ml (n=3 replicates/treatment) for 48 h. Cells 
were fixed in formalin, stained with Amido black, solubilized with 2N NaOH and 
absorbance readings were taken at 595 nm. 
 
Cell migration assay 
 Effects of SPP1 on oTr1 cell migration were evaluated as previously described 
(264, 268).  oTr1 cells were seeded in a confluent layer 8 µm pore transwell inserts 
(Corning-Costar, Corning, NY) after the bottom side of each filter was coated with 100 
µg/ml bovine serum albumin (BSA).  bSPP1 or BSA were then added to lower wells in 
serum-free DMEM-F12 at concentrations of 10, 100 or 1000 ng/ml (n=3 
replicates/treatment).  After 12 h, cells remaining on the top portion of the membrane 
were removed by scraping with a cotton swab and membranes were fixed in 4% wt/vol 
paraformaldehyde (PAF) for 5 min.  Membranes were removed, placed on slides and 
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stained with 4’,6’-diamidino-2-phenylindole (DAPI)(P36935, Invitrogen).  Cells that 
migrated to the bottom surface of the membrane were counted in five independent 
sections of each membrane, which accounted for approximately 70% of the membrane 
area, using a Zeiss Axioplan 2 fluorescence microscope with an Axiocam HR digital 
camera and Axiovision 4.3 software. 
 Additional cell migration assays were performed with the addition of the 
inhibitors to cell signaling, either alone or in combination (see results).  The oTr1 cells 
were also seeded onto Four-well LabTek chambered slides coated with bSPP1 and 
cultured for 1 h with 0, 10, 25 or 50 µM blebbistatin to determine effects of SPP1 to 
promote focal adhesion-mediated cell spreading. 
 
Cell adhesion assays 
 Effects of SPP1 on oTr1 cell adhesion were evaluated as previously described 
(168).  Polystyrene microwells (Corning-Costar) were coated overnight at 4°C with two-
fold serial dilutions (20µg/ml to 20pg/ml) of the following proteins (50µl) in phosphate-
buffered saline (PBS) (n=3 replicates/treatment): bSPP1, rSPP1 (RGD), rSPP1 (RAD), 
hFN (positive control) or BSA (negative control).  After blocking each well in 10 mg/ml 
BSA in PBS (100 µl), 50,000 oTr1 cells were added per well and allowed to attach for 1 
h (37°C, 5% CO2). In all cell attachment experiments, nonadherent cells were removed 
by washing in isotonic saline and wells were fixed in 10% vol/vol formalin in PBS.  
Plates were stained with 0.1% wt/vol Amido black for 15 min, rinsed and solubilized 
with 2 N NaOH to obtain an absorbance reading at 595 nm which directly correlated with 
the number of cells stained in each well (272).  Additional attachment assays were 
performed in which cation levels were varied to determine whether attachment of oTr1 
cells to SPP1 was integrin-dependent (168).  The experiment was performed and 
attachment quantified as described previously, but in the presence or absence of divalent 
cations (2 mM Ca2+, 1 mM Mg2+) in cation-free Puck’s Saline A.  Experiments to block 
integrin-mediated oTr1 cell adhesion (273) were conducted as described previously 
except that cells were pre-incubated for 15 min with blocking antibodies (25 µg/ml) to 
either integrin αvβ3 (LM609, Chemicon), α5 (P1D6, Chemicon) or α2β1 (BHA2.1, 
Chemicon). 
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In vitro bead assay for activation of focal adhesions at apical membranes 
  In vitro bead assays were performed as previously described (264).  Briefly, 
polystyrene beads (10 µm; Polysciences Inc., Warrington, PA) coated with either 
rSPP1(RGD) or rSPP1(RAD) were allowed to settle onto oTr1 cells seeded onto Lab-Tek 
coverglass chamber slides coated with collagen Type I.  After 1 h cells were fixed in 2% 
paraformaldehyde, permeabilized in 1% Triton X-100 and immunofluorescence co-
localization was used to detect integrin αv (AB1930, Chemicon) and TLN (264).  Optical 
slice images from the basal to apical plasma membrane of oTr1 cells were captured used 
a Zeiss Stallion Dual Detector Imaging System with Intelligent Imaging Innovations 
Software (Carl Zeiss Inc., Thornwood, NY).  Fluorescence deconvolution of images was 
used to compare and verify integrin activation, cytoskeletal reorganization and focal 
adhesion assembly at the basal and apical aspects of oTr1 cells. 
 
Statistical analyses 
 All quantitative data were subjected to least squares analyses of variance using the 
General Linear Models (GLM) procedures of the Statistical Analysis System (SAS 
Institute, Cary, NC).  Western blot data were corrected for differences in sample loading 
using the TUBA data as a covariate.  All tests of significance were performed using the 
appropriate error terms according to the expectation of the mean squares for error.  A P-
value ≤ 0.05 was considered significant.  Data are presented as least-square means (LSM) 
with standard errors (SE). 
 
Results 
SPP1 binds αvβ3 and α5β1 integrin heterodimers to activate focal adhesion assembly 
at the basal surface of trophectoderm cells 
 Immunoprecipitations of integins in oTr1 cell lysates were performed using 
antibodies directed to integrin subunits reported to be expressed on ovine Tr cells 
including α4, α5, αv, β1, β3, αvβ3 and αvβ5 (Fig. 4.1A, first panel).  Affinity 
chromatography was used to evaluate integrin expression on oTr1 cells.  Detergent  
extracts of surface-biotinylated oTr1 cells were incubated with SPP1 from bovine milk 
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Fig. 4.1.  SPP1 binds αvβ3 and α5β1 integrin heterodimers to activate focal adhesion 
assembly at the basal surface of oTr1 cells.  Panel A, First Panel: Streptavidin was used 
to detect biotinylated proteins in oTr1 cell lysates immunoprecipitated using antibodies to 
various integrins.  Panel A, Second Panel: Proteins that bound to an SPP1-Sepharose 
column and were eluted with EDTA.  0 = no antibody.  Panel A, Third Panel: Proteins 
that bound to an SPP1-Sepharose column, eluted with EDTA and immunoprecipitated 
using antibodies to various integrins. 0 = no antibody.  Panel A, Fourth Panel: Western 
blot demonstrating the presence of α5 and β1 integrin subunits in oTr1 cell lysates (L), 
but not in SPP1-Sepharose column EDTA eluates (E).  The β3 integrin subunit was used 
as a positive control. Panel B, Immunofluorescence detection of αvβ3 integrin 
heterodimer and talin (TLN) at the basal surface of cells cultured on SPP1.  Mouse IgG 
(mIgG) served as a negative control for integrin αvβ3 and TLN. Panel C, 
Immunofluorescence detection of α5 and β1 integrin subunits at the basal surface of cells 
cultured on SPP1 and of talin (TLN) or β1 integrin subunit at the basal surface of cells 
cultured on type I collagen.  Mouse IgG or rabbit IgG served as negative controls. Panel 
D, Immunofluorescence detection of ACTN at the interface of trophectoderm (Tr) and 
uterine luminal epithelium (LE) on Day 20 of pregnancy in ewes.  Mouse IgG served as a 
negative control.  
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Fig. 4.1 continued. 
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(bSPP1)-Sepharose in the presence of 1.5 mM Mg2+ and 1.5 mM Mn2+.  After incubation, 
the column was washed in the presence of 1.5 mM Mg2+ and 1.5 mM Mn2+and eluted 
with EDTA to chelate cations and release bound integrins.  Integrins eluted in fractions 
E2, E3 and E4, with α-integrin chains migrating at approximately 170 kDa and β-integrin 
chains migrating at 100-120 kDa (Fig.4.1A , second panel). 
Successful immunoprecipitation of labeled oTr1 integrins occurred with 
antibodies to αv, β3 and α5 integrin subunits, as well as an antibody to the integrin αvβ3 
heterodimer (Fig. 4.1A, third panel; note that the bands detected migrated at the same 
sizes as the bands in the eluates shown in the second panel).  An antibody to the αv 
integrin subunit also precipitated a β chain, presumed to be the β3 integrin subunit, as an 
antibody to the β3 integrin subunit precipitated an α chain at the same relative size as the 
bands precipitated by an antibody to the αvβ3 heterodimer.  Thus, the αvβ3 integrin on 
oTr1 cells binds SPP1. 
 We were unable to immunoprecipitate the α5 or β1 integrin subunits from 
membrane extracts of biotinylated oTr1 cells that were eluted from an SPP1-Sepharose 
column or identify α5 or β1 integrin subunits from the same eluates by Western blotting 
(Fig. 4.1A, fourth panel).  However, based upon the α5 integrin subunit 
immunprecipitation results from labeled oTr1 cells, the fact that the β1 subunit is the only 
known binding partner for α5, as well as the complexity of α5β1 integrin binding to ECM, 
immunofluorescence studies were performed to evaluate the impact of functional binding 
of αvβ3 and α5β1 integrins at the basal surface of oTr1 cells. 
Because β1 integrins, but not the αvβ3 heterodimer, bind collagen (274), slides 
were coated with bSPP1 or collagen Type I and immunostained using antisera to αvβ3, 
α5, β1 or talin (TLN).  The αvβ3 integrin heterodimer and TLN were detected as large 
aggregates at the basal surface of oTr1 cells on slides coated with bSPP1 (Fig. 4.1B).  
The β1 integrin subunit was also detected in small aggregates at the basal surface of oTr1 
cells on slides coated with bSPP1 and larger β1 integrin aggregates were detected in cells 
grown on collagen (Figure 4.1C).  These results suggest that the αvβ3 and possibly α5β1 
integrins functionally aggregate at the basal surface of oTr1 cells in response to bSPP1 to 
elicit focal adhesion assembly and integrin activation during ovine Tr cell attachment to 
immobilized bSPP1. 
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The α5 and β1 aggregates on the basal surface of cells grown on slides coated 
with SPP1 are intriguing and may provide insight into the function and binding of this 
integrin in Tr during pregnancy.  Unlike αvβ3 which binds to the RGD sequence in 
numerous ECM proteins, α5β1 integrin binding to ECM appears to be restricted to 
fibronectin (FN) and secreted phosphoprotein 1 (SPP1) (274). Further, the binding of 
both SPP1 and FN to α5β1 is more complex than the interaction between SPP1 and other 
integrin receptors.  For instance, adhesion of SPP1 to the αvβ3 integrin is not affected by 
alteration of SPP1 structure at, or adjacent to, the integrin recognition sequence.  In 
contrast, binding of SPP1 and FN to α5β1 requires not only binding to the RGD portion 
of the integrin recognition sequence, but also binding to both a synergy site (the PHSRN 
sequence in the FN III9 repeat for FN or the SVVYGLR site for SPP1) and a heparin 
binding site (275).  Both FN and SPP1 have a heparin binding site which, in FN, is 
required for focal adhesion formation (276). The heparin binding site in SPP1 overlaps 
with the thrombin cleavage site and likely represses SPP1 proteolysis (277).  It is also 
noteworthy that the N-terminal fragment generated by thrombin cleavage containing both 
the RGD and SVVYGLR sequences is a stronger ligand for the α5β1 integrin than full 
length SPP1 (275).  Therefore, for optimal SPP1 binding to α5β1, the proper presentation 
of the protein is required, and this presentation is likely different when the protein is 
coated on the rigid surface of a glass slide than when it is linked to a Sepharose bead.  It 
is possible that the α5β1 integrin isolated in a membrane extract will not bind efficiently 
to SPP1 without the availability of a synergy site and a heparin binding site.  It is also 
likely that the SPP1 on beads remains in the intact full-length form, whereas it is quite 
conceivable that SPP1 at the base of cultured cells is converted into its thrombin cleavage 
fragment by serine proteases secreted by the oTr1 cells themselves.  Interestingly, 
cleavage of SPP1 occurs in vivo within the lumen of pregnant animals; the source of 
enzymes responsible for this process may be elongating conceptus trophectoderm (183, 
187).  We hypothesize that our immunofluorescence data demonstrating aggregation of 
α5 and β1 integrin subunits into focal adhesions at the basal surface of oTr1 cells on 
SPP1-coated glass contain the unique complement of binding sites to utilize the α5β1 
integrin to bind to SPP1 in contrast to the α5β1 in membrane extracts attached to 
Sepharose beads.  While we cannot definitively state that SPP1 binds α5β1 integrin on 
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oTr1 cells due to the chromatography results,  this possibility can not be excluded due to 
the focal adhesion assembly at the base of oTr1 cells in culture.  Indeed the more 
physiological configuration of the SPP1 in the latter case suggests that SPP1 likely binds 
the α5β1 integrin on oTr1 cells. 
 To establish the ability of ovine Tr cells to undergo integrin activation and 
assemble focal adhesions in vivo during implantation, cryosections of Day 20 ovine 
implantation sites containing conceptus Tr cells attached to uterine LE cells were also 
subjected to immunofluorescence analyses.  Alpha-actinin (ACTN) was detected in 
aggregates within conceptus Tr at implantation sites (Figure 1D).  ACTN is an actin 
binding and bundling protein associated with the cytoplasmic tail of beta integrin 
subunits in focal adhesions, as well as the zonula adherens (adherens junctions).  ACTN 
became increasingly distributed across the apical surfaces of uterine LE and conceptus Tr 
cells on Day 20 of pregnancy, whereas no changes in ACTN distribution were associated 
with adherens junctions in adjacent uterine glandular epithelia within or outside 
implantation sites.  This indicates recruitment of ACTN to the apical surface of uterine 
LE and conceptus Tr during assembly of focal adhesions. 
 
SPP1 activates PI3K-AKT1 and FRAP1-P70S6K-RPS6 signal transduction in 
trophectoderm cells 
 The oTr1 cells were serum-starved for 48h, incubated in the presence or absence 
of bSPP1 and subjected to protein extraction.  Based on dose-response experiments (Fig.  
4.2A), bSPP1 was used at 100 ng/ml in experiments to determine cell signaling pathways 
mediating effects of bSPP1 on P70S6K.  Western blot analyses of whole oTr1 cell 
extracts with antibodies to phosphorylated target proteins indicated that bSPP1 did not 
affect levels of phospho-PDK1 (p-PDK1), but increased phospho-mTOR (p-mTOR) and 
phospho-AKT1 (p-AKT1) and by 1.2- (P<0.05) and 1.7-fold (P<0.05) over basal levels, 
respectively, within 60 min and this effect was maintained to 90 min (Fig. 4.2B-D).  
bSPP1 also stimulated a rapid 2.7-fold increase in p-P70S6K (P<0.01) protein within 30 
min post-treatment that was sustained through 60 min; levels of p-P70S6K then  
decreased at 90 min compared to 60 min, but were still higher than basal levels (Fig.  
4.2E).  The oTr1 cells were pretreated with pharmacologic inhibitors of PI3K (10 μM 
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Fig. 4.2.  SPP1 activates mTOR, P70S6K and RPS6 signal transduction in oTr1 cells.  
Western blot analyses of various intracellular signaling intermediates in oTr1 cells treated 
with soluble SPP1:  A,  Detection of p-RPS6K following treatment with increasing doses 
of bSPP1; B, Detection of p-PDK1; C, Detection of p-mTOR; D, Detection of p-AKT1; 
E, Detection of p-P70S6K.  F, Detection of p-P70S6K following pharmacological 
inhibition of intracellular signaling with LY294002 and/or rapamycin; G, Detection of p-
RPS6 following treatment with soluble SPP1; H, Immunohistochemical detection of p-
RPS6 in conceptus trophectoderm at implantation sites on Days 18 and 20 of pregnancy 
in ewes.  Asterisks indicate statistically significant differences among treatments 
(P<0.05). 
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Fig. 4.2 continued. 
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LY294002) and mTOR kinase activity (25 nM rapamycin), respectively.  Induction of 
phosphorylated P70S6K by bSPP1 was inhibited by both PI3K and mTOR inhibitors 
(P<0.05) (Fig.  4.2F).  In addition, bSPP1 stimulated an increase in p-RPS6, a ribosomal 
protein phosphorylated by P70S6K, by 2.9-fold (P<0.01) within 30 min and this effect 
was maintained to 90 min (Fig.  4.2G).  Immunohistochemical analysis revealed that p-
RPS6 protein was highly expressed in the cytoplasm of conceptus Tr cells from uterine 
implantation sites on Days 18 and 20 of pregnancy (Fig. 4.2H).  These results 
demonstrated that bSPP1 activates PI3K-AKT1 cell signaling to stimulate the mTOR-
P70S6K-RPS6 cell signaling cascade in oTr cells. 
 
SPP1 activates p38 and Erk1/2 phosphorylation in trophectoderm cells 
  Phosphorylation of p38 and Erk1/2 in response to bSPP1 in whole oTr1 cell 
extracts was examined using antibodies against p-p38 and p-Erk1/2 proteins.  In response 
to 100 ng/ml bSPP1, p-p38 increased 2.9-fold (P<0.05) within 60 min and the effect was 
maintained to 90 min (Fig.  4.3A).  In support of these results, sandwich ELISA detected 
increases in p-p38 protein within 30 min of bSPP1 treatment that was maintained through 
90 min (P<0.05) (data not shown).  bSPP1 also stimulated a 1.7-fold (P<0.05) increase in 
p-Erk1/2 within 60 min that was maintained to 90 min (Fig. 4.3B).   
 To determine the cell signaling pathways mediating effects of bSPP1 on p38 and 
Erk1/2, oTr1 cells were pretreated with pharmacologic inhibitors of MAPK-kinase 
(MEK) (25 μM PD098059) and p38 (10 μM SB203580).  The bSPP1-induced increase in 
p-p38 was inhibited specifically by SB203580 (P<0.05) (Fig.  4.3C) and bSPP1-induced 
activation of Erk1/2 was specifically inhibited by PD098059 (P<0.001) (Fig.  4.3D).  
Collectively, these results revealed that bSPP1 activates the p38 and Erk1/2 cell signaling 
pathways in oTr1 cells. 
 
SPP1 activated p38 mediates P70S6K signaling in trophectoderm cells (crosstalk 
between MAPK and mTOR intracellular signaling)   
MAPK has been functionally linked to mTOR cell signaling (278); therefore, we 
determined effects of bSPP1 on interactions between P70S6K and p38 in the 
mTOR/P70S6K and MAPK signaling cascades using oTr1 cells pretreated with bSPP1 
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Fig. 4.3.  SPP1 binds integrins to activate mTOR, P70S6K and Erk1/2 signal transduction 
in oTr1 cells. A, Detection of p38; B, Detection of Erk1/2; C and D, Detection of p-p38 
and p-Erk1/2 in stimulated cells with SPP1 for 60 min after pretreatment with SB203580 
and PD098059 for 30 min; tubulin A (TUBA) was detected as a total protein control; E, 
Detection of p-P70S6K following pharmacological inhibition of intracellular signaling 
with SB203580 at 10 and 30 µM; F, Immunoprecipitation with P70S6K antibody and 
detection with p38 antibody; G, Detection of P70S6K following pharmacological 
inhibition with SB203580 at 5, 10 and 30 µM and immunoprecipitation with p38 
antibody; H, Detection of p-P70S6K and p38 following 30 or 60 min treatment with 100 
ng/ml of wild-type recombinant rat SPP1 (rSPP1 (RGD)) or recombinant rat SPP1 with a 
mutated integrin binding sequence (rSPP1 (RAD)).  Asterisks indicate statistically 
significant differences among treatments (P<0.05). 
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and SB203580, a specific inhibitor of p38.  Western blot analysis of whole oTr1 cell 
extracts with an antibody to p-P70S6K indicated that bSPP1 increased p-P70S6K by 2.7-
fold (P<0.01) and that this effect of bSPP1 was completely inhibited by SB203580 within 
30 min (P<0.01) (Fig. 4.3E).  To demonstrate a direct interaction between p38 and 
P70S6K, extracts of bSPP1-treated oTr1 cells were immunoprecipitated with an antibody 
to P70S6K and analyzed by Western blotting using an antibody to p38.  In response to 
bSPP1, p38 increased 1.8-fold (P<0.01) by 60 min; levels of p38 decreased at 90 min 
compared to 60 min, but remained higher than basal levels (Fig.  4.3F).  In a similar 
experiment, extracts of oTr1 cells treated with bSPP1 and SB203580 were 
immunoprecipitated with an antibody to p38 and analyzed by Western blotting using an 
antibody to P70S6K.  bSPP1 induction of P70S6K was inhibited in a dose-dependent 
manner by SB203580 (P<0.01) (Fig.  4.3G).  These results indicate an interaction 
between P70S6K and p38 for crosstalk between the mTOR and MAPK signaling 
pathways. 
 
SPP1 activates integrin-dependent phosphorylation of P70S6K and p38 in 
trophectoderm cells   
 mTOR signaling has been linked to focal adhesions (266) and SPP1 binds to αvβ3 
and possibly α5β1 integrins via its GRGDS integrin-binding amino acid sequence.  
Therefore,  oTr1 cells were treated with either recombinant wild-type rat SPP1 
(rSPP1(RGD)) or recombinant rat SPP1 containing a mutation of the RGD attachment 
sequence to RAD (rSPP1(RAD)). Western blot analyses of whole oTr1 cell extracts with 
antibodies against p-P70S6K and p-p38 proteins indicated that rSPP1(RGD) increased p-
P70S6K by 2.2-fold (P<0.01) and p-p38 by 1.7 fold (P<0.01) (Fig.  4.3H). In contrast, 
rSPP1(RAD) did not increase either p-P70S6K or p-p38 within 60 min (Figure 3J).  
These results indicate that SPP1 binds integrins via its RGD sequence to activate P70S6K 
and p38 signaling pathways in oTr1 cells. 
 
SPP1 stimulates adhesion and migration, but not proliferation of trophectoderm cells   
 Because αvβ3 and α5β1 integrin heterodimers on oTr1 cells bind SPP1 (Fig. 4.1), 
oTr1 cells were allowed to attach to various concentrations of SPP1 immobilized on 96- 
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well culture plates.  As shown in Fig.  4.4A, bSPP1 and rSPP1(RGD) promoted greater 
attachment of oTr1 cells than human fibronectin (hFN) at all concentrations tested.   In 
addition, rSPP1(RAD) did not promote oTr1 cell attachment, suggesting that the RGD 
integrin-binding amino acid sequence mediates attachment of oTr1 cells to SPP1.  
Integrin heterodimers require divalent cations for functional binding to ligands (279).  
Therefore, the oTr1 cell adhesion assay was performed in the presence or absence of 
physiological levels of divalent cations (2 mM Ca2+ and 1 mM Mg2+) (280). Results 
indicated that oTr1 cell attachment to SPP1 and hFN (P<0.05) was integrin-mediated (Fig.  
4.4B).  These results, coupled with the requirement for the RGD sequence in SPP1, 
indicate that adhesion of oTr1 cells to SPP1 occurs through an RGD-mediated integrin 
mechanism. To confirm that αvβ3 and possibly α5β1 integrins are required for SPP1-
mediated oTr1 cell adhesion, cell attachment experiments were conducted by incubating 
oTr1 cells in the presence of function-blocking antibodies directed to the α5 integrin 
subunit, the αvβ3 integrin heterodimer or α2β1 integrin heterodimer (negative control) 
alone or in combination before being allowed to attach to plates coated with bSPP1.  The 
α2β1 integrin heterodimer is commonly expressed on epithelial cells, but does not bind 
SPP1.  Cell adhesion was significantly inhibited when oTr1 cells were incubated with an 
antibody to the αvβ3 integrin heterodimer, compared to the α2β1 blocker (P<0.05) (Fig. 
4.4C).    A slight reduction in adhesion occurred due to the α5 blocking antibody that was 
not significantly enhanced by addition of α2β1 blocker.  Combination of α5 and αvβ3 
antagonism reduced attachment slightly, but no additional reduction in attachment was 
observed when combining αvβ3 and α2β1 blocking antibodies.  These results confirm 
that adhesion of oTr1 cells to SPP1 is mediated by the αvβ3 and α5β1 integrin 
heterodimers. 
To evaluate effects of SPP1 on oTr1 cell migration, assays were performed with 
various concentrations of bSPP1.  As shown in Fig. 4.4D, bSPP1 stimulated a dose-
dependent increase in migration of oTr1 cells with the greatest effect at 100 and 1,000 
ng/ml (P<0.05).  Therefore, stimulation of migration of oTr1 cells by SPP1 may be 
essential for conceptus elongation. 
The effects of SPP1 on oTr1 proliferation were assessed on cells seeded directly 
on polystyrene wells at 50% confluency.  bSPP1 did not stimulate oTr1 proliferation as 
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Fig. 4.4.  SPP1 stimulates adhesion and migration, but not proliferation of oTr1 cells.  A, 
Adhesion of oTr1 cells to increasing concentrations of immobilized SPP1; B, Adhesion 
of oTr1 cells to immobilized SPP1 in the presence or absence of divalent cations; C, 
Inhibition of adhesion using function-blocking integrin antibodies to specific integrins on 
oTr1 cells; D, Migration of oTr1 cells in response to treatment with soluble SPP1. E, 
Proliferation of oTr1 cells in response to treatment with soluble SPP1. 
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Fig. 4.4 continued. 
 
 
 
 
 
 
 
 
 
 
  
67
 
Fig. 4.4 continued. 
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compared to effects of fetal bovine serum (FBS) (positive control) or bovine serum 
albumin (BSA) (negative control) (P<0.05) (Fig.  4.4E).  Collectively, these experiments 
revealed that SPP1 stimulates adhesion and migration of oTr1 cells, events which are 
essential for conceptus elongation and implantation. 
 
SPP1 stimulates activation of integrin receptors to form focal adhesions at the apical 
surface of trophectoderm cells   
Implantation in all mammalian species is coincident with the unique apical 
expression of integrins on conceptus Tr and uterine LE that is hypothesized to mediate 
attachment between these apposing layers of epithelial cells.  Therefore, it was essential 
to determine whether SPP1 mediates focal adhesion formation at the physiologically 
relevant apical surface of oTr1 cells.  Integrin aggregation and outside-in signaling was 
found to occur in response to rSPP1(RGD) immobilized on polystyrene beads placed at 
the apical surface of oTr1 cells plated on collagen Type I (which does not bind αv or α5 
integrins) (Fig. 4.5).  These apical focal adhesions are represented by 
immunofluorescence co-localization of the integrin αv subunit with TLN and result from 
integrin activation in response to binding of SPP1 on the surface of the bead.  TLN is an 
essential and early component in focal adhesion assembly and a key indicator of integrin 
activation (281).  Basal focal adhesions served as an internal negative control for integrin 
αv and positive control for TLN localization.  No apical focal adhesions were induced by 
beads coated with rSPP1(RAD) containing a mutated integrin binding sequence, as 
evidenced by lack of integrin αv and talin aggregation around the bead.  These results 
demonstrate that SPP1 induces cytoskeletal rearrangement and focal adhesion formation 
necessary for attachment and migration of oTr1 cells. 
 
Functional blockade of adhesion and migration of oTr1 cells with inhibitors of 
integrin binding, myosin II motor activity, and mTOR/PI3K/Erk1/2/p38 signaling   
 Previous results indicated that SPP1 binds the αvβ3 and possibly α5β1 integrins to 
induce focal adhesion formation and activate multiple signaling pathways for adhesion 
and migration of oTr1 cells.  Therefore, it was  determined if  oTr1 cell migration could 
be blocked by using: 1) a functional blocker of myosin II motor activity (blebbistatin); 2)  
  
69
 
 
Fig. 4.5.  SPP1 stimulates activation of integrin receptors to form focal adhesions at the 
apical surface of oTr1 cells.  Immunofluorescence co-localization of integrin αv subunit 
with TLN following incubation of beads coated with either rSPP1(RGD) (intact integrin 
binding sequence) or rSPP1(RAD) (mutated integrin binding sequence). Top panels show 
images taken at the base of the cell; middle panels show images taken from the middle of 
the cell where integrin aggregation and cytoskeletal rearrangement is occurring around 
the bead; bottom panels show the apex of the cell.  Beads coated with rSPP1(RAD) did 
not induce focal adhesion as indicated by absence of integrin αv and talin aggregation 
around the bead (bottom panels). 
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an inhibitor of mTOR signaling (rapamycin); 3) an inhibitor of p38 signaling 
(SB203580); 4) an inhibitor of Erk1/2 signaling (PD098059); and/or 5) an inhibitor of 
PI3K signaling (LY294002). 
Blebbistatin inhibits the ability of myosin II to interact with actin, thus altering the 
contractile forces generated between the cytoskeleton and cell membrane necessary for 
successful cell migration.  Addition of blebbistatin alone or in combination with 
rapamycin, SB203580, PD098059 or LY294002 ablated oTr1 cell migration (P<0.05) 
(Fig.  4.6A-C).  In addition, oTr1 cells incubated on immobilized bSPP1 and treated with 
increasing amounts of blebbistatin exhibited decreased cell spreading (Fig.  4.6D).  These 
results indicate that SPP1-induced migration of oTr1 cells requires integrin activation and 
cytoskeletal force generation.  Because inhibition of focal adhesion motor activity ablated 
migration, the individual contributions of the various signaling pathways listed 
previously were assessed using the specific inhibitors alone or in combination in the 
absence of blebbistatin.  The addition of rapamycin, SB203580, PD098059 or LY294002 
reduced (P<0.05) oTr1 cell migration as compared to control oTr1 cells not treated with 
SPP1 (Fig.  4.6B), although there were no significant (P>0.05) differences among effects 
of the individual inhibitors.  However, specific combinations of inhibitors further 
decreased migration as compared to effects of individual inhibitors (Fig.  4.6C).  Addition 
of SB203580 or PD098059 to rapamycin-treated oTr1 cells further decreased migration 
by 24% and 20%, respectively (P<0.05).  Addition of PD098059 to SB203580-treated 
cells further decreased migration by 13% (P<0.05).  The combination of SB203580 and 
PD098059 further decreased migration of oTr1 cells compared to effects of rapamycin 
alone (33%), SB203580 alone (14%) or PD098059 alone (19%)(P<0.05).  Thus, mTOR, 
p38, PI3K and Erk1/2 each contribute to migration of oTr1 cells and their collective 
effects converge to facilitate optimal migration of oTr1 cells.  Collectively, results of 
function blocking studies demonstrated that SPP1-induced adhesion and optimal motility 
of oTr1 cells requires integrin activation to form focal adhesions and subsequent 
intracellular signaling through mTOR/Erk1/2/p38. 
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Fig. 4.6.  Functional blockade of oTr1 cell migration with inhibitors to myosin II motor 
activity, and mTOR/PI3K/Erk1/2/p38 signaling.  The oTr1 cells were incubated with 
soluble SPP1 in Transwell filter inserts and treated with pharmacological inhibitors of 
intracellular signaling: A, blebbistatin alone or in combination with LY294002, 
rapamycin, SB203580 or PD098059.  The asterisks indicate that untreated control cells 
and cells treated with SPP1 plus blebbistatin or SPP1 plus blebbistatin in combination 
with an additional inhibitor exhibited statistically decreased migration when compared to 
cells treated with SPP1 alone (P<0.05); B, Migration of oTr1 cells treated with 
LY294002, rapamycin, SB203580, PD098059 or blebbistatin were not different from 
untreated control cells.  However, asterisks indicate that cells treated with SPP1 plus an 
individual inhibitor exhibited decreased migration when compared to cells treated with 
SPP1 alone.  Migration in cells not treated with SPP1 was not different than that for 
untreated control cells (P>0.05); C, LY294002, rapamycin, SB203580 or PD098059 in 
various combinations are indicated. The asterisks indicate that untreated control cells, and 
cells treated with SPP1 and a combination of two inhibitors exhibited decreased 
migration when compared to cells treated with SPP1 alone (P<0.05); D, oTr1 cells 
cultured on immobilized SPP1 for 1h and treated with 0, 10, 25, or 50 µM blebbistatin.  
Cells cultured in 10, 25 or 50 µM blebbistatin exhibited impaired cell spreading after 1 h 
of treatment.  
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Fig. 4.6 continued. 
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Discussion 
 Growth and development of mammalian blastocysts during the peri-implantation 
period are prerequisites for implantation, a unique biological event requiring secretions 
from uterine glandular epithelia, which include SPP1 (6).   Indeed, SPP1 in the uterine 
lumen has been linked to implantation in several species including sheep and humans 
(167).  Multiple integrin receptors for SPP1 are present on Tr and LE of humans and 
domestic animals, some of which increase during the peri-implantation period (167, 182, 
262).  Results of the present study indicate that SPP1 binds the αvβ3 and possibly α5β1 
integrins to induce focal adhesion assembly as a prerequisite for adhesion and migration 
of Tr cells by activating: 1) P70S6K via crosstalk between mTOR and MAPK pathways; 
2) mTOR, PI3K, Erk1/2 and p38 signaling to stimulate Tr cell migration; and 3) focal 
adhesion assembly and myosin II motor activity to induce migration of Tr cells.  These 
cell signaling pathways, acting in concert, mediate adhesion, migration and cytoskeletal 
remodeling of Tr cells that is essential for expansion of blastocysts, elongation and 
attachment of Tr to uterine LE for implantation and placentation.  As sheep are used 
extensively as the animal model for studies of pregnancy, the results presented here have 
translational significance to human pregnancy (282). 
 Implantation is a complex event whereby the apical surface of Tr cells of 
morphologically differentiating and growing conceptuses closely appose and attach to the 
apical surface of a relatively static uterine LE.  The apical attachment of two epithelia is 
unique to implantation, and demands specialized modification of the architecture of Tr 
cells as they depolarize their apical domain to allow migration, hyperplasia and 
hypertrophy to occur coincidentally as they make contact across the surface of uterine LE.  
Factors affecting these early events in placental development are essential for the 
exchange of nutrients and gases required for survival and growth of trophoblast initially, 
and subsequently, fetal-placental tissues.  Results of the present study demonstrate that 
SPP1 is a potent stimulator of adhesion and migration of Tr cells through binding to αvβ3 
and possibly α5β1 integrins leading to assembly of focal adhesions.  Focal adhesions are 
physical and biochemical links between the cell and ECM that also serve as signaling 
centers that regulate multiple cellular signaling pathways.  A focal adhesion is composed 
of an ECM ligand, integrin heterodimer and associated cytoskeletal proteins that work 
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together to transmit mechanical forces and regulatory signals from the ECM to the 
signaling machinery and cytoskeleton (283).  A major finding of this study is the 
remarkably high level of adhesion of Tr cells to SPP1 (Fig.  4.4) compared to other 
proteins tested, including FN, requiring robust interactions between integrins on Tr cells 
and extracellular SPP1 to act as primary mediators for adhesion of Tr to uterine LE 
during conceptus development and implantation. 
 Results of the present study are novel in establishing that SPP1 binds integrins to 
induce cell signaling via PI3K-AKT1-mTOR-P70S6K-RPS6, Erk1/2 or p38 to affect 
adhesion and migration of Tr cells of mammalian conceptuses.  Migration and adhesion 
are essential functions of Tr cells responsible for the overlapping events of elongation 
(livestock species), attachment to uterine LE (all mammals) and invasion into the uterine 
endometrium (rodents and primates).  The PI3K-AKT1 cell signaling pathway has 
emerged as a critical component of cell signaling cascades induced by insulin and IGF in 
human endometrium and decidual cells (254), IGF2 in ovine conceptus Tr (268), leucine 
and arginine in mouse blastocysts (22), and glucose in human placenta (21).  Our 
understanding of the role(s) of PI3K-AKT1 cell signaling during implantation is 
significantly advanced by results from the present study demonstrating that SPP1 induces 
activation of PI3K-AKT1 and phosphorylation of mTOR-P70S6K-RPS6, which likely 
complement cell signaling initiated by nutrients and mitogens (255).  mTOR and PI3K-
AKT1 pathways act in parallel to transduce growth factor signals and regulate common 
downstream targets such as P70S6K (242).  In the present study, SPP1-induced 
phosphorylation of P70S6K was inhibited by LY294002 (PI3K-AKT1 inhibitor) and 
rapamycin (mTOR inhibitor).  Therefore, we propose that the collective effects of SPP1, 
nutrients (i.e., leucine, arginine and glucose), and mitogens (i.e., insulin and IGF) are to 
activate the PI3K-AKT1 and mTOR-P70S6K-RPS6 cell signaling pathways that 
stimulate cell proliferation, differentiation and gene expression essential for survival, 
growth and differentiation of Tr cells during the peri-implantation period (see Fig.  4.7A 
and B).    
 Results of the present study further demonstrate that SPP1 activates Erk1/2 and 
p38 in oTr1 cells.  These members of the MAPK family are highly conserved in 
organisms from yeast to humans (256).  Among the well-characterized subfamilies of  
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Fig. 4.7.  SPP1 induction of intracellular signaling pathways in oTr1 cells: Regulation of 
essential physiological events for early pregnancy.  A, Model illustrating that SPP1 acts 
via its RGD sequence to bind αvβ3 and α5β1 integrin heterodimers to induce focal 
adhesions, as well as mTOR, p38 and Erk1/2 signaling to affect cell adhesion and 
migration.  These events are essential for conceptus elongation and adhesion during the 
peri- implantation period of early pregnancy.  B, A working model summarizing 
pathways where L-arginine, SPP1 and IGF2 may activate mTOR cell signaling pathways 
involving  AKT1, TSC1/2 and mTORC1 (cell proliferation and gene expression) or 
mTORC2 (cell migration, cell survival and cytoskeletal organization) to affect Tr of 
conceptuses transitioning from spherical to tubular and filamentous forms  that can signal 
pregnancy recognition, and undergo implantation and placentation. 
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Fig. 4.7 continued. 
 
 
 
 
 
 
 
  
78
MAPKs, Erk1/2 and p38 pathways play important roles in differentiation processes, 
including embryonic and placental development (232, 259, 284).  Results of the present 
study provide the first evidence that SPP1 induces rapid phosphorylation of both Erk1/2 
and p38, as well as crosstalk between P70S6K and p38 in oTr1 cells.  This crosstalk has 
only been reported for osteoblasts (285).  Therefore, SPP1 influences ovine conceptus 
development by simultaneously stimulating the mTOR-P70S6K-RPS6 and MAPK 
pathways during the peri-implantation period of pregnancy.  
 Another exciting finding of the present study is that SPP1 induces PI3K-AKT1-
mTOR-P70S6K-RPS6 or Erk1/2 or p38 cell signaling to affect migration of Tr cells via a 
mechanism requiring formation of focal adhesions.  The ability of blebbistatin to inhibit 
SPP1-induced Tr cell migration through PI3K-AKT1-mTOR-P70S6K-RPS6 or Erk1/2 or 
p38 cell signaling strongly suggests that SPP1 changes tensional integrity (tensegrity) of 
Tr cells as they elongate and attach to uterine LE during implantation.   Cells use 
tensegrity architecture to control shape and structure through changes in stability of 
cytoskeletal elements that include microfilaments, intermediate filaments and 
microtubules (286).  Integrins and associated proteins are regarded as tensegrity 
structures because molecular connections between ECM, integrins, cytoskeletal filaments 
and nuclear scaffolds provide a discrete path for mechanotransduction through cells as 
well as a mechanism for producing integrated changes in cellular and nuclear structure 
(286).  The resulting cytoskeletal complex or focal adhesion physically links integrins to 
the ends of contractile microfilament bundles (“stress fibers”) to form a molecular bridge 
between ECM and cytoskeleton.  In this investigation blebbistatin was used as a highly 
specific small molecule inhibitor with high affinity and selectivity toward myosin II 
which functions by blocking myosin II in an actin-detached state.  Blebbistatin is not 
known to affect other components or mechanisms of the complex cell migration 
process.  Because myosin II is believed to be one of the main components producing the 
force required in the process of cell migration, the specificity of this inhibitor indicates 
the involvement of the actomyosin-based contractility of oTr1 cell migration.  Indeed, 
stimulation of integrin aggregation and recruitment of the cytoskeletal protein TLN 
around an SPP1-coated bead indicates that SPP1 can facilitate the reshaping of the 
cytoskeleton of Tr cells necessary for cell migration. 
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 Based on results from the present  studies, a model had been  proposee  (Fig. 
4.5A-B)  in which: 1) SPP1 serves as a key adhesive ECM protein that mediates Tr cell 
attachment, focal adhesion formation and reorganization of the cytoskeleton necessary 
for cell migration and attachment to uterine LE; 2) IGF2 and SPP1 activate PI3K and 
MAPK signaling pathways to affect Tr migration necessary for cellular and tissue 
reorganization during conceptus elongation (268); and 3) arginine induces proliferation of 
Tr cells required for conceptus development (22, 96); Chapter V of this dissertation).  
Collectively, SPP1, IGF2 and arginine activate mTOR signaling pathways mediated by 
AKT1, TSC1/2 and mTORC1 (cell proliferation and mRNA translation), as well as 
mTORC2 (cell migration, cell survival and cytoskeletal organization) in Tr cells to allow 
conceptuses to make the critical transition from spherical to tubular and filamentous 
forms that is a prerequisite for signaling pregnancy recognition, implantation and 
placentation required for successful pregnancy outcomes in all mammals. 
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CHAPTER V 
EFFECTS OF ARGININE, LEUCINE, GLUTAMINE AND GLUCOSE ON 
TROPHECTODERM CELL SIGNALING, PROLIFERATION AND 
MIGRATION IN VITRO 
 
Introduction 
During the peri-implantation period, blastocysts undergo a morphological 
transition from spherical to tubular and then elongated filamentous forms that  develop 
into  conceptuses (embryo/fetus and its associated extra-embryonic membranes) (4, 41).  
These elongation steps in conceptus development are supported by secretions from 
endometrial epithelia  referred to as histotroph that include  growth factors, hormones, 
cytokines, ions, lipids, glucose and amino acids that derive primarily in response to direct 
or indirect effects of  progesterone (66).  In sheep, studies of the uterine gland knockout 
ewe (UGKO) established that secretions of the endometrial glandular epithelium are 
essential for conceptus survival, elongation of trophectoderm and initiation of pregnancy 
recognition signaling (5, 6, 63, 68).   
Amino acids serve as essential precursors for the synthesis of proteins and many 
biologically active substances including polyamines, nitric oxide, peptides, 
neurotransmitters, nucleotides and creatine (287-289).  Amino acids also function as 
regulators of hormone secretion (290, 291), as major energy sources for fetal-placental 
growth (201, 202, 215, 292), and as cell signaling molecules (119, 205, 287).  In 
particular, nitric oxide, synthesized from L-Arg, is metabolically versatile and has 
potential physiological roles in regulating placental angiogenesis (293) and uterine blood 
flow during gestation (294, 295).  Polyamines also derive from Arg.  In this pathway Arg  
is metabolized to ornithine and ornithine in converted to polyamines by actions of  
ornithine decarboxylase.  The polyamines  are essential for placental development and 
mammalian embryogenesis (296).  Further, Arg  and/or Leu  have pivotal roles in 
outgrowth of trophectoderm required for blastocyst motility and implantation in mice (22, 
96).  Glucose and Gln  are major energy sources for conceptuses during development as 
they  regulate trophoblast cell proliferation and function through the glutamine-fructose-
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6-phosphate-amidotransferase (GFAT)-mediated  target of rapamycin (MTOR, formerly 
FRAP1) signaling pathway (21).   
In support of a crucial role for amino acids and glucose in embryogenesis and 
conceptus growth and development, we reported that: 1) total recoverable amounts of 
Arg, Leu, Gln and glucose increase in the uterine lumen  by 13-, 10-, 15- and 7-fold in 
pregnant, but not cyclic ewes between Day 10 and Day 15 of after onset of estrus  (95); 
2) transporters for cationic, neutral and acidic amino acids are  expressed or increase in 
uterine epithelia and conceptuses (212, 297); and 3) the abundance of both  facilitative 
(SLC2A1) and a sodium-dependent (SLC5A1) glucose transporters increase  in uterine 
epithelia and conceptus trophectoderm (SLC2A3) during the peri-implantation period (94, 
298). A sufficient supply of nutrients to the conceptus may be particularly important for 
domestic livestock species including ruminants and pigs, which have synepitheliochorial 
and epitheliochorial placentae, respectively, and for conceptuses that undergo rapid 
elongation during a protracted peri-implantation period (23).  Despite the requirement for 
histotroph, little is known about contributions of individual nutrients on cell signaling 
pathways in trophectoderm cells and how nutrients stimulate conceptus development 
during pregnancy, particularly in sheep and other ruminants.  Therefore, the purpose of 
the present study was to determine the molecular mechanisms by which Arg, Leu, Gln 
and glucose activate FRAP1-RPS6K-RPS6 in ovine trophoblast cells and their respective 
biological effects on proliferation and migration of those cells.   
 
Materials and Methods 
Cell culture   
Mononuclear ovine trophectoderm (oTr) cells from Day 15 conceptuses were 
isolated and cultured as described previously (268).  One cell line, referred to as oTr, was 
cultured in DMEM-F12 that included 10% FBS, 50U penicillin, 50 µg streptomycin, 0.1 
mM each for non-essential amino acids, 1 mM sodium pyruvate, 2 mM Gln, and 0.7 µM 
insulin.  When the density of cells in dishes reached about 80% confluence, they were 
passaged at a ratio of 1:3 and frozen stocks of cells were prepared at each passage.  For 
experiments, monolayer cultures of oTr cells (between passages 9 and 13) were grown in 
culture medium to 80% confluence on 100 mm tissue culture plates.  Cells were serum 
  
82
starved for 24 h in customized medium that was made based on the levels of each of the 
select nutrients in fetal allantoic fluid (90 ).  For experiments, the medium contained  
approximately one-tenth the amount of each amino acid and glucose compared to culture 
medium, and was deprived of either Arg, Leu, Gln or glucose for 6 h and then treated 
with Arg, Leu, Gln or glucose in a dose- and time-dependent manner.  This design was 
replicated in three independent experiments. 
 
Immunofluorescence analyses  
The effects of amino acids and glucose on phosphorylation of RPS6K and RPS6 
were determined by immunofluorescence microscopy as previously described (234, 264).  
Briefly, oTr cells were grown in Lab-Tek four-well chamber slides (Nalge Nunc 
International, Rochester, NY) and treated with Arg (0.2 mM), Leu (0.2 mM), Gln (0.5 
mM) or glucose (4 mM) for either 30 or 60 min.  At the indicated times, cells were fixed 
for 10 min in paraformaldehyde, rinsed, blocked in 5% normal goat serum, and incubated 
in primary antibody overnight at 4 C.  Rabbit IgG was substituted for the primary 
antibody as a negative control. Cells probed with rabbit anti-human polyclonal phospho-
RPS6K IgG (Thr421/Ser424) (Catalog number 9204) at a 1:200 diluton or rabbit anti-
human polyclonal phospho-RPS6 IgG (Catalog number 2215) at a 1:200 dilution (both 
antibodies were from Cell Signaling Technology, Danvers, MA and used for western 
blotting) were incubated with goat anti-rabbit IgG Alexa 488 (Chemicon) at a 1:200 
dilution for 1 h at room temperature.  Cells were washed in PBS/Tween before incubation 
overnight in mouse anti-RPS6 (Catalog number 2317, Cell Sinaling Technology, Danvers, 
MA) at a 1: 200 dilution at 4°C.  Cells were then washed, incubated in goat anti-mouse 
IgG Alexa 594 at a 1:200 dilution and overlaid with Prolong Gold Antifade with DAPI.  
Slides were stored at 4°C in the dark before microscopic analyses.  Fluorescence images 
of cells after treatment were captured using Axioplan 2 microscope with an Axiocam HR 
digital camera and Axiovision 4 software.  For each primary antibody, images were 
captured with identical microscope and detector settings to facilitate comparisons of 
spatial distribution and fluorescence intensity differences between treatments.  
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Western blot analyses  
Whole cell extracts and immunoblot assays were prepared and performed as 
described previously (234, 268) .  To harvest total cellular protein for western blot 
analyses, oTr cells were rinsed with cold PBS and lysed by incubation in lysis buffer (1% 
Triton X-100, 0.5% Nonidet P-40, 150 mM NaCl, 10 mM Tris, 1 mM EDTA, 1 mM 
EGTA, 0.2 mM Na3VO4, 0.2 mM phenylmethylsulfonylfluoride, 50 mM NaF, 30 mM 
Na4P2O7, 1 µg/ml leupeptin, and 1 µg/ml pepstatin) for 30 min at 4°C.  Cell lysates were 
passed through a 26-gauge needle and clarified by centrifugation (16,000 x g, 15 min, 
4°C).  The protein content was determined using the Bradford protein assay (Bio-Rad, 
Hercules, CA) with bovine serum albumin (BSA) as the standard.  Proteins were 
denatured, separated using SDS-PAGE, transferred to nitrocellulose and western blotting  
performed as described previously (268) using enhanced chemiluminescence detection 
(SuperSignal West Pico, Pierce, Rockford, IL) and X-OMAT AR X-ray film (Kodak, 
Rochester, NY) according to manufacturer’s recommendations.  All antibodies used in 
these experiments were purchased from Cell Signaling Technology (Danvers, MA).  
Immunoreactive proteins were detected by using rabbit anti-mouse polyclonal phospho-
AKT1 IgG (Ser473/Thr308) (Catalog numbers 9271 and 9275) at a 1:1,000 dilution and 
10% SDS-PAGE gel, rabbit anti-human polyclonal phospho-RPS6K IgG 
(Thr421/Ser424) (Catalog number 9204) at  1:1,000 dilution and 10% SDS-PAGE gel,  
and rabbit anti-human polyclonal phospho-RPS6 IgG (Catalog number 2215) at  1:1,000 
dilution and 12% SDS-PAGE gel.  As a loading control, western blotting with mouse 
anti-alpha tubulin (TUBA) IgG (Catalog number; T5168; Sigma, St. Louis, MO) was 
performed.  Multiple exposures of each western blot were conducted to ensure linearity of 
chemiluminescent signals.  Western blots were quantified by measuring the intensity of 
light emitted from correctly sized bands under ultraviolet light using a ChemiDoc EQ 
system and Quantity One software (Bio-Rad, Hercules, CA).  
 
Proliferation assay 
The oTr cells were subcultured in 24-well plates (50% confluent) in growth 
medium until the monolayer reached up to 80% confluency and then switched to serum- 
and insulin-free customized medium.  After starvation for 24 h, cells were deprived of 
  
84
amino acids or glucose for 6 h and treatments were then added to each well (n=3 wells 
per treatment) that included combinations of either: (a) serum- and insulin-free 
customized medium, a negative control; (b) Arg, Leu, Gln or glucose at the indicated 
doses with 5% serum or (c) 10 % serum containing medium as a positive control.  The 
media were changed every 2 days and treated cells were maintained for 4 days.  Cell 
numbers were determined as described previously (236, 299).  Briefly, DMEM was 
removed from cells by vacuum aspiration, and cells were fixed in 50% ethanol for 30 min, 
followed by vacuum aspiration of the fixative.  Fixed cells were stained with a Janus 
Green B in PBS (0.2% w/v) for 3 min at room temperature.  The stain was immediately 
removed using a vacuum aspirator, and the whole plate was sequentially dipped into 
water and destained by gentle shaking.  The remaining water was removed by shaking, 
stained cells were immediately lysed in 0.5N HCl, and absorbance readings were taken at 
595 nm using a microplate reader.  As described previously (299), cell numbers were 
calculated from absorbance readings using the following formula: cell number = 
(absorbance – 0.00462)/0.00006926.  The entire experiment was independently repeated 
three times with different batches of oTr cells between passages 7 and 10.   
 
Migration assay   
Migration assays were conducted with oTr cells as described previously (268, 
300).  Briefly, oTr cells (50,000 cells per 100 μl serum and insulin-free DMEM) were 
seeded on 8 μm pore Transwell inserts (Corning Costar #3422, Corning, NY).  
Treatments that were identical to those previously used for western blotting and 
proliferation assays were then added to each well (n=3 wells per treatment).  After 12 h, 
cells on the upper side of the inserts were removed with a cotton swab.  For evaluation of 
cells that migrated onto the lower surface, inserts were fixed in 50% ethanol for 5 min.  
The transwell membranes were then removed, placed on a glass slide with the side 
containing cells facing up, overlaid with Prolong antifade mounting reagent with DAPI, 
and overlaid with a cover slip (Invitrogen-Molecular Probes, Eugene, OR).  The migrated 
cells were systematically counted using a Zeiss Axioplan 2 fluorescence microscope with 
Axiocam HR digital camera and Axiovision 4.3 software (Carl Zeiss Microimaging, 
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Thornwood, NY).  The entire experiment was repeated at least three times with different 
batches of oTr cells between passages 7 and 10.  
 
Statistical analyses  
All quantitative data were subjected to least squares analyses of variance (301) 
using the General Linear Models (GLM) procedures of the Statistical Analysis System 
(SAS Institute, Cary, NC).  Western blot data were corrected for differences in sample 
loading using the TUBA data as a covariate.  All tests of significance were performed 
using the appropriate error terms according to the expectation of the mean squares for 
error.  A P-value ≤ 0.05 was considered significant.  Data are presented as least-square 
means (LSM) with standard errors (SE). 
 
Results 
Dose dependent phosphorylation of RPS6K by arginine, leucine and glucose, but not 
glutamine  
The oTr cells deprived of amino acids or glucose for 6 h after serum starvation 
were treated with either Arg, Leu, Gln or glucose at the indicated doses (Fig. 5.1).  Cells 
treated with Arg or Leu increased phosphorylation of RPS6K in a dose dependent manner 
over basal levels.  Glucose, the primary metabolic fuel for conceptuses, also activated 
RPS6K, while Gln was ineffective.  Basal levels of RPS6K at time 0 were  similar in all 
groups; however, the exposure time was relatively short for Arg, Leu and glucose treated 
cells because the signal was strong enough to show the effect on phosphorylation of 
RPS6K.  In subsequent experiments, oTr cells were treated with either Arg (0.2 mM), 
Leu (0.2 mM), Gln (0.5 mM), or glucose (4 mM). 
 
Arginine, leucine and glucose, but not glutamine activate AKT1-mTOR-RPS6K-RPS6 
signal transduction in ovine trophoblast cells  
Western blot analyses of whole oTr cell extracts using  antibodies to phospho-
rylated target proteins found that Arg  increased (P<0.01) pAKT1, pRPS6K and pRPS6 
by 2.8- , 4.2-fold  and 12-fold over basal levels, respectively, within 15 min, and this 
activation was maintained to 60 min (Fig. 5.2A).  Leu stimulated a rapid 2.5- fold (P <  
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Fig. 5.1.  Analysis of the phosphorylation of RPS6K in response to arginine (Arg), 
leucine (Leu), glutamine (Gln) and glucose (Gluc) in oTr cells.  Monolayers of 80% 
confluent oTr cells were serum-starved for 24 h, deprived of amino acids or glucose for 6 
h and then treated with one of the nutrients at the doses indicated.  Blots were imaged to 
calculate the normalized values presented as levels of phosphorylated protein relative to 
total protein.  In subsequent experiment, 0.2 mM Arg, 0.2 mM Leu, 0.5 Gln and  4 mM 
glucose was used. 
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Fig. 5.2.  Analysis of time dependent phosphorylation of AKT1, RPS6K and RPS6 in 
response to arginine (Arg), leucine (Leu), glutamine (Gln) and glucose (Gluc) in oTr cells 
at 0, 5, 15, 30 and 60 min after treatment, respectively in Panels A, B, C and D.  
Monolayers of 80% confluent oTr cells were serum-starved for 24 h  and then deprived 
of either Arg, Leu, Gln or Gluc  for 6 h and then treated with physiological 
concentrations of either Arg (0.2 mM), Leu (0.2 mM), Gln (0.5 mM), or glucose (4 mM).   
Blots were imaged to calculate the normalized values as levels phosphorylated protein 
relative to total protein.  
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Fig. 5.3.  Immunocytochemical localization of phosphorylated RPS6K protein in oTr 
cells.  Immunoreactive pRPS6K protein was localized to the nucleus and/or cytoplasm of 
oTr cells using rabbit anti-human phospho-RPS6K (Thr421/Ser424) polyclonal antibody.   
The results indicate that only Arg-treated oTr cells exhibited translocation of pRPS6K 
protein to the nucleus whereas total RPS6K was primarily localized in cytoplasm. 
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0.01)  increase in pAKT1, as well as increases in pRPS6K and pRPS6 by 4.7-fold (P < 
0.001) and 15-fold (P<0.001) within 15 min that were sustained through 60 min (Fig. 
5.2B).  Glucose also stimulated pAKT, pRPS6K and pRPS6 protein abundance by 1.8- (P 
< 0.01), 2.3- (P < 0.005) and 7-fold (P < 0.001) over basal levels within 60 min (Fig. 
5.2D).  Gln did not activate any component of this cell signaling pathway (Fig. 5.2C).  
 
Phosphorylation of RPS6K and RPS6 by arginine, leucine and glucose  
The effects of Arg, Leu and glucose on the phosphorylation of RPS6K proteins 
were determined by immunofluorescence analyses (Fig. 5.3).  In present study, we 
compared localization of total proteins and phosphorylated proteins.  The oTr cells were 
incubated for 30 min with either Arg (0.2 mM), Leu (0.2 mM), Gln (2 mM) or glucose (4 
mM).  In untreated and glucose treated cells, total RPS6K was found primarily in the 
cytosol while low levels of phosphorylated RPS6K were detected in the nuclei (Fig. 5.3). 
The levels of nuclear phosphorylated RPS6K increased after treatment with Arg (Fig. 
5.3).  There was a slight, but  insignificant, increase  in phospho-RPS6K in Leu and Gln 
treated cells  compared to  control cells (Fig. 5.3).  The intracellular location of total 
RPS6 protein was also determined by double-staining immunofluorescence (Fig. 5.4).  
Total RPS6 was detectable mainly in the cytoplasm of untreated and treated cells since 
RPS6 is the ribosomal protein typically activated through the mTOR pathway  for mRNA 
translation in cytoplasm (302).  After 30 min of treatment with Arg, Leu or glucose, 
phosphorylation of cytoplasmic RPS6 proteins increased significantly (Fig. 5.4).   
 
Inhibition of effects of argine, leucin and glucose by rapamycin and LY294002    
To determine the cell signaling pathways mediating effects of Arg, Leu and 
glucose on AKT1, RPS6K and RPS6, oTr cells were pretreated with either 
pharmacological inhibitors of PI3K (25 µM LY294002) or mTOR kinase activity (25 nM 
rapamycin) for 30 min.  Induction of pRPS6K and pRPS6 by Arg, Leu and glucose was 
inhibited by both the  PI3K inhibitor (P < 0.001) and  rapamycin (P < 0.005) (Fig. 5.5) 
which indicated  that activation of the RPS6K-RPS6 pathway by Arg, Leu and glucose is 
required for translational activation of both AKT1 and mTOR in the nutrient-induced cell 
signaling cascade. 
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Fig. 5.4.  Immunofluorescence localization of phosphorylated RPS6 protein in oTr cells.  
Co-localization of pRPS6 and total RPS6 after treatment with Arg (0.2 mM), Leu (0.2 
mM) and glucose (4 mM) revealed that pRPS6 was significantly increased in cytoplasm 
of oTr cells treated with Arg, Leu and glucose compared to untreated cells. 
 
 
 
 
 
 
 
 
 
 
  
91
 
 
 
 
 
 
 
 
Fig. 5.5.  Inhibition of RPS6K and RPS6 phosphorylation.  Monolayers of 80% confluent 
oTr cells were serum-starved for 24 h, deprived of amino acids or glucose (Gluc) for 6 h 
and then pretreated with either 25 μM LY294002 or 25 nM rapamycin for 30 min.  After 
stimulation with Arg (0.2 mM), Leu (0.2 mM) or glucose (4 mM) for 30 min or 60 min, 
total cell lysates were subjected to 10% SDS-PAGE followed by western blotting.  Both 
rapamycin and LY294002 inhibited increases in pRPS6K and RPS6.  Blots were imaged 
to calculate the normalized values presented as levels of phosphorylated protein relative 
to total protein. 
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Effect of arginie, leucine, glutamine and glucose on cell proliferation and migration  
Cell proliferation and migrations assays were conducted to investigate biological 
effects of Arg, Leu, Gln and glucose on oTr cells.  In the cell proliferation assays, 
treatment of oTr cells with Arg, Leu, Gln or glucose in customized medium containing 
5% serum for 4 days increased oTr cell numbers by approximately 14-, 5-, 1.3- and 2.4-
fold, respectively (Fig. 5.6).  In addition, as illustrated in Fig. 5.7, Arg (0.2 mM), Leu 
(0.2 mM), Gln (0.5mM) and glucose  (4 mM) increased migration of oTr cells about 3.3-, 
2.3-, 1.4- and 1.7-fold, respectively.  
 
Discussion 
In the present study, specialized medium containing physiological concentrations 
of all other amino acids were used to mimic the in vivo state and cell deprived of select 
nutrients were used to determine their  individual effects on signal transduction.  Results 
of the present study provide the first detailed analyses of the action of individual amino 
acids and glucose on cell signaling pathways as well as selected biological effects on 
ovine trophectoderm cells.  Results of the present study support our hypothesis (94, 95, 
111, 297) that select nutrients can activate the mTOR cell signaling pathway to stimulate 
proliferation and migration of conceptus trophectoderm cells during the peri-implantation 
period of pregnancy in sheep.   
Results of previous studies showed that early activation of mTOR signaling 
including AKT1, RPS6K and RPS6 by amino acids is required for the development of 
blastocysts and conceptuses (22, 96, 98, 287).  In the present study, we first examined 
molecular mechanisms by which amino acids and glucose stimulate mTOR in vitro by 
determining effects on RPS6K phosphorylation, as an indicator of the activation of 
mTOR/RPS6K cell signaling pathway.  Our results indicated that Arg and Leu, but not 
Gln, increased phosphorylation of RPS6K within 15 min and sustained this state of 
activation to 60 min.   This finding supports several lines of evidence that Arg and Leu 
have the greatest effect on mTOR and RPS6K signaling in cells from the intestine and, in 
fact, most mammalian cells (303-308).  Further, Arg- and Leu-induced phosphorylation 
of AKT1 and RPS6 was inhibited completely by both LY294002 (PI3K-AKT1 inhibitor)  
and rapamycin (mTOR inhibitor).  In response to amino acid stimulation, RPS6K 
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Fig. 5.6.  Dose dependent effects of Arg, Leu, Gln and glucose (Gluc) on proliferation of 
oTr cells.  The oTr cells were seeded at 30% confluency on microwells and cultured with 
indicated dose of Arg, Leu,  Gln or glucose. Cell numbers were determined after 4 days 
of incubation, and data are expressed relative to nontreated control (100%).  The asterisk 
(*) denotes an effect of treatment (*, P < 0.01; **, P < 0.001). All quantitative data are 
presented as LSMs with overall SEs.  Arg (0.2 mM), Leu (0.2 mM) and glucose (4 mM) 
were most effective in stimulating  proliferation of oTr cells by 15- (p<0.001), 5.3- 
(p<0.001) and 2.7- fold (p<0.01), respectively, after  4 days while Gln (0.5 mM) did not 
have a significant effect.   
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Fig. 5.7.  Migration of oTr cells.  The oTr cells were cultured in a transwell plate (n = 
three wells per treatment) and treated with Arg (0.2 mM), Leu (0.2 mM), Gln (0.5 mM) 
or glucose (Gluc, 4 mM).  Cells grown in serum- and insulin-containing DMEM served 
as a positive control.  Cell migration was determined after 12h treatment and expressed as 
LSMs ± SE.  Arg, Leu, and glucose stimulated oTr migration by 3.4-, 2.4- and 1.8- fold 
(p<0.01) after 12 h of treatment, but cells  treated with Gln (0.4 mM) did not show a 
significant change.  The asterisk (*) denotes an effect of treatment (P < 0.01).  
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phosphorylates RPS6 proteins resulting in an increase in mRNA  translation (108, 309, 
310).  In addition, immunoreactive pRPS6K protein translocated to and was particularly 
abundant in nuclei of oTr cells treated with Arg, which  agreed with the spatial 
distribution of pRPS6K in nuclei  of ovine trophectoderm and endoderm (268).  Recently, 
the mTOR/RPS6K signaling cascade was demonstrated to exist in both the cytoplasm and 
nucleus (111, 311, 312).  Phosphorylated RPS6 abundance in cells treated with Arg and 
Leu was significantly increased in cytoplasm, consistent with results from in vivo studies 
which indicated that pRPS6 was present in cytoplasm of conceptus trophectoderm (J. 
Kim and F. W. Bazer, unpublished data).  Unlike Arg and Leu, Gln acts as a key 
regulator for amino acid controlled cell growth (313-315) and as a stimulator of mitogen-
activated protein kinase and (mTOR)/RPS6K pathways, respectively, to enhance mucosal 
cell migration and wound healing in intestinal cells (316).  Our finding that Gln did not 
affect phosphorylation of mTOR/RPS6K pathway proteins is consistent with that of Ban 
et al. (304).  However, we cannot discount the possibility that Gln may be necessary for 
cell signaling cascades (317) because intracellular Gln is known to stimulate mTOR 
signaling by promoting the uptake of amino acids into cells (219, 316, 318, 319) and to 
be  essential for the survival and growth of most cultured cells (320).   
Glucose, a primary energy source, generates ATP to inactive AMPK (AMP 
activated protein kinase) which then  leads to mTOR activation (321), but recent studies 
have indicated that the signals derived from glucose metabolites play important roles in 
the control of other  cellular activities including phosphorylation of mTOR, which is 
essential for cell survival, growth and development (217, 220, 226, 322).  However, little 
is known about signaling pathways stimulated by glucose in ovine trophectoderm during 
conceptus development during early pregnancy.  In the present study, results indicated  
that glucose stimulates phosphorylation and activation of AKT1, RPS6K and RPS6 in 
oTr cells within 60 min and that this effect was inhibited completely by either LY294002 
(PI3K-AKT1 inhibitor) or Rapamycin (mTOR inhibitor).  These results indicate that 
glucose-induced mTOR activation in oTr cells is mediated through  PI3-AKT cell 
signaling.  It has been proposed that glucose stimulation of  mTOR was mediated by 
formation of glutamine-6-phosphate in the GFAT reaction (21) and activity of GFAT is 
regulated by glucose uptake and AMP-activated protein kinase (AMPK) (323, 324).   
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Glucose also stimulated oTr cell proliferation (Fig 6), consistent with results from 
studies with human trophoblasts in that glucose-induced trophoblast cell proliferation is 
mediated through mTOR activation (21).  Further, immunoreactive pRPS6 proteins were 
abundant in cytoplasm of cells treated with glucose, similar to effects mediated by Arg 
and Leu.  Thus glucose stimulates the mTOR signaling pathway through AKT for protein 
translation and proliferation which supports rapid growth of ovine trophoblast cells 
during the peri-implantation period.   
In addition to activation of cell signaling pathways, Arg and Leu increased 
proliferation and migration of oTr cells (Figs. 5.6 and 5.7).   Our laboratory has also 
identified that several candidate molecules including galectin 15, SPP1 and IGF2 that 
play a critical role in  implantation and increase migration of  oTr cells, but not 
proliferation (268, 300).  The effects of Arg and Leu on cell proliferation are striking and 
indicate their physiological importance for conceptus  growth.  We previously reported 
that the expression of NOS, GCH1, and ODC1 in ovine uterine endometria and 
conceptuses increased during peri-implantation when the conceptus is undergoing rapid 
growth, attachment and establishment of pregnancy (325).  Thus, results of the present 
studies strongly support the hypothesis that selected amino acids and glucose transported 
into the uterine lumen by uterine LE and GE stimulate  proliferation and migration of 
conceptus trophectoderm via activation of the AKT1-FRAP1-RPS6K-RPS6 cell signaling 
cascade.  
In conclusion, amino acids and glucose activate the AKT1-mTOR-RPS6K-RPS6 
cell signaling cascade to affect activation of developmentally-regulated genes affecting 
cell proliferation and migration in  ovine conceptuses  during the peri-implantation period.  
These results provide important insights into the mechanisms by which select nutrients 
regulate conceptus development during the peri-implantation period of pregnancy in 
sheep. 
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CHAPTER VI 
ARGININE STIMULATES PROLIFERATION OF OVINE TROPHECTODERM 
CELLS THROUGH FRAP1/mTOR-RPS6K-RPS6 SIGNALING CASCADE AND 
SYNTHESIS OF NITRIC OXIDE AND POLYAMINES 
 
Introduction 
L-Arginine (Arg) is a common substrate for nitric oxide (NO) and polyamine 
syntheses via NO synthase (NOS) and ornithine decarboxylase (ODC) (326), which are 
important for embryonic survival, fetal-placenta growth and development (119, 205), as 
well as trophoblast outgrowth and cell migration (96, 327).  Nitric oxide is a major 
angiogenic factor (328) and plays a role in regulating uteroplacental-fetal blood flows 
that are essential for the transfer of nutrients and oxygen from mother to fetus (203, 327).  
The polyamines, putrescine, spermidine and spermine, are required for DNA and protein 
synthesis and for proliferation and differentiation of mammalian cells (204, 329).  In 
addition, Arg mediates central metabolic pathways for nutrient utilization and protein 
synthesis through FKBP12-rapamycin complex-associated protein 1 (mTOR, also known 
as FRAP1) and NO cell signaling pathways (22, 96, 209).    
Uterine endometrial   and fetuses from many species, including  mice (330, 331), 
rats (332), sheep (91, 197, 325, 333), mares (334), humans (335) and pigs (336, 337), 
have the capacity to catabolize Arg, due to the presence of NOS and ODC, to increase 
production of NO and polyamines during gestation.  In contrast, inhibition of NO 
synthesis by NOS inhibitors such as L-NAME in rats or the absence of NO synthesis in 
eNOS-knockout mice restricts fetal growth (338, 339).  Also, inhibition of polyamine 
synthesis prevents mouse embryogenesis and impairs fetal growth (329).  This evidence 
suggests that Arg-dependent metabolic pathways, including synthesis of NO and 
polyamines, are critical for conceptus growth and development in mammalian species.   
We reported that Arg  increased 10-fold in uterine flushings from ewes during the 
peri-implantation period of pregnancy (95) and that cationic amino acid transporters, such 
as SLC7A1 and SLC7A2, were expressed in trophectoderm and endoderm of conceptuses, 
as well as uterine luminal (LE) and glandular (GE) epithelia in response to progesterone 
and interferon tau (IFNT) in sheep (297).  In ruminants, which have a synepitheliochorial 
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placenta and a protracted preimplantation period, Arg is transported into the uterine 
lumen to support conceptus development; however, little is known about the mechanisms 
whereby Arg stimulates ovine trophoblast hyperplasia and rapid elongation during the 
peri-implantation period of pregnancy.  Therefore, the objectives of the present study 
were to determine whether Arg stimulates trophoblast cell proliferation, and whether 
increased production of NO and polyamines is involved in mediating  cell proliferation.  
 
Materials and Methods 
Cell culture   
Mononuclear ovine trophectoderm (oTr) cells from Day 15 conceptuses were 
isolated and cultured as described previously (181, 268).  One cell line, referred to as 
oTr1, was cultured in DMEM-F12 that included 10% FBS, 50U penicillin, 50 µg 
streptomycin, 0.1 mM each for non-essential amino acids, 1 mM sodium pyruvate, 2 mM 
gluamine, and 0.7 µM insulin.  When the density of cells in dishes reached about 80% 
confluence, they were passaged at a ratio of 1:3, and frozen stocks of cells were prepared 
at each passage.  For experiments, monolayer cultures of oTr cells (between passages 9 
and 13) were grown in culture medium to 80% confluence on 100-mm tissue culture 
plates.  Cells were serum starved for 24 h in customized medium, deprived of arginine for 
6 h, and then treated with Arg in a dose- and time-dependent manner.  For each 
experiment, this design was replicated three independent times. 
 
Immunofluorescence 
The effects of Arg on phosphorylation of RPS6K and RPS6 were determined by 
immunofluorescence microscopy as previously described (234, 264).  Briefly, oTr cells 
were grown in Lab-Tek four-well chamber slides (Nalgene Nunc International, Rochester, 
NY) and treated with 0 or 0.2 mM Arg for 30 min.  Cells were then fixed for 10 min in 
paraformaldehyde, rinsed, blocked in 5% normal goat serum, and incubated in primary 
antibody overnight at 4°C.  Rabbit anti-p4EBP1 antibody (Catalog number 9451, Cell 
Signaling Technology, Danvers, MA) was used at a 1: 200 dilution, and goat anti-rabbit 
IgG Alexa 488 (Chemicon) for 1 h at room temperature.  Cells were then washed and 
overlaid with Prolong Gold Antifade with DAPI.  Slides were stored at 4°C in the dark 
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before immunofluorescence analysis.  Fluorescence images of cells after treatment were 
captured using a Zeiss Stallion Dual Detector Imaging System with Intelligent Imaging 
Innovations Software (Carl Zeiss, Thornwood, NY).   
 
Proliferation assay   
The oTr cells were subcultured into 24-well plates (20% confluent) in growth 
medium until the monolayer reached up to 50% confluency and then switched to serum- 
and insulin-free customized medium.  After starvation for 24 h, cells were deprived of 
Arg for 6 h and then Arg was added to each well (n=3 wells per treatment) that included 
combinations of either: (a) serum- and insulin-free specialized medium, a negative 
control; (b) Arg 0 to 200 µM with 5% serum; or (c) medium containing 10% fetal calf 
serum as a positive control.  The media were changed every 2 days and treated cells were 
maintained for 4 days.  Cell numbers were determined as described previously (236, 299).  
Briefly, DMEM was removed from cells by vacuum aspiration, and cells were fixed in 
50% ethanol for 30 min, followed by vacuum aspiration of the fixative.  Fixed cells were 
stained with a Janus Green B in PBS (0.2% w/v) for 3 min at room temperature.  The 
stain was immediately removed using a vacuum aspirator, and the whole plate was 
sequentially dipped into water and destained by gentle shaking.  The remaining water was 
removed by shaking, stained cells were immediately lysed in 0.5N HCl, and absorbance 
readings were taken at 595 nm using a microplate reader.  As described previously (299), 
cell numbers were calculated from absorbance readings using the following formula: cell 
number = (absorbance – 0.00462)/0.00006926.  The entire experiment was independently 
repeated three times with different batches of oTr cells between passages 7 and 10.   
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Migration assay   
Migration assays were conducted with oTr cells as described previously (268, 
300).  Briefly, oTr cells (50,000 cells per 100 μl serum and insulin-free DMEM) were 
seeded on 8 μm pore Transwell inserts (Corning Costar #3422, Corning, NY).  
Treatments were identical to those previously described for the proliferation assay (n=3 
wells per treatment).  After 12 h, cells on the upper side of the inserts were removed with 
a cotton swab.  For evaluation of cells that migrated onto the lower surface, inserts were 
fixed in 50% ethanol for 5 min.  The transwell membranes were then removed, placed on 
a glass slide with the side containing cells facing up, overlaid with Prolong antifade 
mounting reagent with DAPI (Invitrogen-Molecular Probes, Eugene, OR), and cover 
slipped.  Cells that had migrated were systematically counted using a Zeiss Axioplan 2 
fluorescence microscope with Axiocam HR digital camera and Axiovision 4.3 software 
(Carl Zeiss Microimaging, Thornwood, NY).  The entire experiment was repeated at least 
three times with different batches of oTr cells between passages 7 and 10.  
 
Protein synthesis and degradation  
Protein synthesis and degradation were measured in oTr cells cultured with 
radiolabeled Phe as previously described with minor changes (340).  Briefly, oTr cells 
were incubated with Arg in customized medium at concentrations of 0 and 0.2 mM for 4 
days and then switched to 2 ml medium containing 0.8 µCi L-[ring-2,4-3H]phenylalanine 
(American Radiolabeled Chemicals) for 2 h and maintained at 37°C in an incubator.  
Following incubation, the media were collected and cells washed three times with 2 ml 
ice-cold PBS. The cell pellet was mixed with 2 ml of 2% trichloroacetic acid (TCA) 
(341).   Cells in each well were scraped and then the whole solution was collected and 
centrifuged.  The cell pellet was washed with 5 ml of 2% TCA and dried in air at 37℃.  
After the pellet was dissolved in 0.5 ml of 1 M NaOH, 0.4 ml of the solution was 
transferred to a 20 ml scintillation vial containing 15 ml of Hionic Fluor Scintillation 
cocktail (PerkinElmer, MA, USA). The 3H-Phe radioactivity was determined by a liquid 
scintillation counter after samples had stood overnight at room temperature.  Specific 
activity of 3H-Phe in medium was used to calculate rate of protein synthesis in cells.   
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For determining protein degradation, oTr cells were cultured for 3 days in 2 ml of Arg-
free medium and then in doses from 0 to 2 mM Arg. Beginning on day 4, cells were 
cultured for 24 h in 2 ml of Arg free medium containing 0.1 mM L-phenylalanine plus L-
[3H]-Phe (0.8 µCi/well) and various concentrations of Arg.  After the 24 h culture to label 
cellular proteins, cells were washed three times with 2 ml Arg-free medium containing 1 
mM L-phenylalanine to deplete intracellular free [3H]-Phe (341). The cells were then 
cultured for 2 h in 2 ml medium containing 1 mM L-Phe and various concentrations of 
Arg.  At the end of the 2 h culture period, the medium was collected, cells were washed 
with 2 ml ice-cold PBS, and 2 ml of 2% TCA was added to each well. The whole TCA 
extract was collected into a 15 ml tube and centrifuged at 3,000g for 5 min. The 
supernatant fluid was removed and the pellet was washed three times with 5 ml of 2% 
TCA and dried in air at 37℃. After the pellet was dissolved in 0.5 ml of 1 M NaOH, 0.4 
ml of the solution was transferred to a 20 ml scintillation vial containing 15 ml Hionic 
Fluor Scintillation cocktail for measurement of [3H]-Phe.  For determining [3H]-Phe 
released from prelabeled proteins into the culture medium, the collected medium was 
centrifuged at 3,000g for 2 min to remove dead cells. An aliquot (1 ml) of the supernatant 
fluid was transferred to a 15 ml tube containing 2 ml of 2% TCA.  After the tubes were 
centrifuged at 3,000g for 5 min, all the supernatant fluid was transferred to a 20 ml 
scintillation vial containing 15 ml Hionic Fluor Scintillation cocktail for  measurement of 
[3H]-Phe. The percentage of protein-bound [3H]-Phe released into culture medium 
(namely [3H]-Phe in medium/[3H]-Phe in cell proteins x 100) was calculated to indicate 
protein degradation in oTr cells. 
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Preparation of ovine conceptuses   
Using procedures described previously (342, 343), conceptuses from Day 16 
pregnant ewes (coincident with maximal production of IFNT by the conceptuses) were 
recovered by flushing each uterine horn with 20 ml minimal essential medium (MEM).  
The conceptuses were initially cultured for 6 h in Arg-free medium and then cultured in 
designated doses of Arg for 18 h at 37°C with rocking in a 50% O2, 45% N2, 5% CO2 
atmosphere.  The culture medium was collected after centrifugation and protease 
inhibitors (Complete EDTA-free Protease Inhibitor Cocktail; Roche Diagnostics, 
Indianapolis, IN) were added.  The culture supernatant was diluted and stored at 4°C until 
analyzed.  Conceptuses were homogenized, the homogenate assayed for protein and then 
stored for analyses. 
 
Western blot analyses   
Whole cell extracts and immunoblot assays were prepared and performed as 
described previously (234, 268).   To harvest total cellular protein for western blot 
analyses, oTr cells were rinsed with cold PBS and lysed by incubation in lysis buffer (1% 
Triton X-100, 0.5% Nonidet P-40, 150 mM NaCl, 10 mM Tris, 1 mM EDTA, 1 mM 
EGTA, 0.2 mM Na3VO4, 0.2 mM phenylmethylsulfonylfluoride, 50 mM NaF, 30 mM 
Na4P2O7, 1 µg/ml leupeptin, and 1 µg/ml pepstatin) for 30 min at 4°C.  Cell lysates were 
passed through a 26-gauge needle and clarified by centrifugation (16,000 x g, 15 min, 
4°C).  The protein content was determined using the Bradford protein assay (Bio-Rad, 
Hercules, CA) with bovine serum albumin (BSA) as the standard.  Proteins were 
denatured, separated using SDS-PAGE, transferred to nitrocellulose and western blotting 
performed as described previously (268) using enhanced chemiluminescence detection 
(SuperSignal West Pico, Pierce, Rockford, IL) and X-OMAT AR X-ray film (Kodak, 
Rochester, NY) according to manufacturer’s recommendations.  Immunoreactive proteins 
were detected by using rabbit anti-mouse polyclonal p-mTOR IgG (Catalog numbers 
2971) at a 1:1,000 and mTOR IgG (Catalog numbers 2972) at a 1:2,000 dilution and 10% 
SDS-PAGE gel, rabbit anti-human polyclonal p-RPS6K IgG (Catalog number 9204) at  
1:1,000 and RPS6K IgG (Catalog number 9202) at  1:2,000 dilution and 10% SDS-
PAGE gel, and rabbit anti-human polyclonal phospho-4EBP1 IgG (Catalog number 
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9451) and 4EBP1 IgG (Catalog number 9644) at a 1:1,000 dilution and 12% SDS-PAGE 
gel.  Immunoreactive IFNT was detected using primary rabbit anti-ovine IFNT serum at a 
1:5000 dilution. Rabbit anti-ovine IFNT serum was generated by immunizing rabbits 
with recombinant ovine IFNT (344).  As a loading control, mouse anti-alpha tubulin 
(TUBA) IgG (Catalog number; T5168; Sigma, St. Louis, MO) was used.   Multiple 
exposures of each western blot were performed to ensure linearity of chemiluminescent 
signals.  Western blots were quantified by measuring the intensity of light emitted from 
correctly sized bands under ultraviolet light using a ChemiDoc EQ system and Quantity 
One software (Bio-Rad, Hercules, CA). 
 
Statistical analyses  
Results are expressed as mean ± SEM. The statistical analysis was performed by 
one-way or two-way ANOVA using SPSS 13.0 (SPSS Inc., Chicago, IL, USA).  P values 
of < 0.05 were taken to indicate significance. 
 
Results 
Effects of D-arginine on oTr cell proliferation and phosphorylaton of signal 
transduction    
To identify biological effects and availability of D-Arg in oTr  cells, cell 
proliferation assays were conducted.  It was determined that treatment of oTr cells with 
D-Arg  had no effect on oTr cell proliferation, while L-Arg  at 0.2 mM increased cell 
numbers by approximately 15-fold (P<0.001; Fig. 6.1A).  D-Arg  did not affect the 
phosphorylation status of RPS6K and RPS6 signaling molecules (Fig. 6.1B).  
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Fig. 6.1.  Analysis of oTr cell proliferation and the phosphorylation of signal transduction 
proteins in response to D-arginine (D-Arg).  A.  The oTr cells were seeded at 30% 
confluency in microwells and cultured in Arg-free customized medium containing 0, 0.05, 
0.2, 0.5 and 2 mM D-Arg which did not stimulate cell proliferation; however, oTr cells in 
medium containing 0.2 mM L-Arg had a 15-fold increase in proliferation after 96 h of 
culture.  Data are expressed as means ± SEM (n=8).   Means sharing different letters 
differ (P<0.001).  B. Monolayers of 80% confluent oTr cells were serum-starved for 24 h, 
deprived of Arg for 6 h and then treated with D-Arg at 200 µM for the indicated periods 
of time.  Treatment with D-Arg did not alter levels of phosphorylated protein compared 
to control values.   
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Fig. 6.2.  Proliferation of oTr cells in response to NO donors and putrescine.  A. NO 
donors (SNAP and DETA) increased proliferation of oTr cells.  B. Polyamines 
(putrescine) increased proliferation of oTr cells.  The oTr cells, seeded on microwells, 
were cultured in Arg-free customized medium containing either putrescine, SNAP or 
DETA at the indicated doses.  The cell numbers, determined after 96 h incubation, are 
expressed as means ± SEM (n=8) and  indicated that both NO donors and putrescine 
increased cell proliferation.  Means with  different letters differ (P<0.05).  
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Effect of NO donors and polyamine precursor on oTr cell proliferation 
To evaluate the direct effects of NO and polyamine on cell proliferation, cells 
were treated with either the NO donors, S-nitroso-N-acetyl-DL-penicillamine (SNAP) 
and diethylenetriamine NONOate (DETA) or polyamine precursor, putrescine.  Both 
SNAP and DETA enhanced proliferation of oTr cells (p<0.01); however, effects of 
DETA (10 or 50 µM) were greater than for SNAP (p< 0.01) (Fig. 6.2A).  Putrescine also 
stimulated cell oTr proliferation at 30 µM (p< 0.001) (Fig. 6.2B). 
 
 Inhibitory effects of L-NAME and nor-NOHA on oTr cell proliferation  
Treatment of oTr cells with either L-NAME or nor-NOHA resulted in a 
concentration-dependent decrease in proliferation (Fig. 6.3A and 6.3B).  In the presence 
of 200 µM nor-NOHA, proliferation was reduced to approximately 60% of values for 
cells treated only with Arg (P<0.001). The NOS inhibitor, L-NAME, also inhibited 
proliferation of oTr cells, but the effect was less than that for cells treated with 10 µM 
nor-NOHA (Fig. 6.3B).   
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Fig. 6.3.  Inhibition of Arg-induced proliferation of oTr cells by L-NAME and nor-
NOHA.  The oTr cells were seeded on microwells cultured in 0.2 mM Arg in customized 
medium with either L-NAME or nor-NOHA at the indicated doses.  Based on cell 
numbers determined after 4 days incubation and expressed as means ± SEM (n=8), both 
L-NAME and nor-NOHA decreased cell proliferation.   Means with  different letters 
differ (P<0.001). 
 
 
 
  
108
 
                   
 
 
Fig. 6.4.  Protein synthesis and protein degradation in oTr cells treated with Arg.  The 
oTr cells were cultured in Arg-free customized medium containing 0, 0.05, 0.2, 0.5 and 2 
mM Arg for 96 h and then placed in medium containing Arg.  Results, expressed as 
means ± SEM (n=8), indicated that Arg stimulated protein synthesis (Panel A) and 
inhibited protein degradation (Panel B) by oTr cells.   Means with  different letters differ 
(P<0.001). 
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Effect of arginine on protein synthesis and degradation in oTr cells 
Cell growth is regulated by a balance between protein synthesis and degradation.  
Therefore, we compared the in vitro rates of protein synthesis and degradation based on 
incorporation of [3H]-Phe for 2 h.   Arg-treated cells had a significant increase in protein 
synthesis that ranged from 5- to 8- fold higher than for control cells in medium that 
lacked Arg (Fig. 6.4A).  Furthermore, despite the short period of culture, protein 
degradation in control oTr cells was inhibited by L-Arg (Fig. 6.4B).   
 
Effect of arginine on phosphorylation of mTOR, RPS6K and 4EBP1 proteins 
Arg had no effect (P>0.10) on total MTOR, RPS6K or 4EBP1 proteins in oTr 
cells.  Compared to the control, addition of 0.05 and 0.2 mM Arg, respectively  increased 
levels (P<0.01) of p-mTOR ( 73% and 203%), p-RPS6K (201% and 207%) and  p-
4EBP1  (52% and 204%) (Fig. 6.5).   
 
Production of IFNT in response to arginine by explants cultures of ovine conceptuses  
IFNT,  a protein produced by ovine conceptus trophectoderm, is the  primary 
maternal recognition of pregnancy signal in ruminants (345).  To determine whether Arg 
stimulates synthesis of proteins by ovine conceptuses, amounts of IFNT were  quantified  
in culture medium by western blotting.  Arg (0.2 mM) increased (P<0.05) IFNT 
production and  secretion into culture medium as compared to culture medium lacking  
Arg (Fig. 6.6).  For a loading control, an equal volume of conceptus lysate was loaded 
and probed with α-tubulin.   
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Fig. 6.5.  Relative increases in phosphorylation of select proteins in the mTOR cell 
signaling pathway.  oTr cells were cultured in Arg-free customed medium containing 0, 
0.05 and 0.2 mM Arg  for 96 h.  Western blotting was used to calculate normalized 
values relative to total α-tubulin protein.  Treatment of oTr cells with Arg increased 
abundance of phosphorylated mTOR, RPS6K and 4EBP1 at 0.05 and 0.2 mM, compared 
with control values, but Arg  had no effect on total protein values for these cell signaling 
proteins.  Data are expressed as means ± SEM (n =4).  Means with  different letters differ 
(P<0.001). 
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Fig. 6.6.  The effect of Arg on synthesis and release of IFNT from explant cultures of 
ovine conceptuses.  Ovine conceptuses obtained on Day 16 of pregnancy were washed, 
dissected into equivalent pieces and placed in explant culture medium. Conceptuses were 
cultured in medium lacking Arg for 6 h and then incubated in medium containing 0.2 mM 
Arg for 18 h.  INFT production was normalized to values for amount of alpha tubulin 
(TUBA).   Arg-treated conceptuses released more IFNT than those in control medium 
(P<0.05).  Data are expressed as means ± SEM (n=4).  Means with  different letters differ 
(P<0.05). 
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Stimulation of oTr cell migration by NO  
This experiment determined if the effect of Arg on  migration oTr cells required  
NO synthesis by incubating oTr cells with  SNAP or DETA which are both NO donors.  
Both SNAP and DETA stimulated migration by 1.5- and 1.8- fold (P < 0.01) (Fig. 6.7).   
However, Arg at 200 µM was more effective than either SNAP or DETA in stimulating 
migration of oTr cells (P<0.01).  
 
Effects of arginine on phosphorylation of 4EBP1 and its cellular localization  
The 4EBP1 protein binds directly to eIF4E to inhibit complex assembly for 
translation initiation.  Phosphorylation of 4EBP1 results in its release from eIF4E to 
allow translation of mRNAs to proceed.   Arg significantly increased phosphorylation of 
RPS6K and RPS6, which are key components of the classical mTOR translation pathway 
(Figs. 6.7A, 6.7B and 6.7C).  Therefore, we investigated whether 4EBP1 is present and 
phosphorylated in oTr cells and its intra-cellular localization.  Results indicated that Arg 
increased p-4EBP1 in nuclei of oTr cells and that this phosphorylation was inhibited by 
rapamycin (Fig. 6.8), which suggests that phosphorylation of 4EBP1 occurs via the 
mTOR cell signaling pathway. 
 
Discussion 
Amino acids influence fetal-placental growth and development; therefore, 
providing adequate amounts of these nutrients to the conceptus is critical to pregnancy.  It 
has been reported that Arg supplementation ameliorated intrauterine growth restriction in 
women (346, 347) as well as enhanced fetal survival and growth in rats (201) and gilts 
(202).  Arg is required for protein synthesis and it is a precursor of many metabolically 
important molecules, including proline, ornithine, polyamines, and NO (202, 205).  
Evidence from studies of pigs and sheep indicates that increased availability of Arg in 
fetal fluids is associated with high rates of synthesis of NO and polyamines during early 
gestation when placental growth is most rapid (91, 333, 336, 337).   NO synthase is 
required for the synthesis of NO from Arg, whereas arginase catalyzes the conversion of 
Arg  to urea and to ornithine which is the principal precursor for production of 
polyamines (348).  Impaired NO and polyamine production from Arg is not only  
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Fig. 6.7.  Migration of oTr cells by NO donors.  The oTr cells were cultured in a 
transwell plate (n = three wells per treatment) and treated with either SNAP or DETA.  
Cells grown in 0.2 mM Arg containing DMEM served as a positive control.  DETA at 50 
µM was effective in stimulating oTr migration after 12 h of treatment. Data are expressed 
as means ± SEM (n=4).  a-e Means with  different letters differ (P<0.01). 
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Fig. 6.8.  Immunofluorescence localization of phosphorylated 4EBP1 protein in oTr cells.  
Phosphorylated 4EBP1 was observed in nuclei after treatment with 0.2 mM Arg, and this 
nuclear translocation was inhibited by pretreatment with rapamycin (rapa).  Rabbit IgG 
served as a negative control. 
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responsible for embryonic death and inhibition of trophoblast outgrowth, but also fetal 
defects and failure of implantation which reflect the importance of Arg-dependent 
metabolic pathways in conceptus growth and development (197, 349-351).  It has been 
reported that the mTOR cell signaling pathway is a key regulator of  metabolic actions of 
Arg (305, 306).  However, little is known about the molecular mechanisms whereby Arg  
stimulates proliferation of cells of ovine conceptuses. These studies with cultured oTr 
cells revealed that Arg stimulates the phosphorylation of proteins in the mTOR signaling 
pathway including RPS6K and RPS6 (J. Kim and F.W. Bazer, unpublished observation).  
Polyamine biosynthesis is closely related to DNA synthesis (352) and requires actions via 
a number of cellular pathways relevant for cell proliferation (204), but these molecular 
mechanism are not fully defined.  NO can activate mTOR  and increase synthesis of 
polyamines (96).  Indeed, activation of mTOR  signaling represents an important step in 
the mechanism of action of NO and polyamines (353).  A large body of evidence 
indicates that NO is involved in pregnancy through its functions as a vasodilator (327),  
an important regulator of embryogenesis (205) and trophoblast functions such as 
implantation, as well as differentiation, motility, invasion and apoptosis of cells (354-
356).  Evidence from in vivo expression of ODC1 and NOS in conceptuses and 
endometria also indicate that Arg conversion into polyamines and NO will affect 
conceptus development during the peri-implantation period (325).  Therefore, it was  
hypothesized that Arg increases production of NO and polyamines by oTr cells, and that 
these products increase mTOR  cell signaling for cell proliferation.  To our knowledge, 
results of the present study are the first to indicate that increased biosynthesis of 
polyamines and NO is induced by Arg to enhance cell signaling pathways that stimulate 
proliferation in ovine trophoblast cells.  Further, results of the present study  provide 
evidence that NO donors (SNAP and DETA) and a polyamine precursor (putrescine) 
increase proliferation of oTr cells by up to 3.8- and 6.7- fold.  This effect depends on both 
NO and polyamine biosynthesis, since effects of Arg  were reduced by 28.8% and 58.4%, 
respectively by a NOS inhibitor (L-NAME) and an arginase inhibitor (nor-NOHA).  It is 
important to note, however, that in other cell types, NO may exert antiproliferative effects 
(357, 358) as generation of NO and polyamines compete for Arg as the common 
biosynthetic substrate for NOS and ODC.   
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Cell growth and hypertrophy occurs when protein synthesis exceeds the rate of 
protein degradation (287).  In the ewe,  trophoblast elongation is initiated around 
gestational Day 11 and occurs before implantation as conceptuses dramatically transition 
from spherical to tubular and elongated filamentous forms (23).  During the process of 
elongation, size of the ovine conceptus  increases more than 500-fold (32) due to an 
increase cell number and increased rates of protein synthesis (359).  Results of the 
present study indicated that oTr cells respond to Arg with increases in protein synthesis 
and a parallel increase in cellular proliferation.   Arg also stimulated the synthesis and 
release of IFNT, which is the most abundantly synthesized and secreted protein from 
mononuclear trophectoderm cells of ruminant conceptuses (345).  This result is another 
indicator  of the stimulatory effect of Arg on protein synthesis in oTr cells.  Similarly, 
Arg increases net protein synthesis in skeletal muscle of pigs, rats, and mice (194, 360-
362), as well as intestinal cells (340).  Indeed, increased availability of Arg in the ovine 
uterine lumen (95) is correlated with the increase in endometrial expression of 
transporters for Arg  such as SLC7A2 which is induced at the  onset of blastocyst 
elongation by progesterone and further increased by trophectoderm-derived IFNT (297).  
In addition, it has been reported that mTOR inhibits protein degradation (363), which is 
consistent with the effect of Arg on oTr cells in the present study.  This effect of Arg can 
result from the activation of mTOR signaling to increase  phosphorylation of MTOR, 
RPS6K and 4EBP1 (Fig. 6.5).   
Activated mTOR phosphorylates RPS6K and 4EBP1 in vivo and in vitro (98).  
There is increasing evidence that Arg  can activate mTOR and other kinase-mediated 
signaling pathways to increase protein synthesis by increasing total and phosphosrylated 
RPS6K (364), and also increase cell migration (304, 305).  Consistent with these reports,  
results of the present study indicate that  addition of Arg to culture medium activated the 
mTOR signaling pathway partly through phosphorylation of RPS6K and 4EBP1, 
stimulation of proliferation of oTr cells through a mechanism involving NO and 
polyamines and stimulation of migration of oTr cells through a NO-dependent 
mechanism.  
Besides regulation of translation, mTOR has been reported  to shuttle between the 
nucleus  and cytoplasm for regulation of ribosome biogenesis, macroautophagy or 
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transcription (100, 365-367).  We previously demonstrated that the abundance of  p-
mTOR and p-RPS6K increased in nuclei of  conceptus trophectoderm and endoderm (111, 
268).  Therefore it was important to investigate the intracellular localization of 4EBP1 in 
the present study.  Results indicated that p-4EBP1 is present in the nuclei of Arg-treated 
oTr cells and that this effect was  abrogated by rapamycin.  The presence of p-4EBP1 in 
both  the cytoplasm and in the nucleus has been  observed in our laboratory and by others 
(368-370).  While the significance of  4EBP1 in the nucleus  is not known,  its target 
protein, eIF4E, has been reported to function  as a nuclear regulator of the export of a 
wide variety of RNAs involved in proliferation and  growth of cells (237).  In the future 
we will investigate the functional significance of nuclear translocation of p-4EBP1.   
In conclusion, Arg added to culture medium at physiological concentrations 
stimulated proliferation and migration in oTr cells through mechanisms mediated by NO 
and polyamine synthesis, increased protein synthesis and reduced protein degradation.  
These effects of Arg, mediated via the mTOR cell signaling pathway, provide important 
insights for beneficial effects of dietary supplementation with Arg to improve fetal-
placental growth and development, as well as survival and growth of offspring during the 
neonatal period.   
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CHAPTER VII 
DIFFERENTIAL EFFECTS OF ARGININE, LEUCINE, GLUTAMINE AND 
GLUCOSE ON EXPRESSION OF INTERFERON TAU, ORINITHINE 
DECARBOXYLASE AND NITRIC OXIDE SYNTHASE BY EXPLANT 
CULTURES OF OVINE CONCEPTUSES FROM DAY 16 OF PREGNANCY 
 
Introduction 
In sheep, blastocysts undergo morphological transitions from spherical to tubular 
and then elongated filamentous forms that develop into conceptuses (embryo/fetus and its 
associated extra-embryonic membranes) during the peri-implantation period of pregnancy 
(4, 41).  During the peri-implantation period, elongation of ovine conceptuses is 
dependent on uterine secretions, referred to as histotroph, which is a complex mixture 
that includes growth factors, hormones, cytokines, ions, lipids, glucose and amino acids 
(1, 3).  Studies of the uterine gland knockout ewe (UGKO) indicated that secretions from 
the  GE are required for conceptus survival and elongation of trophectoderm as 
conceptuses were  unable to elongate in the absence  of uterine glands  (5, 6, 63, 68).  
Among the components of histotroph are nutrients   required for energy, metabolism and 
cell signaling.  Growing evidence suggests that the amino acids and glucose have  a role 
as activators of protein synthesis in cells and tissues; however, only recently have their 
roles in modulating intracellular signal transduction pathways been described (371).   
Amino acids are not only cell signaling molecules (119, 205, 287), but also major 
energy sources for fetal-placental growth (201, 202, 215, 292), regulators of gene 
expression and stimulators of the protein phosphorylation cascade.  Additionally, amino 
acids are key molecules in synthesis of  hormones  (290, 291) and nitrogenous substances 
that each has enormous biological importance (287-289).  Of  particular interests is 
arginine (Arg) which is a common substrate for production of NO (nitric oxide) and 
polyamines  via NO synthase (NOS) and ornithine decarboxylase (ODC1) (372).  After 
implantation, NO plays  important roles to regulate placental angiogenesis (293) and 
placental-fetal blood flows to increase  the transfer of nutrients and oxygen from mother 
to fetus (294, 295).  In mouse trophoblast, NO generated by iNOS and eNOS stimulate 
trophectoderm motility by inducing cGMP and modifying the  ECM.  In ovine 
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placentomes, increases in NOS2 (inducible) and NOS3 (endothelial) activities (333) 
stimulate placental NO synthesis, which is closely associated with increases in placental 
vascular growth and utero-placental blood flow in ewes during pregnancy (350).  In NOS 
activity, guanosine triphosphate cyclohydrolase (GCH1) is a rate-limiting enzyme in the 
production of  tetrahydrobiopterin (BH4), which is an essential cofactor for all isoforms 
of NOS (373).  The polyamines also are essential for placental development and 
mammalian embryogenesis (296).  Indeed, polyamines are required for DNA and protein 
synthesis and, therefore, cell proliferation and differentiation (Flynn et al., 2002 
Regulation of mTOR signaling by leucine (Leu)  has been studied extensively in rodents 
(374, 375) and in humans (376).  Further, Arg and Leu ae  required for trophectoderm 
outgrowth and blastocyst motility in mice (22, 96).  Glucose and glutamine (Gln) are 
major nutrients for conceptuses as they enhance trophoblast cell proliferation by 
activating the glutamine-fructose-6-phosphate-amidotransferase (GFAT)-mediated  target 
of rapamycin (mTOR, formerly FRAP1) cell signaling pathway (21).   
The nutrient-induced stimulation of protein synthesis is mediated by mTOR 
signaling (377) that  integrates amino acid availability, cellular energy status, and 
endocrine signals to regulate protein synthesis through control of the phosphorylation 
status and, therefore, state of activation of eukaryotic initiation factor 4E (eIF4E)-binding 
protein-1 (4E-BP1) and ribosomal protein S6 kinase-1 (RPS6K1).  Phosphorylation of 
repressor protein, 4E-BP1, results in its dissociation from eIF4E, allowing it to bind to 
eIF4G to form complexes that mediate binding of mRNA to the 40S ribosomal complex 
in the initiation of mRNA translation (255).  Phosphorylation of RPS6K1 leads to 
activation of several components of the protein translation apparatus (378). 
The purpose of the present study was to determine the differential effects of Arg, 
Leu, Gln and glucose on  expression of total and phosphorylated forms of protein in the 
mTOR cell signaling pathway as well as translatoin of mRNAs for key  molecules 
associated with conceptus development such as NOSs, ODC, GCH1 and IFNT.  To 
investigate the direct effects of nutrients on proteins synthesis, the experiments were 
conducted by using explants cultures of conceptuses immediately after recovery from 
uteri of  Day 16 pregnant ewes. 
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Materials and Methods 
Preparation of ovine conceptuses 
Using procedures described previously (342, 343),  conceptuses from Day 16 
pregnant ewes (coincident with maximal production of IFNT by the conceptuses) were 
recovered by flushing each uterine horn with 20 ml customized medium (90) containing 
approximately one-tenth the amount of each amino acid and glucose present in  fully 
supplemented culture medium.  The conceptuses were starved for 6 in customized 
medium (i.e.,  lacking the select nutrient of interest).  For example, Arg-free medium was 
used initially for the Arg  treatment group.  Then conceptuses were cultured in 0.2 mM 
Arg , 0.2 mM Leu , 0.5 mM Gln  or 4 mM glucose for 18 h at 37°C on a rocking platform  
under an atmosphere of  50% O2, 45% N2, and 5% CO2.  After incubation, the 
conceptuses were homogenized, the homogenate assayed for protein and then stored at -
80°C until analyzed.  
 
RNA isolation 
Total cellular RNA was isolated from cultured conceptuses using TRIzol reagent 
(Life Technologies, Inc.-BRL, Bethesda, MD) according to manufacturer’s 
recommendations. The quantity and quality of total RNA were determined by 
spectrometry and denaturing agarose gel electrophoresis, respectively. 
 
Cloning of partial cDNAs for ovine conceptus mTOR, RPS6K, RPS6, 4EBP1, NOSs, 
GCH1, IFNT and ODC1 
Partial cDNAs for ovine mTOR, RPS6K, RPS6, 4EBP1, NOSs, GCH1, IFNT and 
ODC1 mRNAs were amplified by RT-PCR using total RNA from conceptuses and  
previously described primers (111, 158, 268, 325) and methods as described previously 
(158).  The partial cDNAs of the correct predicted size were cloned into pCRII using a 
T/A Cloning Kit (Invitrogen Corp., Carlsbad, CA), and the sequence of each was verified 
using an ABI PRISM Dye Terminator Cycle Sequencing Kit and ABI PRISM automated 
DNA sequencer (PerkinElmer Applied Biosystems, Foster City, CA).  
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Western blot analysis   
Whole conceptus extracts and immunoblot assays were prepared and performed 
as described previously (234, 268) .  To harvest total cellular protein for western blot 
analyses, conceptuses were rinsed with cold PBS and lysed by homogenization in lysis 
buffer (1% Triton X-100, 0.5% Nonidet P-40, 150 mM NaCl, 10 mM Tris, 1 mM EDTA, 
1 mM EGTA, 0.2 mM Na3VO4, 0.2 mM phenylmethylsulfonylfluoride, 50 mM NaF, 30 
mM Na4P2O7, 1 µg/ml leupeptin, and 1 µg/ml pepstatin) for 30 min at 4°C.  Cell lysates 
were clarified by centrifugation (16,000 x g, 15 min, 4°C).  The protein content was 
determined using the Bradford protein assay (Bio-Rad, Hercules, CA) with bovine serum 
albumin (BSA) as the standard.  Proteins were denatured, separated using SDS-PAGE, 
transferred to nitrocellulose and western blotting performed as described previously (268) 
using enhanced chemiluminescence detection (SuperSignal West Pico, Pierce, Rockford, 
IL) and X-OMAT AR X-ray film (Kodak, Rochester, NY) according to manufacturer’s 
recommendations.  All antibodies for mTOR signaling molecules including RPS6K, 
RPS6 and 4EBP1 were purchased from Cell Signaling Technology (Danvers, MA).  
Immunoreactive proteins were detected by using rabbit anti-mouse polyclonal phospho-
mTOR IgG (Catalog numbers 2971) at a dilution of 1:1,000 and mTOR IgG (Catalog 
numbers 2972) at a dilution of 1:2,000.  Following separaton of proteins on 10% SDS-
PAGE gels the following antisera were used at the noted dilutions: rabbit anti-human 
polyclonal phospho-RPS6K IgG (Thr421/Ser424) (Catalog number 9204;  dilution of 
1:1,000) RPS6K IgG (Catalog number 9202; dilution of 1:2,000); , rabbit anti-human 
polyclonal phospho-4EBP1 IgG (Thr37/46) (Catalog number 2855;   1:1,000 dilution);  
4EBP1 IgG (Catalog numbers 9452;   1:1,000 dilution);  rabbit anti-human polyclonal 
phospho-RPS6 IgG (Catalog number 2215;   1:1,000 dilution);  RPS6 IgG (Catalog 
numbers 2972;   1:2,000 dilution);   mouse anti-NOS3 polyclonal IgG (catalog no. 
610297; BD Transduction Laboratories. 1 µg/ml), purified rabbit anti-rat GCH1 
polyclonal IgG (produced by Drs. C. J. Meininger and G. Wu, Texas A&M University, 
College Station, TX; catalog no. 89980,  Thermo Scientific, 2 µg/ml) and purified  rabbit 
anti-ODC1 polyclonal IgG (catalog no. HPA001536; Atlas Antibodies AB, Stockholm, 
Sweden, 0.5 µg/ml) at final concentrations of 2 µg/ml, 2 µg/ml, 1 µg/ml, 2 µg/ml, 2 
µg/ml, and 0.5 µg/ml, respectively (325).  As a loading control, western blotting with 
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mouse anti-alpha tubulin (TUBA) IgG (Catalog number; T5168; Sigma, St. Louis, MO) 
was performed.  Multiple exposures of each western blot were conducted to ensure 
linearity of chemiluminescent signals.  Western blots were quantified by measuring the 
intensity of light emitted from correctly sized bands under ultraviolet light using a 
ChemiDoc EQ system and Quantity One software (Bio-Rad, Hercules, CA).  
 
Statistical analyses  
All quantitative data were subjected to least squares analyses of variance (301) 
using the General Linear Models (GLM) procedures of the Statistical Analysis System 
(SAS Institute, Cary, NC).  Western blot data were corrected for differences in sample 
loading using the TUBA data as a covariate.  All tests of significance were performed 
using the appropriate error terms according to the expectation of the mean squares for 
error.  A P-value ≤ 0.05 was considered significant.  Data are presented as least-square 
means (LSM) with standard errors (SE). 
 
Results 
Regulation of mTOR, RPS6K, RPS6 and 4EBP1 mRNAs by arginine, leucine, 
glutamine and glucose  
To determine whether Arg, Leu, Gln and glucose increase the expression of genes 
of the mTOR pathway associated with conceptus development, we performed RT-PCR 
using specific primers for mTOR, RPS6K, RPS6 and 4EBP1 mRNAs and  found 
constitutive expression of these genes in untreated and treated conceptuses, but there was 
no effect of addition of  Arg, Leu, Gln or  glucose on expression of any of those  mRNAs 
(Fig. 7.1).    
 
Regulation of NOSs, ODC, GCH1 and IFNT mRNAs by arginine, leucine, glutamine 
and glucose 
The expression of mRNAs for  NOS2 (inducible), NOS3 (endothelial), ODC, 
GCH1 and IFNT was evaluated by RT-PCR (Fig.7.2).   Effects of Arg, Leu, Gln and 
glucose on expression of these genes in explant cultures of ovine conceptuses were not 
detected.    
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Fig. 7.1. Expression of mTOR, RPS6K, 4E-BP and RPS6 transcripts in response to 
arginine (Arg), leucine (Leu), glutamine (Gln) and glucose (Gluc) in ovine conceptuses 
evaluated by RT-PCR.  Conceptuses were isolated from Day 16 pregnant ewes, washed 
with customized medium, starved in selected nutrient free medium (e.g., Arg free 
medium for Arg treatment group) and then treated with either 0.2 mM Arg, 0.2 mM Leu, 
0.5 mM Gln or  4 mM glucose.   Following incubation, total cellular RNA was isolated, 
the quantity and quality of total RNA were determined, and control gene β-actin were run 
on 1% agarose gels. 
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Fig. 7.2. Expression of NOS2, NOS3, ODC1, GCH1 and IFNT transcripts in response to 
arginine (Arg), leucine (Leu), glutamine (Gln) and glucose (Gluc) in ovine conceptuses 
evaluated by RT-PCR.  Conceptuses were isolated from Day 16 pregnant ewes, washed 
with customized medium, starved in selected nutrient free medium (e.g., Arg free 
medium for Arg treatment group) and then treated with either 0.2 mM Arg, 0.2 mM Leu, 
0.5 mM Gln or  4 mM glucose.   Following incubation, total cellular RNA was isolated, 
the quantity and quality of total RNA were determined, and control gene β-actin were run 
on 1% agarose gel. 
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However, Arg treated conceptuses expressed increased amounts of GCH1 mRNA  
compared to untreated conceptuses . 
 
Effects of arginine, leucine, glutamine and glucose on mTOR, RPS6K, RPS6 and 
4EBP1 proteins 
The effects of Arg, Leu, Gln and glucose on the relative protein levels for both 
total and phoshporylated forms of mTOR, RPS6K, 4EBP1 and RPS6 were determined by 
western blotting.  Compared with the control  explants cultures of conceptuses, Arg 
increased levels of total mTOR and RPS6K by 2.4- and 2.3- (P< 0.01) fold while Leu 
increased mTOR and RPS6K by 2.0- and 1.9- (P< 0.01) fold  The effects of Arg and Leu 
on phosphorylation of mTOR and RPS6K  were similarly significant.   The abundance of 
total mTOR and RPS6K proteins was increased  2.4- and 2.4- (P<0.01) fold by glucose 
as was the abundance of  phophorylated mTOR and RPS6K (P<0.01).  In conceptuses 
treated with Gln, total mTOR, RPS6K and p-RPS6K were increased by 1.8-, 1.9- and 2.0- 
(P<0.01) fold, but the increase in  p-mTOR was not significant  (Fig. 7.3A).  
Western blot analyses of conceptus extracts with antibodies to total RPS6 and 
4EBP1 proteins indicated  that Arg increased total RPS6 and 4EBP1 by 3.1- and  3.2- 
(P< 0.05) fold, while Leu increased their abundance by 2.0- and 2.2- (P< 0.01) fold.  The 
addition of Arg to culture medium increased protein levels of phosphorylated forms of 
RPS6 and 4EBP1 by 3.2- and 4.9- (P< 0.05) fold.  Leu increased the levels of 
phorphorylated form of RPS6 and 4EBP1 by 2.1- and 2.3- fold (P< 0.01).  The levels of 
total RPS6 and 4EBP1 proteins were increased by 2.2- and 2.3- (P<0. 01) fold by Gln 
and the effects of Gln on phophorylated RPS6 and 4EP1 were  similar.   Treatment of 
conceptuses with glucose increased total RPS6 and 4EBP1 by 3.3- (P<0.05) and 2.3- 
(P<0.01) fold, and  phosphorylated RPS6 and 4EBP by 2.9- (P<0.01) and 4.9- P<0.05) 
fold (Fig. 7.3B).  
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Fig. 7.3. Relative increases in total and phosphorylated mTOR, RPS6K, 4E-BP and RPS6 
proteins by arginine (Arg), leucine (Leu), glutamine (Gln) and glucose (Gluc). 
Conceptuses were isolated from Day 16 pregnant ewes, washed with customized medium, 
starved in selected nutrient free medium (e.g., Arg free medium for Arg treatment  group) 
and then treated with either 0.2 mM Arg, 0.2 mM Leu, 0.5 mM Gln or  4 mM glucose.   
Following incubation, total proteins were extracted, assayed and subjected to SDS-PAGE 
gel for analysis.  Western blotting images are of representative results.   
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Fig. 7.3 continued. 
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Effects of arginine, leucine, glutamine and glucose on NOS2, NOS3, ODC1, GCH1 
and IFNT proteins  
To investigate the effects of Arg, Leu, Gln and glucose on protein synthesis, 
conceptus proteins were evaluated using SDS-PAGE and immunoblotting  with 
antibodies against NOS2, NOS3, ODC1 and GCH1 proteins (Fig. 7.4).  In response to 
Leu, Gln and glucose, there was no effect on abundance of IFNT.  However, Arg 
stimulated IFNT synthesis by 2.3- (P< 0.01) fold compared with controls.  In addition, 
Arg stimulated synthesis of  ODC1, NOS2 and NOS3 by 2.0-, 2.1- and 2.3 fold (P<0.01).  
For  conceptuses treated with Leu and Gln, expression of ODC1 and NOS2 were not 
increased, but abundance of NOS3 was increased 2.0-fold (P<0.01) by Gln.  GCH1 
abundance was increased by Arg and glucose, 2.2- and 2.1-(P< 0.01) fold, respectively, 
whereas Leu and Gln had no effect on abundance of GCH1.  
 
Discussion 
The availability of nutrients in the uterine lumen determine conceptus survival 
and, growth and development during the critical peri-implantation period of pregnancy in 
mammals (1, 63).  Available evidence suggests that nutritional deficiencies during early 
pregnancy lead to a poorer outcome of pregnancy (1, 21, 63, 213), as well as have an 
adverse impact on  postnatal growth and health (119).  Mammalian target of rapamycin 
(mTOR) responds to alterations in amino acid and glucose availability and controls 
transcription and translation of proteins associated to cell proliferation and growth (22, 
Wen, 2005 #1237, 374).  The RNAs and proteins in the mTOR pathway are expressed in  
ovine conceptus endoderm and trophoblast (111); however, the nutritional factors 
affecting protein translation in the ovine conceptus, and the molecular mechanisms 
mediating their effects, are not  known.  The present study was to assess the role of 
mTOR cell signaling pathway in the regulation of synthesis of  IFNT, NOS, ODC and 
GCH1 proteins by select nutrients. 
In both yeast and mammals, mTOR regulates transcription, as well as rRNA 
processing and mRNA translation. Inhibition of the mTOR pathway with rapamycin or 
by nutrient starvation results in a down-regulation of transcription of mRNAs (379, 380), 
tRNA, and rRNA (381, 382).  Therefore, the present study  first determined whether Arg, 
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Fig. 7.4.  Relative  increases in NOS2, NOS3, ODC1, GCH1 and IFNT proteins in 
response to  arginine (Arg), leucine (Leu), glutamine (Gln) and glucose (Gluc).   
Conceptuses were isolated from Day 16 pregnant ewes, washed with customized medium, 
starved in selected nutrient free medium (e.g., Arg free medium for Arg treatment group) 
and then treated with either 0.2 mM Arg, 0.2 mM Leu, 0.5 mM Gln or  4 mM glucose.   
Following incubation, total proteins were extracted, assayed and subjected to SDS-PAGE 
gel for analysis. Western blotting images are of representative results.   
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Leu, Gln and glucose  induced gene expression in vitro in explant cultures of ovine 
conceputuses from Day 16 of pregnancy.  Results from present study showed that these 
amino acids and glucose did not induce gene transcription, except that Arg increased 
expression of GCH1 mRNA.  Although this increase of GCH1 mRNA was not confirmed 
quantitatively, it is likely that Arg affects GCH1 gene transcription since GCH1 mRNA is 
very abundant in ovine conceptuses during the peri-implantation period of pregnancy 
(325).   GCH1 is the key enzyme for synthesis of BH4 (tetrahydrobiopterin), an essential 
cofactor for NOS activity (383), so increased GCH1 expression would  stimulate NO 
synthesis through increased activity of isoforms of NOS.  This hypothesis could explain 
the “arginine paradox” which has been used to refer to the dependence of cellular NO 
production on exogenous Arg administration despite the theoretical saturation of NOS 
enzymes with intracellular Arg.  To identify this mechanism, further investigation is 
needed to determine if Arg-stimulates  transcription of GCH1 gene(s) and whether GCH1 
expression supports cell growth by increasing NOS activity.   
We next  examined  expression of proteins by Arg, Leu, Gln  and glucose and 
found that that these select nutrients increased phosphorylation of mTOR and that this 
change was associated with increased abundance of key proteins in the mTOR pathway .  
This effect may also reflect a decrease in the amount of degradation of proteins (194, 
361).  Additionally, Arg, Leu, and Gln stimulated the phosphorylation of RPS6K, RPS6 
and 4EBP1 which is consistent with  reports of increases in protein synthesis and 
translational efficiency in cells (304, 340, 384, 385).  Results of the present study extend 
the  original observation that Arg and Leu stimulate phosphorylation of proteins of the 
mTOR signaling pathway in ovine conceptuses (unpublished data).  Although we 
previously showed that addition Gln to culture medium failed to change the levels of 
phosphorylated  proteins in the mTOR cell signaling pathway in trophoblast cells, Gln  
did increase protein synthesis in explants cultures of Day 16 ovine conceptuses in the 
present study.  These differential effects of Gln  on ovine trophectoderm cells versus the 
explants cultures  of ovine conceptus trophoblast  may indicate differential effects on  cell 
type, cell activity and presence of extra-embryonic endoderm which has an intense level 
of metabolism and energy consumption that may change uptake of Gln and its possible 
use as an energy source to compliment that of  glucose metabolism (386).  This finding of 
  
131
differential effects of  Arg and Leu versus Gln  may be particularly noteworthy because 
mTOR represents a bifurcation point for distal parallel signaling pathways, leading to the 
phosphorylation of 4E-BP1 and RPS6K, and it also appears to represent a signal 
integration center for the stimulatory effects of growth factors and nutrients including 
glucose on cellular functions (99, 387, 388).   
Glucose is the primary energy source for embryos/conceptuses and its availability 
for oxidation and glycolysis increases between Days 13 and 19 of pregnancy (389, 390), 
which is coincident with the rapid elongation period to form filamentous conceptuses 
(63).  Metabolism of glucose through  glycolysis and the pentose cycle generates ATP 
and NADPH required for production of NO for oxidative defense and ribose-5-phosphate 
for nucleotide synthesis.  Glucose stimulates RPS6K via the mTOR kinase, which 
functions as an ATP sensor (391) and also is a mitogen for trophoblast cell growth and 
proliferation through the GFAT-mediated mTOR cell signaling pathway (21).    
In the present study, glucose alone increased mTOR phosphorylation and its 
downstream effectors, RPS6K and 4EBP1.  These results are consistent with those  
reported for  muscle cells (392), in which glucose activates phosphorylation of RPS6K.  
Similarly, the administration of glucose increases mucosal and muscle protein synthesis 
(393, 394) and such increases result because of the enhanced rate of protein initiation 
rather than the elongation step in translation. The accelerated rate of protein synthesis in 
response to glucose is concomitant with increases in  amounts of inactive 4EBP1 and  
increased phosphorylation and activation of RPS6K and RPS6 (392).  
Further, we examined the ability of Arg, Leu, Gln and glucose to increase  
abundance of NOS2, NOS3, ODC, GCH1 and IFNT proteins in explants cultures of 
ovine conceptuses because molecules that stimulate mTOR activity in trophectoderm can 
stimulate translation of mRNAs critical to conceptus development, including ODC and 
NOS (22, 114).  Results of the present study provide the initial evidence that  amino acids 
and glucose affect  expression of NOS3, GCH1, and ODC1 on ovine conceptuses and 
that the effects are likely  mediated through increased phosphorylation and activation 
S6K1 and 4EBP1.  Indeed, expression of NOSs and ODC1 proteins is essential for 
conceptus development since Arg is the substrate for  producing NO and polyamines via 
arginase and ODC1, as well as  stimulating  intracellular signaling, cell proliferation, and 
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protein synthesis (197, 395).  It is also important to note that expression of GCH1 protein 
is essential for BH4 production and NOS activity.   Previous work indicated that GCH1 
activity is correlated positively with NO production in ovine placentae and uterine 
endometria between Days 30 and 140 of pregnancy (333), an  effect  greatly influenced 
by changes in BH4 availability (383).  Available evidence indicates that  expression of 
GCH1 protein and mRNA may be differently regulated at transcriptional and 
translational levels (383).  An important finding in the present study was that the Arg is  
most effective in stimulating protein  synthesis, mTOR signaling, IFNT synthesis and 
abundance of essential components of the mTOR pathway, as well as a potent stimulator 
of  of cell proliferation and cell migration.  
In conclusion, Arg, Leu, Gln and glucose differentially increase NOS2, NOS3, 
ODC1, GCH1 and IFNT by explants cultures of Day 16 ovine conceptuses.  This effect 
was associated with increased abundance of  phosphorylated and activated mTOR, 
RPS6K, and RPS6, as well as  inactivation of 4EBP1.  These results provide important 
evidence that availability of select nutrients can  increase  expression of cell signaling 
molecules and affect conceptus growth, development, and survival through stimulation of 
protein synthesis during the peri-implantation period of pregnancy. 
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CHAPTER VIII 
SUMMARY AND CONCLUSIONS 
 
Summary 
Histotroph, secretions from uterine epithelia and selective transport of molecules 
from maternal serum, is required for conceptus elongation and development as well as 
successful pregnancy.  The results from UGKO ewes revealed a requirement for 
secretions from LE and GE to support conceptus development beyond Day 14 (5, 6).  
Despite the importance of secreted factors from the endometrium, little is known about 
functions and mechanism of histotroph on conceptus.  The present  research focused on  
elucidating  the mechanisms whereby  components of histotroph including IGF2 (growth 
factor), SPP1 (cell matrix protein), amino acids and glucose (nutrients) affect the mTOR 
signaling pathway, and to determine the functional roles of these selected components of 
histotroph using ovine trophectoderm (oTr) cells and explants cultures of Day 16 ovine 
conceptuses to gain insight into how they may affect survival and development of ovine 
conceptuses.     
IGF2, a potent stimulator of cellular proliferation, differentiation, and 
development, regulates uterine functions and conceptus growth in several species;  
however, the expression pattern of IGF2 in peri-implantation ovine conceptuses and its 
mechanism of action was not well defined.  Therefore, experiments outlined in Chapter 
III  determined temporal and cell speicific changes in expression of IGF2 in uterine 
endometria of cyclic (Days 10-16) and early pregnant (Days 10-20) ewes,  as well as in 
peri-implantation conceptuses (Days 13-20 of gestation) from  ewes.  In situ 
hybridization analyses found that IGF2 mRNA was most abundant in the caruncular 
endometrial stroma of both cyclic  and pregnant ewes. In the intercaruncular 
endometrium, IGF2 mRNA transitioned from stroma to luminal epithelium (LE) between 
Days  14 and 20 of pregnancy. IGF2 mRNA was present in all cells of the conceptus, but 
was particularly abundant in the primitive endoderm and yolk sac.  To understand the 
mechanisms by which IGF2 plays a critical role in conceptus survival and development, 
we investigated the cell signaling pathway and its functional consequence on ovine 
trophectoderm cells.  In oTr  cells isolated from Day 15 conceptuses, IGF2 increased the 
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abundance of p-PDK1, p-AKT1, p-GSK3B, mTOR/FRAP1, and p-RPS6K protein within 
15 min, and the increase was maintained for 90 min.  IGF2 also elicited a rapid increase 
in p-ERK1/2 and p-P38 MAPK proteins that was maximal at 15 or 30 min post-treatment.  
Moreover, IGF2 increased migration of oTr  cells. Collectively, these results support the 
hypothesis that IGF2 coordinately activates multiple cell signaling pathways critical to 
survival, growth, and differentiation of the ovine conceptus during early pregnancy. 
Attachment and migration of trophectoderm cells, hallmarks of blastocyst 
implantation in mammals, are unique uterine events.  Secreted phosphoprotein 1 (SPP1) 
in the uterus binds integrins on conceptus trophectoderm  and uterine LE, affecting cell-
cell and cell-matrix interactions.  The signal transduction pathways activated by SPP1 
and integrins in conceptuses have not been elucidated.  Results of this study demonstrated 
that SPP1 binds αvβ3 and α5β1 integrins to induce focal adhesion assembly, a 
prerequisite for adhesion and migration of trophectoderm, through activation of: 1) 
P70S6K via crosstalk between FRAP1/MTOR and MAPK pathways; 2) MTOR, PI3K, 
ERK1/2 and P38 MAPK signaling to stimulate oTr cell migration; and 3) focal adhesion 
assembly and myosin II motor activity to induce migration of oTr cells.  These cell 
signaling pathways, acting in concert, mediate adhesion, migration and cytoskeletal 
remodeling of oTr cells essential for expansion and elongation of conceptuses and 
attachment to uterine LE for implantation. 
Histotroph is required for survival and development of ovine conceptuses 
(embryo and extra-embryonic membranes).  Results from our laboratory indicate that 
arginine (Arg), leucine (Leu), glutamine (Gln) and glucose increase in the uterine lumen 
between Days 10 and 15 of pregnancy, coincident with increases in expression of amino 
acid and glucose transporters by uterine epithelia, as well as trophectoderm and yolk sac 
of  conceptuses.  Therefore, we hypothesized that Arg, Leu, Gln and glucose have 
differential effects on hypertrophy, hyperplasia and differentiated functions of cells 
critical to ovine conceptus development.  Primary oTr cells isolated from Day 15 
conceptuses were serum-starved for 24h in a customized medium, deprived of select 
nutrients and then treated with either Arg, Leu, Gln or glucose.  Western blot analyses of 
whole oTr cell extracts showed that Arg, Leu and glucose, but not Gln, increased  
phosphorylated AKT1 (pAKT1)  2.8- , 2.5- and 1.8- fold, respectively, within 15 min and 
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the increase was maintained to  60 min.  Arg, Leu and glucose also stimulated 4.2-, 4.7-, 
and 2.3-fold increases in phosphorylated RPS6K within 15 min, as well as increases in 
pRPS6 protein between 0 and 30 min post-treatment that were sustained to 60 min.  
When oTr cells were treated with Arg, phosphorylated RPS6K proteins increased in 
nuclei, but remained low in nuclei of cells treated with Leu and glucose.  
Immunocytochemical analyses also revealed abundant amounts of phosphorylated RPS6 
proteins in the cytoplasm of oTr cells treated with Arg, Leu and glucose.  Further, Arg 
and Leu increased (P<0.001) proliferation and migration of oTr cells.  Collectively, these 
results indicate that Arg, Leu and glucose, but not Gln, in histotroph coordinately activate 
AKT1-MTOR and RPS6K-RPS6 signaling pathways to stimulate hypertrophy, 
hyperplasia, and/or migration of conceptus trophectoderm. 
During the peri-implantation period in sheep, L-arginine (Arg) in the uterine 
lumen is an essential substrate for synthesis of nitric oxide and polyamines required for 
survival and development of ovine conceptuses.  The hypothesis that Arg stimulates 
hypertrophy, hyperplasia and differentiation of  ovine conceptus trophectoderm is 
supported by results from our laboratory indicating significant increases in Arg 
availability in the uterine lumen between Days 10 and 15 of pregnancy, expression of 
cationic amino acid transporters by uterine epithelia and conceptuses, and abundant 
ornithine decarboxylase (ODC) and nitric oxide synthase (NOS) expression by oTr cells.  
It was also found  that Arg activates the mTOR/FRAP1 and the RPS6K cell signaling 
pathway.  Therefore, this study examined effects of Arg on signal transduction, and the 
effects of Arg and the NO donors, SNAP and DETA, or putrescine (precursor for 
spermidine and spermine) on oTr cell proliferation.  Further, the inhibition of these 
effects by L-NAME (an inhibitor of NOS) and Nor-NOHA (an inhibitor of arginase) was 
assessed.  Arg treatment increased relative protein levels for p-MTOR, p-RPS6K and p-
4EBP1.  Consistent with activation of these signaling pathways, Arg increased protein 
synthesis and reduced protein degradation in oTr cells.  Both NO and polyamines 
enhanced cell proliferation in a dose-dependent manner.  The effects of Arg were 
partially inhibited by both L-NAME and Nor-NOHA.  These results indicate that Arg 
enhances production of polyamines and NO and activates the MTOR/FRAP1-RPS6K-
RPS6 signaling pathway to stimulate proliferation of oTr. 
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 Nutrients are a primary requirement to stimulate  protein synthesis, and 
development of ovine conceptuses.  It was shown Arg, Leu, and glucose stimulate protein 
synthesis through the phosphorylation of mTOR signaling molecules, thereby leading to 
an increase in cell proliferation in trophoblast cells.  However, Gln did not elicit those  
responses.   Therefore, one  study aimed to  clarify  whether Arg, Leu, Gln and glucose 
exposure  influenced  gene expression and protein synthesis in explants cultures of 
conceptuses from Day 16 of pregnancy.    The ovine conceptuses isolated from Day 16 
pregnant ewes were deprived of select nutrients and then cultured with either Arg, Leu, 
Gln or glucose.  After incubation for 18 h, the levels of mRNA and protein for mTOR, 
RPS6K, 4EBP1 and RPS6 were analyzed by using RT-PCR and immunoblot analysis.  
Further, the expression of mRNAs and proteins for NOS, ODC1, GCH1 and IFNT were  
evaluated in conceptus tissue.  Expression of  mTOR, RPS6K, 4EBP1 and RPS6 mRNAs  
was not different between  untreated and treated conceptuses.  ODC1, NOS, and IFNT 
mRNAs were  detectable, but there was no significant difference among the Arg, Leu, 
Gln and glucose treated and control  group.  Interestingly, GCH1 mRNA levels increased 
in Arg-treated explants cultures of ovine conceptuses. Western blot analyses of conceptus 
extracts showed that Arg, Leu, Gln and glucose did increase phosphorylation of mTOR, 
RPS6K, 4EBP1 and RPS6, and that these increases were  reflected by increased levels of 
total protein.   Protein analyses also revealed that Arg and glucose were  most effective in  
increasing  the amounts of ODC1, NOS2 and GCH1 wherease Leu and Gln fail to 
increase  synthesis of  ODC1 and NOS proteins.  Importantly, only conceptuses treated 
with Arg significantly increase IFNT synthesis.  These findings suggest that Arg, Leu, 
Gln and glucose differentially regulate protein synthesis and that these effects are 
regulated through phoshphorylation and activation of the mTOR cell signaling pathway.    
 
Conclusions 
 In conclusion, results from the present studies provided the basis for a model 
whereby nutrients, SPP1 and IGF2 likely affect conceptus development. First, results of 
these studies provide strong evidence for SPP1-induced integrin-mediated force-
generated migration and cell adhesion mechanisms in Tr cells utilizing mTOR, MAPK14 
(p38), MAPK1/MAPK3 (Erk1/2), as well as a novel link between p38 and mTOR 
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signaling pathways (see Figs. 3.8 and 4.7A).  Second, as shown in this model (see Fig. 
4.7B), results of this study indicate that: 1) SPP1 serves as a key adhesive ECM protein 
that mediates Tr cell attachment, focal adhesion formation and reorganization of the 
cytoskeleton necessary for cell migration and attachment to uterine LE; 2) IGF2 and 
SPP1 activate PI3K and MAPK signaling pathways to affect Tr migration necessary for 
cellular and tissue reorganization during conceptus elongation (268); and 3) Arg induces  
proliferation of Tr cells required for conceptus development in sheep as has been reported 
for mice (22, 96).  Collectively, SPP1, IGF2 and arginine activate mTOR signaling 
pathways mediated by AKT1, TSC1/2 and mTORC1 (cell proliferation and mRNA 
translation), as well as mTORC2 (cell migration, cell survival and cytoskeletal 
organization) in Tr cells to allow conceptuses to make the critical transition from 
spherical to tubular and filamentous forms that is a prerequisite for signaling pregnancy 
recognition, implantation and placentation required for successful pregnancy outcomes in 
all mammals. 
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